Molecule;Standard Type;Standard Relation;Standard Value;Standard Units;pChEMBL Value;Comment;Compound Key;Assay;Assay Description;BAO Format;Target;Target Pref. Name;Target Organism;Target Type;Document;Source;Max Phase;#Ro5 Violations;Molecular Weight;Ligand Efficiency BEI;Ligand Efficiency LE;Ligand Efficiency LLE;Ligand Efficiency SEI;ALogP;Assay Organism;Assay Tissue ChEMBL ID;Assay Tissue Name;Assay Cell Type;Assay Subcellular Fraction;Organism Tax ID;BAO Format ID;Published Type;Published Relation;Published Value;Published Units;Canonical Smiles;Data Validity Comment;Document Journal;Document Year;SRC ID;UO Units;Potential Duplicate
CHEMBL247758;EC50;=;49;nM;7.31;;22;CHEMBL887072;Agonist activity at human cloned mu opioid receptor assessed as stimulation of [35S]GTPgammaS binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139195;Scientific Literature;0;2;624.74;;;;;0.24;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)Cc2c(C)cc(cc2C)C(=O)N)C(=O)O;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL2113275;IC50;=;25;nM;7.6;;8;CHEMBL919398;Agonist activity at human opioid gamma receptor expressed in CHO cells assessed as inhibition of DAGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147138;Scientific Literature;0;2;805.07;;;;;8.09;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O[C@]12CCC(=O)[C@@H]3Oc4c(OC(=O)CCCCCCCCC(=O)Oc5ccc6C[C@@H]7C8CCCC[C@]8(CCN7CC9CCC9)c6c5)ccc%10C[C@H]1N(CC=C)CC[C@@]23c4%10;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL224671;IC50;=;18;nM;7.75;;6;CHEMBL919398;Agonist activity at human opioid gamma receptor expressed in CHO cells assessed as inhibition of DAGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147138;Scientific Literature;0;2;835.14;;;;;8.49;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(OC(=O)CCCCCCCCC(=O)Oc5ccc6C[C@@H]7C8CCCC[C@]8(CCN7CC9CCC9)c6c5)c%10O[C@@H]1[C@]2(CCN3CC%11CCC%11)c4%10;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL80;IC50;=;2;nM;8.7;;Naloxone;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;4;0;327.38;26.57;0.5;7.4;12.43;1.3;;;;;;9606;BAO_0000357;;;;;Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL2113301;EC50;=;11.7;nM;7.93;;5h;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;530.67;;;;;3.98;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccccc1\C=C\C(=O)NC[C@H]2C[C@]34CC[C@@]2(OC)[C@@H]5Oc6c(OC)ccc7C[C@H]3N(C)CC[C@@]45c67;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL2113304;EC50;=;7.23;nM;8.14;;6b;CHEMBL896951;Agonist activity at human delta opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;500.64;;;;;3.97;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1CNC(=O)\C=C\c4ccccc4C)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5C)c67;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL3707082;IC50;=;6.4;nM;8.19;;10;CHEMBL753178;In vitro binding affinity against cloned human Opioid receptor mu 1 expressed in HEK 293S cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145019;Scientific Literature;0;0;321.42;25.49;0.47;4.25;18.75;3.94;;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H]1[C@H]2c3cc(O)ccc3C[C@H](N1CC4CC4)c5ccc(O)cc25;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL109040;EC50;=;6.7;nM;8.17;;3a;CHEMBL749730;Effective concentration agonistic activity towards Opioid receptor mu 1;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145844;Scientific Literature;0;0;415.53;;;;;4.35;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2CC3N(C)CC[C@@]4([C@H]5C(=O)CC[C@@]34C/C/5=C\c6ccccc6)c2c1O;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL2113670;EC50;=;4.85;nM;8.31;;5c;CHEMBL749726;EC50 for binding of [35S]- GTPdeltaS in cloned human Opioid receptor mu 1 (DAMGO) transfected onto CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1132936;Scientific Literature;0;0;397.52;20.92;0.39;5.27;16.25;3.04;;;;CHO;;9606;BAO_0000219;;;;;CCO[C@H](C)[C@@H]1C[C@]23C=C[C@]1(OC)[C@H]4Oc5c(O)ccc6C[C@H]2N(C)CCC34c56;;J. Med. Chem.;2000;1;UO_0000065;False
CHEMBL214929;IC50;=;5.9;nM;8.23;;5;CHEMBL744603;In vitro binding affinity towards mu opioid receptors was determined using [3H][p-Cl-Phe]- 4] DPDPE or [3H]deltorphin II;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1131989;Scientific Literature;0;2;583.69;14.1;0.27;8.95;3.78;-0.72;;;;;;9606;BAO_0000357;;;;;CCCC[C@@H](N)C(=O)NNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc2ccc(O)cc2;;Bioorg. Med. Chem. Lett.;1999;1;UO_0000065;False
CHEMBL77196;IC50;=;3;nM;8.52;;11;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;338.45;25.18;0.47;5.67;12.8;2.85;;;;;;9606;BAO_0000357;;;;;C[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc3c(C)cc(O)cc3C;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL518712;EC50;=;9.8;nM;8.01;;13;CHEMBL1030613;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136834;Scientific Literature;0;0;295.43;;;;;3.5;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3cc4nc[nH]c4cc3[C@@]1(C)CCN2CC5CC5;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL1169585;EC50;=;0.66;nM;9.18;;"1a ; etrophine";CHEMBL749727;EC50 for binding of [35S]- GTPdeltaS in cloned human oOpioid receptor mu 1 (DAMGO) transfected onto CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1132936;Scientific Literature;0;0;411.54;22.31;0.42;6.02;14.77;3.16;;;;CHO;;9606;BAO_0000219;;;;;CCC[C@@](C)(O)[C@@H]1CC23C=C[C@]1(OC)[C@H]4Oc5c(O)ccc6CC2N(C)CCC34c56;;J. Med. Chem.;2000;1;UO_0000065;False
CHEMBL514769;EC50;=;1.01;nM;9;;3;CHEMBL1007140;Activity at monocloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140920;Scientific Literature;0;0;447.54;;;;;2.15;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@H](CC[C@@]36O)NC(=O)c7cccnc7;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL509528;IC50;=;0.32;nM;9.49;;14;CHEMBL955670;Agonist activity at mu opioid receptor in human SHSY5Y cells assessed as inhibition of forskolin-stimulated cAMP production;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1150362;Scientific Literature;0;2;779.98;;;;;3.75;Homo sapiens;;;SH-SY5Y;;9606;BAO_0000219;;;;;CCCCCCC(N)C(=O)N[C@@H](Cc1c(C)cc(O)cc1C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](Cc5ccccc5)C(=O)N;;Bioorg. Med. Chem.;2008;1;UO_0000065;False
CHEMBL611930;EC50;=;4.5;nM;8.35;;6;CHEMBL1071838;Activity at mu opioid receptor expressed in HEK293 cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1152554;Scientific Literature;0;1;615.48;;;;;3.52;;;;HEK293;;9606;BAO_0000219;;;;;OC(=O)C(=O)O.Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccc(Br)cc7;;Bioorg. Med. Chem.;2009;1;UO_0000065;False
CHEMBL611931;EC50;=;8.8;nM;8.06;;7;CHEMBL1071838;Activity at mu opioid receptor expressed in HEK293 cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1152554;Scientific Literature;0;1;662.48;;;;;3.36;;;;HEK293;;9606;BAO_0000219;;;;;OC(=O)C(=O)O.Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccc(I)cc7;;Bioorg. Med. Chem.;2009;1;UO_0000065;False
CHEMBL2208351;IC50;=;11;nM;7.96;;18;CHEMBL2213834;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203245;Scientific Literature;0;2;522.69;;;;;5.99;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC1C2Cc3ccc(cc3C1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cc5)c6ccc7OCOc7c6;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL2208358;IC50;=;27;nM;7.57;;5;CHEMBL2213834;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203245;Scientific Literature;0;2;508.71;;;;;6.27;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1cccc(c1)c2ccc(CCNC(=O)c3ccc4CC5C(C)C(C)(CCN5CC6CC6)c4c3)cc2;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL25230;IC50;=;2.1;nM;8.68;;SNC-86;CHEMBL749744;Binding affinity against cloned human Opioid receptor mu 1 using [125I]FK33824 as radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1133468;Scientific Literature;0;0;435.61;19.92;0.37;4.14;18.46;4.54;;;;;;9606;BAO_0000357;;;;;CCN(CC)C(=O)c1ccc(cc1)[C@@H](N2C[C@@H](C)N(CC=C)C[C@@H]2C)c3cccc(O)c3;;J. Med. Chem.;2000;1;UO_0000065;False
CHEMBL38874;EC50;=;55;nM;7.26;;DAMGO;CHEMBL870421;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1146899;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Med. Chem.;2006;1;UO_0000065;True
CHEMBL202462;IC50;=;100;nM;7;;19;CHEMBL866455;Inhibition of loperamide-stimulated [35S]GTP-gamma-S binding to membranes containing mu opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149448;Scientific Literature;0;0;275.44;;;;;4.18;Homo sapiens;;;;;9606;BAO_0000019;;;;;CCC[C@@H]1C[C@](C)([C@@H](C)CN1CC)c2cccc(O)c2;;Bioorg. Med. Chem. Lett.;2006;1;UO_0000065;False
CHEMBL312792;IC50;=;4.7;nM;8.33;;12;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;396.49;21;0.39;5.93;8.97;2.4;;;;;;9606;BAO_0000357;;;;;CC(=O)OC[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc3c(C)cc(O)cc3C;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL200129;IC50;=;0.6;nM;9.22;;10;CHEMBL870570;Displacement of [3H]DAMGO from mu opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147769;Scientific Literature;0;3;971.13;9.5;0.19;10.48;2.83;-1.26;Homo sapiens;;;;;9606;BAO_0000357;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]2CSSC[C@@H](NC(=O)[C@@H](N)Cc3ccc(O)cc3)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)NNC(=O)[C@H](Cc5ccccc5)NC(=O)CNC2=O;;Bioorg. Med. Chem. Lett.;2006;1;UO_0000065;False
CHEMBL328902;IC50;=;0.74;nM;9.13;;3;CHEMBL744603;In vitro binding affinity towards mu opioid receptors was determined using [3H][p-Cl-Phe]- 4] DPDPE or [3H]deltorphin II;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1131989;Scientific Literature;0;2;617.71;14.78;0.28;9.8;4.19;-0.67;;;;;;9606;BAO_0000357;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)NNC(=O)[C@H](N)Cc3ccccc3;;Bioorg. Med. Chem. Lett.;1999;1;UO_0000065;False
CHEMBL2179656;EC50;=;2.15;nM;8.67;;17h;CHEMBL2186797;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2177065;Scientific Literature;0;2;565.11;;;;;6.68;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@]2(Cc6cc(cnc46)c7ccc(Cl)cc7)OCCCc8ccccc8)c35;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2179652;EC50;=;1.74;nM;8.76;;17d;CHEMBL2186797;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2177065;Scientific Literature;0;2;605.18;;;;;7.46;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)c7ncc(cc7C[C@@]36OCCCc8ccccc8)c9ccc(Cl)cc9;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL38874;EC50;=;3.04;nM;8.52;;DAMGO;CHEMBL2166341;Agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by liquid scintillation counter;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2163332;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Med. Chem.;2012;1;UO_0000065;True
CHEMBL2163916;EC50;=;0.0334;nM;10.48;;12;CHEMBL2166341;Agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by liquid scintillation counter;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2163332;Scientific Literature;0;2;612.69;;;;;1.95;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](C(=C)C(=O)N)c5occc5;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL199931;EC50;=;2.5;nM;8.6;;11 (MCL-196);CHEMBL863310;Activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148605;Scientific Literature;0;2;763.03;;;;;7.98;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(OC(=O)CCCCCCCCC(=O)Oc6ccc7C[C@@H]8C9CCCC[C@]9(CCN8CC%10CCC%10)c7c6)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL263096;EC50;=;2.2;nM;8.66;;(-)2e;CHEMBL887396;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as maximal stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;1;430.59;;;;;5.44;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C(NCc1ccccc1)Oc2ccc3CC4C5CCCCC5(CCN4CC6CC6)c3c2;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL2113666;EC50;=;0.04;nM;10.4;;8e;CHEMBL864218;Stimulation of [35S]GTPgammaS binding to human recombinant MOR;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1146036;Scientific Literature;0;0;448.95;;;;;3.53;Homo sapiens;;;;;9606;BAO_0000019;;;;;CN1CC[C@]23[C@H]4Oc5cccc(C[C@@H]1[C@@]2(CCC4=O)NC(=O)\C=C\c6ccccc6Cl)c35;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL2113308;EC50;=;11.3;nM;7.95;;6f;CHEMBL896951;Agonist activity at human delta opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;531.61;;;;;3.57;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1CNC(=O)\C=C\c4ccc(cc4)[N+](=O)[O-])[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5C)c67;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL607069;EC50;=;0.9;nM;9.05;;7b;CHEMBL864218;Stimulation of [35S]GTPgammaS binding to human recombinant MOR;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1146036;Scientific Literature;0;0;478.98;;;;;3.54;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35NC(=O)\C=C\c6ccc(Cl)cc6;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL3338874;EC50;=;57.6;nM;7.24;;17b, SYK-524;CHEMBL3381489;Agonist activity at human MOR expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3352005;Scientific Literature;0;0;355.39;;;;;2.6;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@]1(O[C@H]2CO[C@@H]3N2[C@H]1O[C@@]3(C)c4ccccc4O)c5ccccc5O;;Bioorg. Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL2387196;EC50;=;4.7;nM;8.33;;13;CHEMBL2389089;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2385080;Scientific Literature;0;1;368.57;;;;;5.21;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CCC1C(=O)N(C2CCN(CC2)[C@@H]3CC[C@@H](CC3)C(C)C)c4ccccc14;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL511142;EC50;=;0.11;nM;9.96;;17a;CHEMBL1019886;Activity at human cloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;4;0;467.65;;;;;4.41;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL2113305;EC50;=;0.3;nM;9.52;;6c;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;521.06;;;;;4.32;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1CNC(=O)\C=C\c4ccccc4Cl)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5C)c67;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL2113296;EC50;=;10.6;nM;7.97;;5c;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;535.08;;;;;4.62;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)[C@@]6(CC[C@@]35C[C@@H]6CNC(=O)\C=C\c7ccccc7Cl)OC;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL219599;IC50;=;1.8;nM;8.74;;33;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;364.53;;;;;4.18;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3ccccc3C)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL319536;IC50;=;1.1;nM;8.96;;3;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;309.45;;;;;4.23;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN(CCc2ccccc2)CC[C@@]1(C)c3cccc(O)c3;;J. Med. Chem.;2006;1;UO_0000065;True
CHEMBL374678;IC50;=;15;nM;7.82;;29;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;364.53;;;;;4.27;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCCN(Cc3ccccc3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL376690;IC50;=;0.73;nM;9.14;;26;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;350.51;;;;;3.88;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3ccccc3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL226166;EC50;=;92;nM;7.04;;10b;CHEMBL904888;Agonist activity at human mu opioid receptor expressed in CHO membrane assessed as stimulation of [35S]GTPgammaS binding;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1143667;Scientific Literature;0;0;384.52;;;;;4.57;Homo sapiens;;;;;9606;BAO_0000249;;;;;Oc1ccc2C[C@@H]3[C@@H]4Cc5c(C[C@]4(CCN3CC6CC6)c2c1)[nH]c7ccccc57;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL226166;IC50;=;12;nM;7.92;;10b;CHEMBL904889;Antagonist activity at human mu opioid receptor expressed in CHO membrane assessed as inhibition of DAMGO-induced [35S]GTP-gamma-S binding;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1143667;Scientific Literature;0;0;384.52;;;;;4.57;Homo sapiens;;;;;9606;BAO_0000249;;;;;Oc1ccc2C[C@@H]3[C@@H]4Cc5c(C[C@]4(CCN3CC6CC6)c2c1)[nH]c7ccccc57;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL412996;IC50;=;40;nM;7.4;;8;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;1;426.6;;;;;5.62;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2C[C@@H](N(Cc3ccccc3)C[C@H]2C[C@@]1(C)c4cccc(O)c4)c5ccccc5;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL373707;IC50;=;1.5;nM;8.82;;13;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;363.51;;;;;3.1;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2C[C@@H](NC[C@H]2C[C@@]1(C)c3cccc(c3)C(=O)N)c4ccccc4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL218980;IC50;=;22;nM;7.66;;17;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;350.51;;;;;3.57;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2C[C@@H](Cc3ccccc3)NC[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL319536;IC50;=;1.1;nM;8.96;;3;CHEMBL909317;Antagonist activity against human cloned mu opioid receptor expressed in CHO cells assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137299;Scientific Literature;0;0;309.45;;;;;4.23;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN(CCc2ccccc2)CC[C@@]1(C)c3cccc(O)c3;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL1707;IC50;=;1.5;nM;8.82;;loperamide hydrochloride;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;4;1;513.51;18.5;0.35;3.73;20.16;5.09;;;;;;9606;BAO_0000357;;;;;Cl.CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL270642;IC50;=;56;nM;7.25;;8;CHEMBL948139;Binding affinity to mu opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1141623;Scientific Literature;0;0;263.38;27.53;0.52;4.26;22.18;2.99;;;;;;9606;BAO_0000357;;;;;CO[C@@]1(CCCC[C@@H]1CN(C)C)c2cccc(O)c2;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL1400;IC50;=;47;nM;7.33;;2, (+/-)-M1;CHEMBL948139;Binding affinity to mu opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1141623;Scientific Literature;0;0;249.35;29.39;0.56;5;16.77;2.33;;;;;;9606;BAO_0000357;;;;;CN(C)C[C@H]1CCCC[C@]1(O)c2cccc(O)c2;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL511884;IC50;=;25;nM;7.6;;6b;CHEMBL1019888;Activity at human cloned mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;258.36;;;;;1.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC1C2Cc3ccc(cc3C1(C)CCN2C)C(=O)N;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL19019;EC50;=;16;nM;7.8;;3, NTRX;CHEMBL958391;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;4;0;341.41;;;;;1.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL471048;EC50;=;1.6;nM;8.8;;14;CHEMBL958391;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;0;0;314.38;;;;;1.36;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23CC(=O)CC[C@H]2[C@H]1Cc4ccc(C(=O)N)c(O)c34;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL56695;EC50;=;4.9;nM;8.31;;2, CCDC710250;CHEMBL958391;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;0;0;368.43;;;;;0.92;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL511302;IC50;=;52;nM;7.28;;8;CHEMBL958397;Antagonist activity against human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;0;0;512.39;;;;;1.4;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;[I-].C[N+]1(CC2CC2)CC[C@]34CC(=O)CC[C@@]3(O)[C@H]1Cc5ccc(C(=O)N)c(O)c45;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL229440;EC50;=;2.65;nM;8.58;;9, tDADAE;CHEMBL889398;Agonist activity at human mu opioid receptor by [35S]GTP-gamma-S binding assay;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145383;Scientific Literature;0;2;551.6;;;;;-0.49;Homo sapiens;;;;;9606;BAO_0000019;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]2C\C=C\C[C@@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)CNC2=O)C(=O)O;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL218242;IC50;=;1.6;nM;8.8;;39;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;366.51;;;;;3.58;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3ccccc3O)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL219318;IC50;=;1.8;nM;8.74;;36;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;384.95;;;;;4.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3ccccc3Cl)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL217999;IC50;=;9.5;nM;8.02;;35;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;364.53;;;;;4.18;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3ccc(C)cc3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL373446;IC50;=;0.63;nM;9.2;;54;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;356.54;;;;;3.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3cccs3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL219152;IC50;=;18;nM;7.75;;51;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;351.49;;;;;3.27;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3ccncc3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL219466;IC50;=;13;nM;7.89;;49;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;351.49;;;;;3.27;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3ccccn3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL373709;IC50;=;80;nM;7.1;;48;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;401.55;;;;;4.42;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3ccnc4ccccc34)C[C@H]2C[C@@]1(C)c5cccc(O)c5;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL375633;IC50;=;16;nM;7.8;;47;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;1;400.57;;;;;5.03;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3cccc4ccccc34)C[C@H]2C[C@@]1(C)c5cccc(O)c5;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL450500;IC50;=;69;nM;7.16;;(+/-)-5.2a;CHEMBL1030679;Displacement of [125I]FK33824 from human cloned mu opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1152717;Scientific Literature;0;0;287.43;24.91;0.49;3.4;33.68;3.76;Homo sapiens;;;;;9606;BAO_0000357;;;;;COCCNC1C(CCc2ccccc12)c3ccsc3;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL31605;EC50;=;0.8;nM;9.1;;10a;CHEMBL749731;GTPgammaS binding in cloned human Opioid receptor mu 1 transfected into hamster ovary cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1133656;Scientific Literature;0;0;423.55;;;;;3.16;;;;ovary;;9606;BAO_0000219;;;;;CO[C@]12C=CC3(CC14CCC(C)(C)[C@H]4O)C5Cc6ccc(O)c7O[C@H]2C3(CCN5C)c67;;J. Med. Chem.;2000;1;UO_0000065;False
CHEMBL461050;IC50;=;58;nM;7.24;;(R)-(R)-6.3f;CHEMBL1030679;Displacement of [125I]FK33824 from human cloned mu opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1152717;Scientific Literature;0;2;508.09;14.24;0.28;1.79;20.09;5.45;Homo sapiens;;;;;9606;BAO_0000357;;;;;COCCN([C@H]1[C@@H](C=Cc2ccccc12)N3CCN(CC3)c4ccccc4)C(=O)c5sccc5Cl;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL307889;IC50;=;25.3;nM;7.6;;35;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;437.58;17.36;0.32;4.61;7.94;2.99;;;;;;9606;BAO_0000357;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2CNC(=O)C(C)(C)C;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL346436;EC50;=;11;nM;7.96;;16 MCL-179;CHEMBL749732;Inhibitory activity in stimulating [35S]-GTP-gamma S binding mediated by the Opioid receptor mu 1 in chinese Hamster Ovary (CHO) cell membranes was determined;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145905;Scientific Literature;0;2;775.13;10.27;0.19;-2.69;13.47;10.65;;;;;;9606;BAO_0000019;;;;;O=C(CCCCCCCC(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL102900;EC50;=;29;nM;7.54;;2;CHEMBL2389089;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2385080;Scientific Literature;0;0;338.5;;;;;4.01;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C1Cc2ccccc2N1C3CCN(CC3)C4C5CCCC4CCC5;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL566346;EC50;=;3;nM;8.52;;9;CHEMBL1056145;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154777;Scientific Literature;0;1;495.7;;;;;6.66;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;OC(=O)CCCCCCCCC(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL565679;EC50;=;13;nM;7.89;;7a;CHEMBL1056145;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154777;Scientific Literature;0;2;523.76;;;;;7.15;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(CCCCCCC(C)C(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)C(=O)O;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL574143;IC50;=;29.8;nM;7.53;;6;CHEMBL1058518;Displacement of [3H]DAMGO from mu opioid receptor expressed in CHO cells after 90 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154775;Scientific Literature;0;3;945.04;7.96;0.15;8.39;2.3;-0.86;;;;CHO;;9606;BAO_0000219;;;;;CC(=O)N(CCCC[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)O)C(=O)C;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL112035;EC50;=;19.26;nM;7.71;;2e;CHEMBL747703;Agonistic activity against human opioid Mu receptor transfected into Chinese hamster ovary (CHO) cells using [3H]-DAMGO as radioligand;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1131901;Scientific Literature;0;0;325.37;;;;;1.03;;;;CHO;;9606;BAO_0000219;;;;;CN1CCC23C4Oc5c(O)ccc(CC1C2(O)Cc6c[nH]nc46)c35;;Bioorg. Med. Chem. Lett.;1999;1;UO_0000065;False
CHEMBL504973;IC50;=;49.2;nM;7.31;;7;CHEMBL970213;Agonist activity at mu opioid receptor assessed as inhibition of forskolin-induced cAMP production in human SH-SY5Y cells pretreated for 24 hrs with excess ligand after 15 mins;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149874;Scientific Literature;0;2;593.69;;;;;-0.28;Homo sapiens;;;SH-SY5Y;;9606;BAO_0000219;;;;;CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc3ccc(O)cc3)C(=O)N;;Bioorg. Med. Chem.;2008;1;UO_0000065;False
CHEMBL147511;IC50;=;16;nM;7.8;;10, MCL-144;CHEMBL1056147;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154777;Scientific Literature;0;2;789.16;;;;;11.04;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C(CCCCCCCCC(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL297428;IC50;=;15;nM;7.82;;1b;CHEMBL1019888;Activity at human cloned mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;298.43;;;;;2.72;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC1C2Cc3ccc(cc3C1(C)CCN2CC4CC4)C(=O)N;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL49269;IC50;=;1.7;nM;8.77;;1;CHEMBL893251;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147995;Scientific Literature;0;0;297.44;;;;;3.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1;;Bioorg. Med. Chem.;2007;1;UO_0000065;True
CHEMBL301160;EC50;=;1.6;nM;8.8;;2, MCL-101;CHEMBL893250;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding after 60 mins;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147995;Scientific Literature;0;0;311.47;;;;;4.25;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1;;Bioorg. Med. Chem.;2007;1;UO_0000065;True
CHEMBL356473;EC50;=;34;nM;7.47;;5b;CHEMBL749734;Maximum % effect of standard (DAMGO) was reported against Opioid receptor mu 1;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1135445;Scientific Literature;0;2;544.7;;;;;5.92;;;;;;9606;BAO_0000019;;;;;Cc1ccc(cc1)c2cn(Cc3ccccc3)c4[C@@H]5Oc6c(O)ccc7CC8N(CC9CC9)CC[C@@]5(c67)[C@@]8(O)Cc24;;J. Med. Chem.;2002;1;UO_0000065;False
CHEMBL1161413;EC50;=;49;nM;7.31;;6 (S,R,S,R);CHEMBL749654;Compound tested at 10 uM for the ability to induce Opioid receptor mu 1-mediated binding of [35S]GTP-gamma-S to G proteins in CHO membrane preparations;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145973;Scientific Literature;0;1;516.68;;;;;3.76;;;;;;9606;BAO_0000249;;;;;Cc1cc(O)cc(C)c1C[C@H](N)[C@H](O)C\C=C\[C@H](O)[C@@H](Cc2ccccc2)C(=O)NCCc3ccccc3;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL114379;IC50;=;1.2;nM;8.92;;21;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;0;0;385.85;23.12;0.45;4.96;14.93;3.96;;;;;;9606;BAO_0000357;;;;;Oc1nc2ccccc2n1C3CCN(Cc4cc5OCOc5cc4Cl)CC3;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL70;EC50;=;6.4;nM;8.19;;morphine;CHEMBL925790;Activation of human mu opioid receptor expressed in HEK293a cells coexpressing YFP-labelled alphai1 and CFP-labelled beta-1-gamma-2 Gi subunits assessed as decrease in fluorescence resonance energy transfer signal at 10 uM;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147037;Scientific Literature;4;0;285.34;28.72;0.53;6.99;15.48;1.2;Homo sapiens;;;HEK293-A;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35;;J. Biol. Chem.;2007;1;UO_0000065;False
CHEMBL3707089;IC50;=;7;nM;8.15;;17;CHEMBL753178;In vitro binding affinity against cloned human Opioid receptor mu 1 expressed in HEK 293S cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145019;Scientific Literature;0;1;499.7;16.32;0.29;0.4;29.87;7.75;;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H]1[C@H]2c3cc(NCc4ccccc4)ccc3C[C@H](N1CC5CC5)c6ccc(NCc7ccccc7)cc26;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL70;EC50;=;7;nM;8.15;;morphine;CHEMBL925791;Activation of human mu opioid receptor expressed in HEK293a cells by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147037;Scientific Literature;4;0;285.34;;;;;1.2;Homo sapiens;;;HEK293-A;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35;;J. Biol. Chem.;2007;1;UO_0000065;False
CHEMBL256010;IC50;=;9.9;nM;8;;23;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;2;528.69;;;;;5.05;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)N[C@@H](CCc3ccccc3)C(=O)O)CC[C@@]1(C)c4cccc(O)c4;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL403633;IC50;=;1.2;nM;8.92;;16;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;0;438.57;;;;;3.44;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H](NC(=O)[C@H](CN1CC[C@](C)([C@@H](C)C1)c2cccc(O)c2)Cc3ccccc3)C(=O)O;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL511142;EC50;=;2.3;nM;8.64;;1a;CHEMBL749731;GTPgammaS binding in cloned human Opioid receptor mu 1 transfected into hamster ovary cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1133656;Scientific Literature;4;0;467.65;;;;;4.41;;;;ovary;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;J. Med. Chem.;2000;1;UO_0000065;False
CHEMBL249985;IC50;=;24;nM;7.62;;10;CHEMBL942703;Antagonist activity at human mu opioid receptor expressed in CHO cell membrane assessed as inhibition of DAMGO induced [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140563;Scientific Literature;0;2;508.71;;;;;6.27;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc(cc1)c2ccc(CCNC(=O)c3ccc4CC5[C@H](C)[C@](C)(CCN5CC6CC6)c4c3)cc2;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL146756;EC50;=;2.9;nM;8.54;;19 MCL-145;CHEMBL749732;Inhibitory activity in stimulating [35S]-GTP-gamma S binding mediated by the Opioid receptor mu 1 in chinese Hamster Ovary (CHO) cell membranes was determined;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145905;Scientific Literature;0;2;702.98;12.14;0.22;0.07;14.45;8.47;;;;;;9606;BAO_0000019;;;;;O=C(Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)\C=C\C(=O)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL1169580;EC50;=;7.3;nM;8.14;;"1b ; Isoetrophine";CHEMBL749729;EC50 for binding of [35S]- GTPdeltaS in cloned human opioid mu receptors (DAMGO) transfected onto CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1132936;Scientific Literature;0;0;411.54;19.77;0.37;4.98;13.09;3.16;;;;CHO;;9606;BAO_0000219;;;;;CCC[C@](C)(O)[C@@H]1CC23C=C[C@]1(OC)[C@H]4Oc5c(O)ccc6CC2N(C)CCC34c56;;J. Med. Chem.;2000;1;UO_0000065;False
CHEMBL110640;EC50;=;1.97;nM;8.71;;8;CHEMBL749655;Concentration necessary to produce 50% of the Emax value, i.e. to stimulate [35S]GTP-gamma-S, binding to recombinant human Opioid receptor mu 1 expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148330;Scientific Literature;0;1;459.63;;;;;5.11;;;;CHO;;9606;BAO_0000219;;;;;COc1cccc2C[C@H]3N(CC4CC4)CCC5(CC(=O)CC[C@@]35OCCCc6ccccc6)c12;;J. Med. Chem.;2004;1;UO_0000065;False
CHEMBL895;IC50;=;1;nM;9;;Nalbuphine;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;4;0;357.45;25.18;0.47;7.29;12.3;1.71;;;;;;9606;BAO_0000357;;;;;O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CCC6)c45;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL1790710;IC50;=;4;nM;8.4;;1;CHEMBL757306;Binding affinity towards Opioid receptor mu 1 was evaluated;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1133766;Scientific Literature;0;2;685.78;12.25;0.23;10.94;3.05;-2.54;;;;;;9606;BAO_0000357;;;;;CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N;;J. Med. Chem.;2000;1;UO_0000065;False
CHEMBL115222;IC50;=;0.9;nM;9.05;;40;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;0;0;470.96;19.21;0.37;6.59;12.17;2.46;;;;;;9606;BAO_0000357;;;;;CNC(=O)CN1CN(c2ccccc2)C3(CCN(Cc4cc5OCOc5cc4Cl)CC3)C1=O;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL217102;IC50;=;0.29;nM;9.54;;4j;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;1;507.07;;;;;4.8;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NCCCCc7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL217479;IC50;=;0.87;nM;9.06;;4g;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;1;521.06;;;;;4.33;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)CCCc7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL267027;IC50;=;0.028;nM;10.55;;4b;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;1;507.03;;;;;3.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)CCc7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL277530;IC50;=;8.84;nM;8.05;;5k;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;1;507.03;;;;;3.85;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)Cc7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL502411;IC50;=;21;nM;7.68;;2;CHEMBL1000649;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of 100 nM loperamide-stimulated GTPgammaS binding by cell based assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136971;Scientific Literature;0;1;577.69;13.29;0.24;5.03;6.22;2.65;Homo sapiens;;;;;9606;BAO_0000219;;;;;O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](Cc4ccccc4)C(=O)N5CCC[C@@H]5C(=O)N[C@H]1Cc6ccccc6;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL384118;IC50;=;4.98;nM;8.3;;5h;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;1;519.09;;;;;4.88;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC\C=C\Cc7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL438871;EC50;=;2.5;nM;8.6;;11;CHEMBL941715;Agonist activity at human mu opioid receptor expressed in CHO cell membrane by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140563;Scientific Literature;0;2;513.13;;;;;6.91;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cc5)c6ccc(Cl)cc6;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL584993;IC50;=;0.81;nM;9.09;;1;CHEMBL1058518;Displacement of [3H]DAMGO from mu opioid receptor expressed in CHO cells after 90 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154775;Scientific Literature;0;3;961.09;9.46;0.19;9.4;2.86;-0.31;;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCN(N=C=S)N=C=S)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)O;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL584994;IC50;=;4.25;nM;8.37;;3;CHEMBL1058518;Displacement of [3H]DAMGO from mu opioid receptor expressed in CHO cells after 90 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154775;Scientific Literature;0;3;931.01;8.99;0.17;9.62;2.56;-1.25;;;;CHO;;9606;BAO_0000219;;;;;CC(=O)N(CCC[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)O)C(=O)C;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL895;IC50;=;96;nM;7.02;;6;CHEMBL958397;Antagonist activity against human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;4;0;357.45;;;;;1.71;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CCC6)c45;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL333357;EC50;=;0.04;nM;10.4;;1, endomorphin-2;CHEMBL945984;Antagonist activity at mu opioid receptor expressed in CHO cells assessed as release of intracellular calcium ions by aequorin luminescence-based calcium assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1141475;Scientific Literature;0;1;571.68;;;;;1.19;;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL392269;EC50;=;89;nM;7.05;;12;CHEMBL897687;Agonist activity at human mu opioid receptor expressed in CHO membrane by [35S]GTP-gamma-S binding assay;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149641;Scientific Literature;0;0;387.48;;;;;1.19;Homo sapiens;;;;;9606;BAO_0000249;;;;;CO[C@]12CC(O)[C@@]3(C[C@@H]1[C@H](C)O)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4C)c56;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL220248;IC50;=;54;nM;7.27;;25;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;336.48;;;;;3.88;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(C[C@H]2C[C@@]1(C)c3cccc(O)c3)c4ccccc4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL218506;IC50;=;52;nM;7.28;;14;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;336.48;;;;;3.7;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2C[C@H](NC[C@H]2C[C@@]1(C)c3cccc(O)c3)c4ccccc4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL80464;IC50;=;83.2;nM;7.08;;24;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;381.52;18.56;0.35;4.69;10.14;2.39;;;;;;9606;BAO_0000357;;;;;CN(C)C[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc3c(C)cc(O)cc3C;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL1161416;EC50;=;7.9;nM;8.1;;5 (S,S,R,R);CHEMBL749654;Compound tested at 10 uM for the ability to induce Opioid receptor mu 1-mediated binding of [35S]GTP-gamma-S to G proteins in CHO membrane preparations;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145973;Scientific Literature;0;2;559.71;;;;;2.62;;;;;;9606;BAO_0000249;;;;;Cc1cc(O)cc(C)c1C[C@H](N)[C@@H](O)C\C=C\[C@@H](O)[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL401278;EC50;=;6.8;nM;8.17;;5;CHEMBL941715;Agonist activity at human mu opioid receptor expressed in CHO cell membrane by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140563;Scientific Literature;0;1;478.68;;;;;6.26;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)NCCc5cccc(c5)c6ccccc6;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL77001;EC50;=;37.1;nM;7.43;;25;CHEMBL758076;Agonist potency using GTP-gamma [35S]- binding assay for mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;443.59;16.75;0.31;3.81;9.45;3.62;;;;;;9606;BAO_0000357;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2CNCc4ccccc4;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL49269;IC50;=;1.7;nM;8.77;;1;CHEMBL1769436;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1765082;Scientific Literature;0;0;297.44;;;;;3.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1;;J. Med. Chem.;2011;1;UO_0000065;True
CHEMBL390866;IC50;=;85;nM;7.07;;10;CHEMBL1769436;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1765082;Scientific Literature;0;0;367.56;;;;;4.74;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Nc1nc2cc3c(C[C@@H]4[C@@H]5CCCC[C@]35CCN4CC6CCC6)cc2s1;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL1774952;EC50;=;22;nM;7.66;;12, MCL-714;CHEMBL1777022;Agonist activity at human mu-opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1772956;Scientific Literature;0;2;845.32;;;;;12.49;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C(CCCCCNc1nc2cc3c(C[C@@H]4[C@@H]5CCCC[C@]35CCN4CC6CC6)cc2s1)CCCCNc7nc8cc9c(C[C@@H]%10[C@@H]%11CCCC[C@]9%11CCN%10CC%12CC%12)cc8s7;;Bioorg. Med. Chem.;2011;1;UO_0000065;False
CHEMBL1946020;IC50;=;63;nM;7.2;;7;CHEMBL1947874;Displacement of radiolabeled FK33-824 from mu opioid receptor expressed in HEK293 cell membranes;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1944587;Scientific Literature;0;2;513.66;14.02;0.26;0.84;13.68;6.36;;;;HEK293;;9606;BAO_0000219;;;;;CCN(CC)C(=O)c1ccc(cc1)C(=C2CCN(Cc3ccc(F)cc3)CC2)c4cccc(NC(=O)C)c4;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL474755;EC50;=;34.4;nM;7.46;;7a;CHEMBL1023001;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1152801;Scientific Literature;0;0;485.58;;;;;4.09;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36OC(=O)\C=C\c7ccccc7;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL386272;EC50;=;17.8;nM;7.75;;4b;CHEMBL1023001;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1152801;Scientific Literature;0;1;519.04;;;;;4.32;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)\C=C\c7ccc(Cl)cc7;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL38874;EC50;=;55;nM;7.26;;DAMGO;CHEMBL958391;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;True
CHEMBL49269;EC50;=;0.8;nM;9.1;;1;CHEMBL1769433;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1765082;Scientific Literature;0;0;297.44;;;;;3.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1;;J. Med. Chem.;2011;1;UO_0000065;True
CHEMBL562340;EC50;=;33;nM;7.48;;7c;CHEMBL1053216;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153456;Scientific Literature;0;0;384.52;;;;;4.57;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@]34CN(CC5CC5)CC[C@@]3(Cc6[nH]c7ccccc7c6C4)c2c1;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL403190;IC50;=;1.5;nM;8.82;;18;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;1;514.67;;;;;4.66;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)O)CC[C@@]1(C)c4cccc(O)c4;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL401789;IC50;=;3.8;nM;8.42;;24;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;0;482.58;;;;;2.89;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)N[C@@H](CC(=O)O)C(=O)O)CC[C@@]1(C)c3cccc(O)c3;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL271662;IC50;=;6.8;nM;8.17;;15;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;2;549.11;;;;;5.76;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(CCC(=O)N(Cc2cccc(Cl)c2)[C@@H](Cc3ccccc3)C(=O)O)CC[C@@]1(C)c4cccc(O)c4;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL56585;IC50;=;13;nM;7.89;;1;CHEMBL1030612;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136834;Scientific Literature;0;0;271.4;;;;;3.33;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1[C@H]2Cc3ccc(O)cc3[C@]1(C)CCN2CC4CC4;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL38874;EC50;=;1;nM;9;;DAMGO;CHEMBL925791;Activation of human mu opioid receptor expressed in HEK293a cells by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147037;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;HEK293-A;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Biol. Chem.;2007;1;UO_0000065;False
CHEMBL512150;IC50;=;26;nM;7.58;;4;CHEMBL958397;Antagonist activity against human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;0;0;386.49;;;;;1.44;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(C[C@@H](O)CC[C@@]35O)c2c1O;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL386492;IC50;=;0.53;nM;9.28;;4a, C-CAM;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;1;505.01;;;;;4.02;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)\C=C\c7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL263482;IC50;=;4.91;nM;8.31;;5g;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;1;535.08;;;;;4.63;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)CCCc7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL448428;IC50;=;0.26;nM;9.59;;4k;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;0;493;;;;;3.55;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)Cc7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL375068;EC50;=;1.15;nM;8.94;;4;CHEMBL913686;Activity at mu opioid receptor assessed as increase in calcium level in CHO cells by aequorin luminescence based calcium assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1141402;Scientific Literature;0;2;688.83;;;;;3.44;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cc1cc(C[C@H](N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](Cc5cccc6ccccc56)C(=O)N)cc(C)c1O;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL112191;IC50;=;16;nM;7.8;;27;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;0;0;371.87;20.96;0.41;3.56;15.43;4.24;;;;;;9606;BAO_0000357;;;;;COc1ccc(CN2CCC(CC2)n3c(O)nc4ccccc34)c(Cl)c1;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL373984;EC50;=;8.9;nM;8.05;;MCL-450;CHEMBL870437;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1146900;Scientific Literature;0;2;732.97;;;;;5.8;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2C(=O)NCCC(=O)Oc4ccc5C[C@@H]6[C@@H]7CCCC[C@]7(CCN6CC8CCC8)c5c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL80;IC50;=;7.3;nM;8.14;;2a;CHEMBL909317;Antagonist activity against human cloned mu opioid receptor expressed in CHO cells assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137299;Scientific Literature;4;0;327.38;;;;;1.3;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O;;J. Med. Chem.;2006;1;UO_0000065;True
CHEMBL218520;IC50;=;26;nM;7.58;;7;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;350.51;;;;;4.05;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2C[C@@H](N(C)C[C@H]2C[C@@]1(C)c3cccc(O)c3)c4ccccc4;;J. Med. Chem.;2006;1;UO_0000065;True
CHEMBL115222;IC50;=;0.9;nM;9.05;;33;CHEMBL757059;Binding affinity against mu opiate receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134625;Scientific Literature;0;0;470.96;19.21;0.37;6.59;12.17;2.46;;;;;;9606;BAO_0000357;;;;;CNC(=O)CN1CN(c2ccccc2)C3(CCN(Cc4cc5OCOc5cc4Cl)CC3)C1=O;;J. Med. Chem.;2001;1;UO_0000065;True
CHEMBL3707083;IC50;=;16;nM;7.8;;9;CHEMBL753178;In vitro binding affinity against cloned human Opioid receptor mu 1 expressed in HEK 293S cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145019;Scientific Literature;0;0;281.36;27.71;0.51;4.64;17.84;3.16;;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H]1[C@H]2c3cc(O)ccc3C[C@H](N1C)c4ccc(O)cc24;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL517779;IC50;=;30;nM;7.52;;11b;CHEMBL1019888;Activity at human cloned mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;354.49;;;;;2.76;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(CCCC[C@@]35O)c2c1;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL115652;IC50;=;2;nM;8.7;;39;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;0;0;399.88;21.75;0.42;5.7;16.1;3;;;;;;9606;BAO_0000357;;;;;Clc1cc2OCOc2cc1CN3CCC4(CC3)N(CNC4=O)c5ccccc5;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL326962;IC50;=;16.7;nM;7.78;;34;CHEMBL757059;Binding affinity against mu opiate receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134625;Scientific Literature;0;0;365.43;21.28;0.39;5.44;14.39;2.34;;;;;;9606;BAO_0000357;;;;;O=C1NCN(c2ccccc2)C13CCN(Cc4ccc5OCOc5c4)CC3;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL321170;EC50;=;9.8;nM;8.01;;17;CHEMBL749655;Concentration necessary to produce 50% of the Emax value, i.e. to stimulate [35S]GTP-gamma-S, binding to recombinant human Opioid receptor mu 1 expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148330;Scientific Literature;0;0;443.59;;;;;4.48;;;;CHO;;9606;BAO_0000219;;;;;O=C1CC[C@@]2(OCCCc3ccccc3)[C@H]4Cc5cccc6OC1C2(CCN4CC7CC7)c56;;J. Med. Chem.;2004;1;UO_0000065;False
CHEMBL110124;EC50;=;15.2;nM;7.82;;3b;CHEMBL749730;Effective concentration agonistic activity towards Opioid receptor mu 1;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145844;Scientific Literature;0;0;429.56;;;;;4.74;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2CC3N(C)CC[C@@]4([C@H]5C(=O)CC[C@@]34C/C/5=C(/C)\c6ccccc6)c2c1O;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL38874;EC50;=;55;nM;7.26;;DAMGO;CHEMBL1030613;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136834;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;True
CHEMBL2110315;EC50;=;1.9;nM;8.72;;4b;CHEMBL843115;Activity was evaluated in human mu opioid receptors transfected with CHO cells by [35S]GTP-gamma-S, assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1132136;Scientific Literature;0;0;395.54;;;;;4.03;;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(CC1[C@]26CC[C@]47OC(C)(C)C(C)(C)[C@@H]7C6)c35;;Bioorg. Med. Chem. Lett.;1999;1;UO_0000065;False
CHEMBL92503;IC50;=;0.88;nM;9.06;;4;CHEMBL744603;In vitro binding affinity towards mu opioid receptors was determined using [3H][p-Cl-Phe]- 4] DPDPE or [3H]deltorphin II;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1131989;Scientific Literature;0;2;617.71;14.66;0.27;9.73;4.16;-0.67;;;;;;9606;BAO_0000357;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)NNC(=O)[C@@H](N)Cc3ccccc3;;Bioorg. Med. Chem. Lett.;1999;1;UO_0000065;False
CHEMBL433697;EC50;=;7.4;nM;8.13;;13 MCL-139;CHEMBL749732;Inhibitory activity in stimulating [35S]-GTP-gamma S binding mediated by the Opioid receptor mu 1 in chinese Hamster Ovary (CHO) cell membranes was determined;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145905;Scientific Literature;0;2;705;11.53;0.21;-0.56;13.76;8.69;;;;;;9606;BAO_0000019;;;;;O=C(CCC(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL3262547;EC50;=;22.3;nM;7.65;;5d;CHEMBL3270915;Agonist activity at human mu opioid receptor transfected in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259735;Scientific Literature;0;0;374.53;;;;;4.55;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CCC1C(=O)N(C2CCN(CC2)C3CCc4ccccc4C3)c5ccccc15;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL92286;IC50;=;2;nM;8.7;;8;CHEMBL744603;In vitro binding affinity towards mu opioid receptors was determined using [3H][p-Cl-Phe]- 4] DPDPE or [3H]deltorphin II;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1131989;Scientific Literature;0;2;656.74;13.25;0.25;8.89;3.72;-0.19;;;;;;9606;BAO_0000357;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)NNC(=O)[C@H](N)Cc3c[nH]c4ccccc34;;Bioorg. Med. Chem. Lett.;1999;1;UO_0000065;False
CHEMBL432041;IC50;=;1.6;nM;8.8;;7;CHEMBL744603;In vitro binding affinity towards mu opioid receptors was determined using [3H][p-Cl-Phe]- 4] DPDPE or [3H]deltorphin II;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1131989;Scientific Literature;0;2;633.71;13.88;0.26;9.77;3.7;-0.97;;;;;;9606;BAO_0000357;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)NNC(=O)[C@H](N)Cc3ccc(O)cc3;;Bioorg. Med. Chem. Lett.;1999;1;UO_0000065;False
CHEMBL3264745;EC50;=;5.1;nM;8.29;;4e;CHEMBL3271443;Agonist activity at human mu opioid receptor expressed in HEK293 cells by CellKey method;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259551;Scientific Literature;0;0;486.57;17.04;0.31;5.19;11.6;3.1;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC=C)CC[C@]45[C@@H]6[C@@H]7O[C@]34CC[C@@]6(OCOc1c25)N(Cc8ccccc8)C7=O;;ACS Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL31030;EC50;=;4.2;nM;8.38;;10b;CHEMBL749731;GTPgammaS binding in cloned human Opioid receptor mu 1 transfected into hamster ovary cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1133656;Scientific Literature;0;0;463.62;;;;;3.94;;;;ovary;;9606;BAO_0000219;;;;;CO[C@]12C=CC3(CC14CCC(C)(C)[C@H]4O)C5Cc6ccc(O)c7O[C@H]2C3(CCN5CC8CC8)c67;;J. Med. Chem.;2000;1;UO_0000065;False
CHEMBL3219778;IC50;=;37.8;nM;7.42;;2;CHEMBL3227490;Antagonist activity at human mu opioid receptor expressed in Gqi5 transfected CHO cells assessed as inhibition of DAMGO-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3217593;Scientific Literature;0;2;699.85;10.61;0.2;7.02;3.95;0.4;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CC6)c45;;MedChemComm;2013;1;UO_0000065;False
CHEMBL278789;IC50;=;0.72;nM;9.14;;dermorphin;CHEMBL1058518;Displacement of [3H]DAMGO from mu opioid receptor expressed in CHO cells after 90 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154775;Scientific Literature;0;3;802.89;11.39;0.22;11.14;3.09;-2;;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)N;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL324297;IC50;=;1.5;nM;8.82;;12;CHEMBL757059;Binding affinity against mu opiate receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134625;Scientific Literature;0;0;396.4;22.26;0.42;5.6;8.58;3.22;;;;;;9606;BAO_0000357;;;;;Oc1nc2ccccc2n1C3CCN(Cc4cc5OCOc5cc4[N+](=O)[O-])CC3;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL386272;IC50;=;0.97;nM;9.01;;5a;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;1;519.04;;;;;4.32;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)\C=C\c7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL325750;IC50;=;24.9;nM;7.6;;42;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;0;0;379.49;20.04;0.38;4.98;12.39;2.62;;;;;;9606;BAO_0000357;;;;;O=C1NCN(c2ccccc2)C13CCN(Cc4ccc5nsnc5c4)CC3;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL222597;EC50;=;2.51;nM;8.6;;7c;CHEMBL919065;Activity at human recombinant mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149288;Scientific Literature;0;0;472.63;;;;;4.18;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2CC3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)c7c(C[C@@]36O)c8CCCCc8n7CC9CC9;;J. Med. Chem.;2004;1;UO_0000065;False
CHEMBL1790709;IC50;=;8.2;nM;8.09;;2;CHEMBL757306;Binding affinity towards Opioid receptor mu 1 was evaluated;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1133766;Scientific Literature;0;3;847.92;9.54;0.18;12.8;2.28;-4.71;;;;;;9606;BAO_0000357;;;;;CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)[C@@H](C)O)C(=O)N[C@@H](CO[C@H]3O[C@@H](CO)[C@H](O)[C@@H](O)[C@H]3O)C(=O)N;;J. Med. Chem.;2000;1;UO_0000065;False
CHEMBL115229;IC50;=;19.3;nM;7.71;;24;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;0;0;394.39;19.56;0.36;4.58;7.5;3.13;;;;;;9606;BAO_0000357;;;;;Oc1nc2ccccc2n1C3=CCN(Cc4cc5OCOc5cc4[N+](=O)[O-])CC3;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL210005;EC50;=;3;nM;8.52;;(-)-16;CHEMBL870418;Antagonist activity against human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1146899;Scientific Literature;0;1;478.68;;;;;6.26;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1[C@H]2Cc3ccc(cc3[C@]1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cc5)c6ccccc6;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL593214;EC50;=;8.9;nM;8.05;;4;CHEMBL1074532;Inverse agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1152554;Scientific Literature;0;0;550.61;;;;;3.06;;;;HEK293;;9606;BAO_0000219;;;;;Cc1ccc(cc1)C(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56.OC(=O)C(=O)O;;Bioorg. Med. Chem.;2009;1;UO_0000065;False
CHEMBL1946023;IC50;=;33;nM;7.48;;10;CHEMBL1947874;Displacement of radiolabeled FK33-824 from mu opioid receptor expressed in HEK293 cell membranes;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1944587;Scientific Literature;0;2;529.66;14.13;0.26;0.9;12.09;6.58;;;;HEK293;;9606;BAO_0000219;;;;;CCN(CC)C(=O)c1ccc(cc1)C(=C2CCN(Cc3ccc(F)cc3)CC2)c4cccc(NC(=O)OC)c4;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL3707102;IC50;=;8;nM;8.1;;13;CHEMBL753178;In vitro binding affinity against cloned human Opioid receptor mu 1 expressed in HEK 293S cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145019;Scientific Literature;0;1;459.64;17.62;0.32;1.13;29.66;6.97;;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H]1[C@H]2c3cc(NCc4ccccc4)ccc3C[C@H](N1C)c5ccc(NCc6ccccc6)cc25;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL376413;IC50;=;1.1;nM;8.96;;56;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;356.55;;;;;4.26;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(CC3CCCCC3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL219495;IC50;=;2;nM;8.7;;27;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;364.53;;;;;3.92;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(CCc3ccccc3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL218135;IC50;=;6.7;nM;8.17;;23;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;378.52;;;;;3.45;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(C[C@H]2C[C@@]1(C)c3cccc(O)c3)C(=O)Cc4ccccc4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL219554;IC50;=;1.4;nM;8.85;;55;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;356.54;;;;;3.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3ccsc3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL217950;IC50;=;6.1;nM;8.21;;53;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;340.47;;;;;3.47;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3cocc3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL374455;IC50;=;7.2;nM;8.14;;52;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;340.47;;;;;3.47;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3occc3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL218136;IC50;=;74;nM;7.13;;46;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;1;400.57;;;;;5.03;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3ccc4ccccc4c3)C[C@H]2C[C@@]1(C)c5cccc(O)c5;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL384895;IC50;=;22;nM;7.66;;45;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;1;456.63;;;;;5.46;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3cccc(OCc4ccccc4)c3)C[C@H]2C[C@@]1(C)c5cccc(O)c5;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL383320;EC50;=;3;nM;8.52;;5;CHEMBL919396;Agonist activity at human opioid gamma receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147138;Scientific Literature;0;1;495.7;;;;;6.66;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;OC(=O)CCCCCCCCC(=O)Oc1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC5CCC5)c2c1;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL651;IC50;=;4.1;nM;8.39;;methadone;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;4;0;309.45;27.1;0.5;4.1;41.3;4.29;;;;;;9606;BAO_0000357;;;;;CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c2ccccc2;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL3086308;EC50;=;0.52;nM;9.28;;12, MCL-742;CHEMBL3090458;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085732;Scientific Literature;0;0;462.46;;;;;3.58;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Br.CNc1nc2C[C@]34CCN(CC5CC5)[C@H](Cc6ccc(O)cc36)[C@@H]4Cc2s1;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3086307;EC50;=;51;nM;7.29;;11, MCL-743;CHEMBL3090458;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085732;Scientific Literature;0;0;395.57;;;;;3.89;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CNc1nc2C[C@]34CCN(CC5CC5)[C@H](Cc6ccc(OC)cc36)[C@@H]4Cc2s1;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3216156;EC50;=;16.87;nM;7.77;;SYK-404;CHEMBL3097535;Agonist activity at human recombinant mu opioid receptor expressed in CHO cells after 2 hrs by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3091434;Scientific Literature;0;0;489.44;;;;;2.72;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cl.Cl.C[C@H](O)CN1CC[C@]23Cc4nc5ccccc5cc4C[C@@]2(O)C1Cc6ccc(O)cc36;;Bioorg. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3086303;EC50;=;39;nM;7.41;;7, MCL-741;CHEMBL3090458;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085732;Scientific Literature;0;0;381.55;;;;;3.43;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@@H]3[C@@H]4Cc5sc(N)nc5C[C@]4(CCN3CC6CC6)c2c1;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL138750;IC50;=;16;nM;7.8;;6;CHEMBL754686;Concentration required to inhibit agonist (loperamide) stimulated [35S]GTP-gamma-S, binding to membranes containing the cloned human mu opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136497;Scientific Literature;0;0;350.51;;;;;4.49;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(CCc2ccccc2)CC[C@@]1(C)c3cccc(NC(=O)C)c3;;Bioorg. Med. Chem. Lett.;2003;1;UO_0000065;False
CHEMBL115280;IC50;=;83.5;nM;7.08;;43;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;0;0;413.52;17.12;0.31;2.67;15.8;4.41;;;;;;9606;BAO_0000357;;;;;O=C1NCN(c2ccccc2)C13CCN(Cc4cccc(Oc5ccccc5)c4)CC3;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL522143;IC50;=;19.5;nM;7.71;;NAP;CHEMBL2444608;Antagonist activity at MOR (unknown origin) assessed as inhibition of DAMGO-induced agonism;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440098;Scientific Literature;0;0;447.54;17.23;0.32;5.56;8.12;2.15;Homo sapiens;;;;;9606;BAO_0000357;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccncc7;;Bioorg. Med. Chem.;2013;1;UO_0000065;False
CHEMBL226217;IC50;=;3;nM;8.52;;22b;CHEMBL904889;Antagonist activity at human mu opioid receptor expressed in CHO membrane assessed as inhibition of DAMGO-induced [35S]GTP-gamma-S binding;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1143667;Scientific Literature;0;0;367.52;;;;;3.12;Homo sapiens;;;;;9606;BAO_0000249;;;;;Nc1nc2C[C@]34CCN(CC5CC5)[C@H](Cc6ccc(O)cc36)[C@@H]4Cc2s1;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL235239;EC50;=;12;nM;7.92;;13;CHEMBL897687;Agonist activity at human mu opioid receptor expressed in CHO membrane by [35S]GTP-gamma-S binding assay;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149641;Scientific Literature;0;0;387.48;;;;;1.19;Homo sapiens;;;;;9606;BAO_0000249;;;;;CO[C@]12CC(O)[C@@]3(C[C@@H]1[C@@H](C)O)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4C)c56;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL584790;IC50;=;81;nM;7.09;;4b;CHEMBL1056147;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154777;Scientific Literature;0;2;845.27;;;;;12.31;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(C)(CCCCCCC(C)(C)C(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)C(=O)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL2113299;EC50;=;26;nM;7.58;;5f;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;545.64;;;;;3.88;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)[C@@]6(CC[C@@]35C[C@@H]6CNC(=O)\C=C\c7ccc(cc7)[N+](=O)[O-])OC;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL3707103;IC50;=;82;nM;7.09;;18;CHEMBL753178;In vitro binding affinity against cloned human Opioid receptor mu 1 expressed in HEK 293S cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145019;Scientific Literature;0;1;471.65;15.02;0.27;-0.93;25.96;8.02;;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H]1[C@H]2c3cc(Nc4ccccc4)ccc3C[C@H](N1CC5CC5)c6ccc(Nc7ccccc7)cc26;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL3707095;IC50;=;56;nM;7.25;;14;CHEMBL753178;In vitro binding affinity against cloned human Opioid receptor mu 1 expressed in HEK 293S cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145019;Scientific Literature;0;1;431.58;16.8;0.3;0.01;26.56;7.24;;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H]1[C@H]2c3cc(Nc4ccccc4)ccc3C[C@H](N1C)c5ccc(Nc6ccccc6)cc25;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL2113307;EC50;=;35.4;nM;7.45;;6e;CHEMBL896951;Agonist activity at human delta opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;521.06;;;;;4.32;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1CNC(=O)\C=C\c4ccc(Cl)cc4)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5C)c67;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL217395;IC50;=;0.03;nM;10.52;;5b;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;1;521.06;;;;;4.24;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)CCc7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL401615;IC50;=;1.2;nM;8.92;;27;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;0;495.66;;;;;3.55;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCCN)C(=O)O)CC[C@@]1(C)c3cccc(O)c3;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL255354;IC50;=;3;nM;8.52;;17;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;0;438.57;;;;;3.44;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@@H](NC(=O)[C@H](CN1CC[C@](C)([C@@H](C)C1)c2cccc(O)c2)Cc3ccccc3)C(=O)O;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL403191;IC50;=;63;nM;7.2;;13;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;2;528.69;;;;;5.15;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(CCC(=O)N(CCc2ccccc2)[C@@H](Cc3ccccc3)C(=O)O)CC[C@@]1(C)c4cccc(O)c4;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL441899;IC50;=;28;nM;7.55;;5;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;1;500.64;;;;;4.86;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(CCC(=O)N[C@@H](Cc2ccc(cc2)c3ccccc3)C(=O)O)CC[C@@]1(C)c4cccc(O)c4;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL2387200;EC50;=;58;nM;7.24;;17;CHEMBL2389089;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2385080;Scientific Literature;0;1;354.54;;;;;5.1;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC1CC(=O)N(C2CCN(CC2)C3CCCCCCC3)c4ccccc14;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL470005;IC50;=;3.8;nM;8.42;;11;CHEMBL958397;Antagonist activity against human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;0;0;356.47;;;;;2.07;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CC4)CC[C@@]5(CCCC[C@@]35O)c2c1O;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL611933;EC50;=;6.8;nM;8.17;;10;CHEMBL1071838;Activity at mu opioid receptor expressed in HEK293 cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1152554;Scientific Literature;0;0;571.03;;;;;3.41;;;;HEK293;;9606;BAO_0000219;;;;;OC(=O)C(=O)O.Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccc(Cl)cc7;;Bioorg. Med. Chem.;2009;1;UO_0000065;False
CHEMBL1852814;EC50;=;2.32;nM;8.63;;10;CHEMBL2184591;Agonist activity at mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTP-gammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2176919;Scientific Literature;0;0;461.56;18.71;0.35;6.55;9.1;2.08;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)Cc7ccncc7;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL70;IC50;=;4.3;nM;8.37;;Morphine;CHEMBL2183870;Agonist activity at human MOR expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 15 mins by cAMP EIA;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2177066;Scientific Literature;4;0;285.34;;;;;1.2;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL1852555;EC50;=;1.46;nM;8.84;;11;CHEMBL2184591;Agonist activity at mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTP-gammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2176919;Scientific Literature;0;0;475.59;18.58;0.34;6.37;9.31;2.47;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)CCc7ccncc7;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL3262093;EC50;=;2.75;nM;8.56;;2a;CHEMBL3267139;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by beta-plate liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259633;Scientific Literature;0;0;471.6;;;;;4.13;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@]12C=C[C@@]3(C[C@@H]1[C@H](O)c4ccccc4)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5CC8CC8)c67;;J. Med. Chem.;2014;1;UO_0000065;False
CHEMBL371970;IC50;=;90;nM;7.05;;3;CHEMBL866455;Inhibition of loperamide-stimulated [35S]GTP-gamma-S binding to membranes containing mu opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149448;Scientific Literature;0;1;337.51;;;;;5.01;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC[C@@H]1C[C@](C)([C@@H](C)CN1CCc2ccccc2)c3cccc(O)c3;;Bioorg. Med. Chem. Lett.;2006;1;UO_0000065;False
CHEMBL383094;IC50;=;9;nM;8.05;;24;CHEMBL866455;Inhibition of loperamide-stimulated [35S]GTP-gamma-S binding to membranes containing mu opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149448;Scientific Literature;0;1;345.57;;;;;6.13;Homo sapiens;;;;;9606;BAO_0000019;;;;;CCCCCCCN1C[C@H](C)[C@@](C)(C[C@H]1CCC)c2cccc(O)c2;;Bioorg. Med. Chem. Lett.;2006;1;UO_0000065;False
CHEMBL3264747;EC50;=;9;nM;8.05;;4h;CHEMBL3271437;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]-GTP[gammaS] binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259551;Scientific Literature;0;0;486.57;16.54;0.31;4.72;11.26;3.33;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@]56[C@@H]7[C@@H]8O[C@]35CC[C@@]7(OCOc1c26)N(C8=O)c9ccccc9;;ACS Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL402964;IC50;=;21;nM;7.68;;19;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;2;590.76;;;;;6.33;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)N[C@@H](Cc3ccc(cc3)c4ccccc4)C(=O)O)CC[C@@]1(C)c5cccc(O)c5;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL255555;IC50;=;25;nM;7.6;;12;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;2;514.67;;;;;5.11;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(CCC(=O)N(Cc2ccccc2)[C@@H](Cc3ccccc3)C(=O)O)CC[C@@]1(C)c4cccc(O)c4;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL404583;IC50;=;70;nM;7.16;;11;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;2;500.64;;;;;5.11;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(CCC(=O)N([C@@H](Cc2ccccc2)C(=O)O)c3ccccc3)CC[C@@]1(C)c4cccc(O)c4;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL401508;IC50;=;5.5;nM;8.26;;4;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;0;430.59;;;;;3.92;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(CCC(=O)N[C@@H](CC2CCCCC2)C(=O)O)CC[C@@]1(C)c3cccc(O)c3;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL401716;IC50;=;7.8;nM;8.11;;3;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;0;424.54;;;;;3.19;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(CCC(=O)N[C@@H](Cc2ccccc2)C(=O)O)CC[C@@]1(C)c3cccc(O)c3;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL270401;IC50;=;5.3;nM;8.28;;22;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;2;520.71;;;;;5.39;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)N[C@@H](CC3CCCCC3)C(=O)O)CC[C@@]1(C)c4cccc(O)c4;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL494854;EC50;=;0.69;nM;9.16;;12;CHEMBL1007140;Activity at monocloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140920;Scientific Literature;0;0;497.6;;;;;3.3;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccc8ccccc8n7;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL33986;IC50;=;14;nM;7.85;;11a;CHEMBL1019888;Activity at human cloned mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;4;0;327.47;;;;;3.37;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(CCCC[C@@]35O)c2c1;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL517567;IC50;=;4;nM;8.4;;17b;CHEMBL1019888;Activity at human cloned mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;494.68;;;;;3.81;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]4Cc5ccc(C(=O)N)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL38874;EC50;=;1;nM;9;;DAMGO;CHEMBL925790;Activation of human mu opioid receptor expressed in HEK293a cells coexpressing YFP-labelled alphai1 and CFP-labelled beta-1-gamma-2 Gi subunits assessed as decrease in fluorescence resonance energy transfer signal at 10 uM;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147037;Scientific Literature;0;2;513.6;17.52;0.33;9.94;5.17;-0.94;Homo sapiens;;;HEK293-A;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Biol. Chem.;2007;1;UO_0000065;False
CHEMBL270833;IC50;=;36;nM;7.44;;14;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;2;590.76;;;;;6.77;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(CCC(=O)N(Cc2ccc(cc2)c3ccccc3)[C@@H](Cc4ccccc4)C(=O)O)CC[C@@]1(C)c5cccc(O)c5;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL258115;IC50;=;43;nM;7.37;;9;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;0;480.65;;;;;4.56;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC(C)CN([C@@H](Cc1ccccc1)C(=O)O)C(=O)CCN2CC[C@](C)([C@@H](C)C2)c3cccc(O)c3;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL403325;IC50;=;10;nM;8;;6;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;0;438.57;;;;;3.58;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(CCC(=O)N[C@@H](CCc2ccccc2)C(=O)O)CC[C@@]1(C)c3cccc(O)c3;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL469189;IC50;=;28;nM;7.55;;cis-rac-12;CHEMBL973308;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1150274;Scientific Literature;0;0;322.46;;;;;3.15;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc4c(N)ncnc4c3[C@@]1(C)CCN2CC5CC5;;Bioorg. Med. Chem.;2008;1;UO_0000065;False
CHEMBL522375;IC50;=;31;nM;7.51;;rac-26;CHEMBL973308;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1150274;Scientific Literature;0;0;313.44;;;;;2.3;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(C(=O)N)c(N)c3[C@@]1(C)CCN2CC4CC4;;Bioorg. Med. Chem.;2008;1;UO_0000065;False
CHEMBL512150;EC50;=;3.1;nM;8.51;;4;CHEMBL958391;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;0;0;386.49;;;;;1.44;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(C[C@@H](O)CC[C@@]35O)c2c1O;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL38874;IC50;=;3.18;nM;8.5;;DAMGO;CHEMBL1252310;Agonist activity at mu opioid expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1250436;Scientific Literature;0;2;513.6;;;;;-0.94;;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem.;2010;1;UO_0000065;False
CHEMBL3580744;EC50;=;5.248;nM;8.28;;6;CHEMBL3584507;Agonist activity at human recombinant mu opioid receptor expressed in CHO cells co-expressing C-terminally modified GGalphaqi5 assessed as stimulation of calcium release by Fluo-4 AM dye-based fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3580572;Scientific Literature;0;2;767.81;10.78;0.21;7.4;3.53;0.88;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]2CCCCNC(=O)C[C@H](NC(=O)[C@H](Cc3ccc(cc3)C(F)(F)F)NC(=O)[C@H](Cc4ccccc4)NC2=O)C(=O)N;;ACS Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL2151734;EC50;=;0.079;nM;10.1;;3, BVD02;CHEMBL2156219;Agonist activity at human MOR expressed in HEK293 cell membrane assessed as inhibition of forskolin-induced cAMP accumulation by by liquid scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2150869;Scientific Literature;0;1;511.62;;;;;0.4;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H](N(C)C(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N(C)CC(=O)N;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL2208347;IC50;=;4.5;nM;8.35;;14;CHEMBL2213834;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203245;Scientific Literature;0;1;494.68;;;;;5.97;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1[C@H]2Cc3ccc(cc3[C@]1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cc5)c6ccc(O)cc6;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL112656;EC50;=;58.42;nM;7.23;;2c;CHEMBL747703;Agonistic activity against human opioid Mu receptor transfected into Chinese hamster ovary (CHO) cells using [3H]-DAMGO as radioligand;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1131901;Scientific Literature;0;0;413.48;;;;;2.77;;;;CHO;;9606;BAO_0000219;;;;;CN1CCC23C4Oc5c(O)ccc(CC1C2(O)Cc6cnc(nc46)c7ccccc7)c35;;Bioorg. Med. Chem. Lett.;1999;1;UO_0000065;False
CHEMBL249985;EC50;=;11;nM;7.96;;10;CHEMBL941715;Agonist activity at human mu opioid receptor expressed in CHO cell membrane by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140563;Scientific Literature;0;2;508.71;;;;;6.27;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc(cc1)c2ccc(CCNC(=O)c3ccc4CC5[C@H](C)[C@](C)(CCN5CC6CC6)c4c3)cc2;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL249567;EC50;=;16;nM;7.8;;7;CHEMBL941715;Agonist activity at human mu opioid receptor expressed in CHO cell membrane by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140563;Scientific Literature;0;1;481.48;;;;;5.36;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)NCCc5ccc(Br)cc5;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL3216936;EC50;=;4.24;nM;8.37;;18;CHEMBL1678401;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1671784;Scientific Literature;0;1;591.58;;;;;3.66;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cl.Cl.OC(=O)CN[C@@H]1CC[C@@]2(OCCCc3ccccc3)[C@H]4Cc5ccc(O)c6O[C@@H]1[C@]2(CCN4CC7CC7)c56;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL38874;EC50;=;13.7;nM;7.86;;DAMGO;CHEMBL749736;Stimulation of [35S]GTP-gamma-S, binding to recombinant human Opioid receptor mu 1 expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144921;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL2387197;EC50;=;37.3;nM;7.43;;14;CHEMBL2389089;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2385080;Scientific Literature;0;1;354.54;;;;;5.1;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CCC1C(=O)N(C2CCN(CC2)C3CCCCCCC3)c4ccccc14;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL3086305;IC50;=;1.8;nM;8.74;;9, MCL-744;CHEMBL3090457;Antagonist activity at human mu opioid receptor transfected in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085732;Scientific Literature;0;0;409.56;;;;;3.5;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(=O)Nc1nc2C[C@]34CCN(CC5CC5)[C@H](Cc6ccc(O)cc36)[C@@H]4Cc2s1;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL58646;EC50;=;3.7;nM;8.43;;1, 8-CAC;CHEMBL870418;Antagonist activity against human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1146899;Scientific Literature;0;0;298.43;;;;;2.72;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)N;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL2443256;EC50;=;5.012;nM;8.3;;(R)-24;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;0;370.56;;;;;4.99;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Cc1csc(CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4)c1;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL2443254;EC50;=;31.62;nM;7.5;;(R)-22;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;0;342.53;;;;;4.61;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;C(C[C@]1(CCOC2(CCCC2)C1)c3ccccn3)NCC4CCCC4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3086308;IC50;=;2.5;nM;8.6;;12, MCL-742;CHEMBL3090457;Antagonist activity at human mu opioid receptor transfected in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085732;Scientific Literature;0;0;462.46;;;;;3.58;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Br.CNc1nc2C[C@]34CCN(CC5CC5)[C@H](Cc6ccc(O)cc36)[C@@H]4Cc2s1;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL76573;IC50;=;1.3;nM;8.89;;26;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;423.6;20.98;0.39;5.42;11.31;3.47;;;;;;9606;BAO_0000357;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2CNCC(C)(C)C;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL319536;IC50;=;2;nM;8.7;;3;CHEMBL754686;Concentration required to inhibit agonist (loperamide) stimulated [35S]GTP-gamma-S, binding to membranes containing the cloned human mu opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136497;Scientific Literature;0;0;309.45;;;;;4.23;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(CCc2ccccc2)CC[C@@]1(C)c3cccc(O)c3;;Bioorg. Med. Chem. Lett.;2003;1;UO_0000065;True
CHEMBL2443258;EC50;=;50.12;nM;7.3;;(R)-26;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;0;354.49;;;;;4.52;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Cc1oc(CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4)cc1;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL2443279;EC50;=;12.59;nM;7.9;;(R)-20;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;0;356.54;;;;;4.68;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;C(C[C@]1(CCOC2(CCCC2)C1)c3ccccn3)NCc4ccsc4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL75802;IC50;=;5.4;nM;8.27;;31;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;488.66;16.92;0.32;4.04;9.09;4.23;;;;;;9606;BAO_0000357;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2C\N=C(\S)/Nc4ccccc4;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL515864;EC50;=;1.26;nM;8.9;;5;CHEMBL1007140;Activity at monocloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140920;Scientific Literature;0;0;447.54;;;;;2.15;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@H](CC[C@@]36O)NC(=O)c7ccncc7;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL584995;IC50;=;0.38;nM;9.42;;4;CHEMBL1058518;Displacement of [3H]DAMGO from mu opioid receptor expressed in CHO cells after 90 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154775;Scientific Literature;0;3;975.12;9.66;0.19;9.34;2.96;0.08;;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCCN(N=C=S)N=C=S)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)O;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL115652;IC50;=;2;nM;8.7;;32;CHEMBL757059;Binding affinity against mu opiate receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134625;Scientific Literature;0;0;399.88;21.75;0.42;5.7;16.1;3;;;;;;9606;BAO_0000357;;;;;Clc1cc2OCOc2cc1CN3CCC4(CC3)N(CNC4=O)c5ccccc5;;J. Med. Chem.;2001;1;UO_0000065;True
CHEMBL2113295;EC50;=;85.3;nM;7.07;;5b;CHEMBL896951;Agonist activity at human delta opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;514.67;;;;;4.28;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)[C@@]6(CC[C@@]35C[C@@H]6CNC(=O)\C=C\c7ccccc7C)OC;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL219317;IC50;=;16;nM;7.8;;32;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;379.5;;;;;3.91;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(C[C@H]2C[C@@]1(C)c3cccc(O)c3)C(=O)Nc4ccccc4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL470005;EC50;=;10;nM;8;;11;CHEMBL958391;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;0;0;356.47;;;;;2.07;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CC4)CC[C@@]5(CCCC[C@@]35O)c2c1O;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL2113300;EC50;=;14.3;nM;7.84;;5g;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;545.64;;;;;3.88;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)[C@@]6(CC[C@@]35C[C@@H]6CNC(=O)\C=C\c7ccccc7[N+](=O)[O-])OC;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL2113306;EC50;=;15.9;nM;7.8;;6d;CHEMBL896951;Agonist activity at human delta opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;500.64;;;;;3.97;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1CNC(=O)\C=C\c4ccc(C)cc4)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5C)c67;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL495402;IC50;=;67;nM;7.17;;7;CHEMBL953421;Displacement of [3H]diprenorphin from human mu opioid receptor expressed in CHO cell membrane;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1150320;Scientific Literature;0;0;382.96;18.73;0.39;3.56;12.95;3.61;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN(CCO)CCN1c2cc3[nH]c(SC(C)(C)C)nc3cc2Cl;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL219097;IC50;=;66;nM;7.18;;19;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;302.46;;;;;2.99;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(C)[C@H]1CN2C[C@H](C)[C@@](C)(C[C@@H]2CN1)c3cccc(O)c3;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL426523;IC50;=;0.54;nM;9.27;;6;CHEMBL909317;Antagonist activity against human cloned mu opioid receptor expressed in CHO cells assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137299;Scientific Literature;0;0;335.49;;;;;4.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2C[C@@H](CC[C@H]2C[C@@]1(C)c3cccc(O)c3)c4ccccc4;;J. Med. Chem.;2006;1;UO_0000065;True
CHEMBL3325715;EC50;=;41;nM;7.39;;20;CHEMBL3370190;Agonist activity at human mu opioid receptor expressed CHO-K1 cells coexpressing Galpha15 assessed as induction of intracellular calcium release by FLIPR calcium assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3351626;Scientific Literature;0;0;367.67;20.09;0.48;2.64;21.17;4.75;Homo sapiens;;;CHO-K1;;9606;BAO_0000219;;;;;Cc1nn(c2CC(C)(C)CC(=O)c12)c3ccc(Cl)cc3Br;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL518950;EC50;=;67;nM;7.17;;16;CHEMBL993921;Agonist activity at human mu opioid receptor expressed in CHOK1 cells by [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1143349;Scientific Literature;0;1;422.66;;;;;5.99;Homo sapiens;;;CHO-K1;;9606;BAO_0000219;;;;;CN1CCC[C@H](C1)c2nc3ccccc3n2C4CCN(CC4)C5(C)CCCCCCC5;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL481512;EC50;=;34;nM;7.47;;1, MCOPPB;CHEMBL993921;Agonist activity at human mu opioid receptor expressed in CHOK1 cells by [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1143349;Scientific Literature;0;1;408.63;;;;;5.64;Homo sapiens;;;CHO-K1;;9606;BAO_0000219;;;;;CC1(CCCCCCC1)N2CCC(CC2)n3c(nc4ccccc34)[C@@H]5CCCNC5;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL58646;EC50;=;2.7;nM;8.57;;2, 8-CAC;CHEMBL2353039;Partial agonist activity at human mu opioid receptor expressed in CHO cell membrane assessed as stimulation of [35S]GTPgammaS binding after 60 mins by liquid scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2346652;Scientific Literature;0;0;298.43;;;;;2.72;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)N;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL336234;IC50;=;1.9;nM;8.72;;4;CHEMBL754686;Concentration required to inhibit agonist (loperamide) stimulated [35S]GTP-gamma-S, binding to membranes containing the cloned human mu opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136497;Scientific Literature;0;0;336.48;;;;;3.63;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(CCc2ccccc2)CC[C@@]1(C)c3cccc(c3)C(=O)N;;Bioorg. Med. Chem. Lett.;2003;1;UO_0000065;False
CHEMBL384497;IC50;=;0.12;nM;9.92;;5d;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;1;507.07;;;;;4.71;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NCCCc7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL325842;IC50;=;6.3;nM;8.2;;25;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;0;0;399.88;20.51;0.4;4.71;15.18;3.49;;;;;;9606;BAO_0000357;;;;;Clc1cc2OCOc2cc1CN3CCC(CC3)N4C(=O)CNc5ccccc45;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL411089;IC50;=;1.64;nM;8.79;;5i;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;2;519.09;;;;;5.18;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NCC\C=C\c7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL1773091;IC50;=;7.6;nM;8.12;;13b, MCL-693;CHEMBL1777023;Antagonist activity at human mu-opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1772956;Scientific Literature;0;2;615.86;;;;;8.08;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CCCC[C@@]13CCN(CC4CCC4)[C@@H]2Cc5ccc(OC(=O)CCCCCCCCC(=O)OCc6ccccc6)cc35;;Bioorg. Med. Chem.;2011;1;UO_0000065;False
CHEMBL1774950;EC50;=;2;nM;8.7;;15a, MCL-696;CHEMBL1777022;Agonist activity at human mu-opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1772956;Scientific Literature;0;2;821.07;;;;;7.2;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O[C@@]12CCCC[C@@]13CCN(CC4CCC4)[C@@H]2Cc5ccc(OC(=O)CCCCCCCCC(=O)Oc6ccc7C[C@H]8N(CC=C)CC[C@@]9%10[C@@H](Oc6c79)C(=O)CC[C@@]8%10O)cc35;;Bioorg. Med. Chem.;2011;1;UO_0000065;False
CHEMBL607016;EC50;=;0.5;nM;9.3;;7e;CHEMBL864218;Stimulation of [35S]GTPgammaS binding to human recombinant MOR;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1146036;Scientific Literature;0;0;478.98;;;;;3.54;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35NC(=O)\C=C\c6ccccc6Cl;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL403515;IC50;=;15;nM;7.82;;52;CHEMBL864838;Displacement of [3H]naloxone from mu opioid receptor expressed in BHK cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145308;Scientific Literature;0;0;389.54;20.08;0.37;3.55;21.99;4.27;Homo sapiens;;;BHK;;9606;BAO_0000219;;;;;O=C1NCN(c2ccccc2)C13CCN(CC3)C4(CCCCC4)c5ccccc5;;Bioorg. Med. Chem. Lett.;2006;1;UO_0000065;False
CHEMBL611929;EC50;=;16;nM;7.8;;5;CHEMBL1071838;Activity at mu opioid receptor expressed in HEK293 cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1152554;Scientific Literature;0;1;604.58;;;;;3.77;;;;HEK293;;9606;BAO_0000219;;;;;OC(=O)C(=O)O.Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccc(cc7)C(F)(F)F;;Bioorg. Med. Chem.;2009;1;UO_0000065;False
CHEMBL593215;EC50;=;2.3;nM;8.64;;9;CHEMBL1071838;Activity at mu opioid receptor expressed in HEK293 cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1152554;Scientific Literature;0;1;605.47;;;;;4.06;;;;HEK293;;9606;BAO_0000219;;;;;OC(=O)C(=O)O.Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccc(Cl)c(Cl)c7;;Bioorg. Med. Chem.;2009;1;UO_0000065;False
CHEMBL375119;IC50;=;1.3;nM;8.89;;18;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;342.53;;;;;3.91;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2C[C@@H](NC[C@H]2C[C@@]1(C)c3cccc(O)c3)C4CCCCC4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL80463;IC50;=;1;nM;9;;28;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;472.59;19.04;0.35;5.35;8.36;3.65;;;;;;9606;BAO_0000357;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2CNC(=O)Nc4ccccc4;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL80463;EC50;=;18.8;nM;7.73;;28;CHEMBL758076;Agonist potency using GTP-gamma [35S]- binding assay for mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;472.59;16.35;0.3;4.08;7.17;3.65;;;;;;9606;BAO_0000357;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2CNC(=O)Nc4ccccc4;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL2107292;EC50;=;21;nM;7.68;;10a;CHEMBL1019886;Activity at human cloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;285.39;;;;;2.97;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1[C@@H]2N(CC3CC3)CC[C@@]1(C)c4cc(O)ccc4C2=O;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL169346;EC50;=;92;nM;7.04;;(-)45;CHEMBL749733;Incorporation of [35S]- GTPgammaS into CHO membranes expressing human Opioid receptor mu 1;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145777;Scientific Literature;0;0;298.43;23.58;0.44;3.81;15.19;3.23;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC[C@]12CCN(CC3CC3)C([C@@H]1C)C(=O)c4ccc(N)cc24;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL310146;IC50;=;33.2;nM;7.48;;21;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;394.52;18.96;0.35;5.06;7.3;2.42;;;;;;9606;BAO_0000357;;;;;CC(=N)NC[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc3c(C)cc(O)cc3C;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL2113302;EC50;=;74.2;nM;7.13;;5i;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;530.67;;;;;3.98;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc(\C=C\C(=O)NC[C@H]2C[C@]34CC[C@@]2(OC)[C@@H]5Oc6c(OC)ccc7C[C@H]3N(C)CC[C@@]45c67)cc1;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL387016;IC50;=;96.3;nM;7.02;;3e;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;0;355.43;;;;;1.83;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL607127;EC50;=;2.5;nM;8.6;;7c;CHEMBL864218;Stimulation of [35S]GTPgammaS binding to human recombinant MOR;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1146036;Scientific Literature;0;0;458.56;;;;;3.19;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35NC(=O)\C=C\c6ccc(C)cc6;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL383896;IC50;=;0.24;nM;9.62;;4i;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;1;505.06;;;;;4.88;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NCC\C=C\c7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL369919;EC50;=;12;nM;7.92;;4 (MCL-406);CHEMBL863310;Activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148605;Scientific Literature;0;2;821.16;;;;;9.79;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C(CCCCCCCCC(=O)Oc1ccc2C[C@@H]3C4CCCC[C@]4(CCN3C[C@@H]5CCCO5)c2c1)Oc6ccc7C[C@@H]8C9CCCC[C@]9(CCN8C[C@@H]%10CCCO%10)c7c6;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL1834249;IC50;=;11;nM;7.96;;page no 6539, R53C1;CHEMBL1837092;Agonist activity at Mu-type opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1833812;Scientific Literature;0;3;814.9;;;;;-1.78;;;;;;9606;BAO_0000019;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NC2Cc3ccccc3CN(CC(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)N5CCC[C@H]5C(=O)N[C@@H](CO)C(=O)N)C2=O;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL203307;IC50;=;50;nM;7.3;;2;CHEMBL866455;Inhibition of loperamide-stimulated [35S]GTP-gamma-S binding to membranes containing mu opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149448;Scientific Literature;0;0;323.48;;;;;4.62;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@@H]1C[C@](C)([C@@H](C)CN1CCc2ccccc2)c3cccc(O)c3;;Bioorg. Med. Chem. Lett.;2006;1;UO_0000065;False
CHEMBL1618305;IC50;=;7.196;nM;8.14;;NALOXONAZINE;CHEMBL1909182;DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine);cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1909046;DrugMatrix;0;1;650.78;12.51;0.23;4.86;6.24;3.28;;;;CHO-K1;Membrane;9606;BAO_0000249;;;;;Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)\C(=N\N=C\6/CC[C@@]7(O)[C@H]8Cc9ccc(O)c%10O[C@@H]6[C@]7(CCN8CC=C)c9%10)\CC[C@@]35O;;;;15;UO_0000065;False
CHEMBL201661;IC50;=;16;nM;7.8;;17;CHEMBL866455;Inhibition of loperamide-stimulated [35S]GTP-gamma-S binding to membranes containing mu opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149448;Scientific Literature;0;1;365.56;;;;;5.79;Homo sapiens;;;;;9606;BAO_0000019;;;;;CCC[C@@H]1C[C@](C)([C@@H](C)CN1CCCc2ccccc2)c3cccc(O)c3;;Bioorg. Med. Chem. Lett.;2006;1;UO_0000065;False
CHEMBL2048771;EC50;=;8.8;nM;8.06;;4d, MCL-713;CHEMBL2050641;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;402.58;20.01;0.37;2.59;22.69;5.47;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccccc1CNc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4CC6CC6)c3c2;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2048764;EC50;=;3.6;nM;8.44;;3e, MCL-705;CHEMBL2050641;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;444.62;18.99;0.35;2.55;25.03;5.89;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C(Nc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)c6ccc7OCOc7c6;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL404303;IC50;=;7.9;nM;8.1;;20;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;2;564.73;;;;;5.82;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)N[C@@H](Cc3cccc4ccccc34)C(=O)O)CC[C@@]1(C)c5cccc(O)c5;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL324297;IC50;=;1.5;nM;8.82;;23;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;0;0;396.4;22.26;0.42;5.6;8.58;3.22;;;;;;9606;BAO_0000357;;;;;Oc1nc2ccccc2n1C3CCN(Cc4cc5OCOc5cc4[N+](=O)[O-])CC3;;J. Med. Chem.;2001;1;UO_0000065;True
CHEMBL146054;IC50;=;43;nM;7.37;;13;CHEMBL749745;Binding affinity in CHO cells stably expressing cloned human Opioid receptor mu 1 by displacing diprenorphine;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1132115;Scientific Literature;0;0;355.87;20.7;0.4;2.58;17.84;4.79;;;;CHO;;9606;BAO_0000219;;;;;CC(N1CCC(CC1)n2c(O)nc3ccccc23)c4ccccc4Cl;;J. Med. Chem.;1999;1;UO_0000065;False
CHEMBL397035;IC50;=;6.4;nM;8.19;;(-)2d;CHEMBL887397;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as DAMGO-stimulated [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;1;416.57;;;;;5.77;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C(Nc1ccccc1)Oc2ccc3CC4C5CCCCC5(CCN4CC6CC6)c3c2;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL427862;EC50;=;2.4;nM;8.62;;(-)2c;CHEMBL887396;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as maximal stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;0;368.52;;;;;4.26;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CCNC(=O)Oc1ccc2CC3C4CCCCC4(CCN3CC5CC5)c2c1;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL2113372;EC50;=;51.4;nM;7.29;;6c;CHEMBL749736;Stimulation of [35S]GTP-gamma-S, binding to recombinant human Opioid receptor mu 1 expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144921;Scientific Literature;0;0;485.63;;;;;4.89;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CCCCCCC(=O)N[C@]12Cc3c([nH]c4ccccc34)[C@@H]5Oc6c(O)ccc7CC1N(C)CC[C@@]25c67;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL2397018;EC50;=;2.81;nM;8.55;;7;CHEMBL2399071;Agonist activity at mu opioid receptor (unknown origin) expressed CHO cells assessed as stimulation of [35S]-GTP[gammaS] binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2396652;Scientific Literature;0;0;495.58;17.26;0.32;5.04;9.32;3.51;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)c7cnc8ccccc8c7;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL38874;EC50;=;40;nM;7.4;;DAMGO;CHEMBL923555;Agonist activity at human recombinant mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144846;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Med. Chem.;2008;1;UO_0000065;False
CHEMBL238017;EC50;=;15;nM;7.82;;10;CHEMBL897687;Agonist activity at human mu opioid receptor expressed in CHO membrane by [35S]GTP-gamma-S binding assay;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149641;Scientific Literature;0;0;387.48;;;;;1.19;Homo sapiens;;;;;9606;BAO_0000249;;;;;CO[C@]12C(O)C[C@@]3(C[C@@H]1[C@H](C)O)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4C)c56;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL2334770;EC50;=;0.0397;nM;10.4;;5;CHEMBL2341394;Agonist activity at FLAG-tagged mu-type opioid receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins by liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2331515;Scientific Literature;0;2;622.73;;;;;2.22;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CC[C@H](C2)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](C(=C)C(=O)N)c5ccccc5;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL2443272;EC50;=;2.512;nM;8.6;;(R)-13;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;1;384.95;;;;;5.28;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Clc1cccc(CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4)c1;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL511142;EC50;=;1.995;nM;8.7;;Buprenorphine;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;4;0;467.65;;;;;4.41;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL2443259;EC50;=;25.12;nM;7.6;;(R)-27;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;1;384.59;;;;;5.3;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Cc1cc(C)c(CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4)s1;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL216558;IC50;=;1.21;nM;8.92;;4h;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;1;505.06;;;;;4.58;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC\C=C\Cc7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL217710;IC50;=;1.84;nM;8.73;;4f;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;1;519.04;;;;;4.41;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)C\C=C\c7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL443311;IC50;=;0.0125;nM;10.9;;4d;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;0;493.05;;;;;4.41;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NCCCc7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL437983;IC50;=;1.4;nM;8.85;;26;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;0;481.64;;;;;3.16;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCN)C(=O)O)CC[C@@]1(C)c3cccc(O)c3;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL256834;IC50;=;14;nM;7.85;;7;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;0;438.57;;;;;3.54;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(CCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)O)CC[C@@]1(C)c3cccc(O)c3;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL1627325;EC50;=;10.96;nM;7.96;;9, [tBu-D-Gly5]NPS;CHEMBL1001565;Antagonist activity at human recombinant mu opioid receptor expressed in CHO cells coexpressing alphaqi5 assessed as inhibition of dermorphin-induced intracellular calcium mobilization;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136992;Scientific Literature;0;;2243.63;;;;;;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CSCC[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)C(C)(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL278789;EC50;=;10.47;nM;7.98;;dermorphin;CHEMBL1001565;Antagonist activity at human recombinant mu opioid receptor expressed in CHO cells coexpressing alphaqi5 assessed as inhibition of dermorphin-induced intracellular calcium mobilization;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136992;Scientific Literature;0;3;802.89;;;;;-2;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)N;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL3217050;EC50;=;60;nM;7.22;;5g;CHEMBL3089286;Agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085655;Scientific Literature;0;1;479.54;;;;;5.09;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cl.Cl.CCN(C)[C@H]1C[C@H]2C[C@@](C1)([C@H](C)CN2CCCc3ccccc3)c4cccc(O)c4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL218404;IC50;=;2.1;nM;8.68;;22;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;364.49;;;;;3.52;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(C[C@H]2C[C@@]1(C)c3cccc(O)c3)C(=O)c4ccccc4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL1200401;IC50;=;1.7;nM;8.77;;Buprenorphine hydrochloride;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;0;0;504.11;18.75;0.35;4.36;14.11;4.41;;;;;;9606;BAO_0000357;;;;;Cl.CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL420863;IC50;=;2.4;nM;8.62;;26;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;0;0;399.88;21.56;0.42;4.35;14.43;4.27;;;;;;9606;BAO_0000357;;;;;Cc1ccc2nc(O)n(C3CCN(Cc4cc5OCOc5cc4Cl)CC3)c2c1;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL1161424;EC50;=;4.2;nM;8.38;;9;CHEMBL749654;Compound tested at 10 uM for the ability to induce Opioid receptor mu 1-mediated binding of [35S]GTP-gamma-S to G proteins in CHO membrane preparations;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145973;Scientific Literature;0;1;517.67;;;;;4.19;;;;;;9606;BAO_0000249;;;;;Cc1cc(O)cc(C)c1C[C@H](N)[C@@H](O)C\C=C\[C@H](O)[C@@H](Cc2ccccc2)C(=O)OCCc3ccccc3;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL242756;EC50;=;73;nM;7.14;;9a;CHEMBL749648;Agonistic activity against Opioid receptor mu 1 in Chinese hamster ovary membranes;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149134;Scientific Literature;0;0;353.54;;;;;4.35;Cricetulus griseus;;;;;9606;BAO_0000249;;;;;Nc1nc2cc3c(C[C@@H]4[C@@H]5CCCC[C@]35CCN4CC6CC6)cc2s1;;J. Med. Chem.;2004;1;UO_0000065;True
CHEMBL245049;EC50;=;50;nM;7.3;;(-)1b;CHEMBL887396;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as maximal stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;0;314.43;;;;;3.09;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CNC(=O)Oc1ccc2CC3C4CCCCC4(CCN3C)c2c1;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL263096;IC50;=;16;nM;7.8;;(-)2e;CHEMBL887397;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as DAMGO-stimulated [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;1;430.59;;;;;5.44;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C(NCc1ccccc1)Oc2ccc3CC4C5CCCCC5(CCN4CC6CC6)c3c2;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL217658;IC50;=;1.56;nM;8.81;;4l;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;0;479.02;;;;;4.02;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NCCc7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL215926;IC50;=;1.45;nM;8.84;;5j;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;2;521.1;;;;;5.1;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NCCCCc7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL216365;IC50;=;1.27;nM;8.9;;5f;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;1;533.07;;;;;4.71;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)C\C=C\c7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL202327;IC50;=;39;nM;7.41;;23;CHEMBL866455;Inhibition of loperamide-stimulated [35S]GTP-gamma-S binding to membranes containing mu opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149448;Scientific Literature;0;1;331.54;;;;;5.74;Homo sapiens;;;;;9606;BAO_0000019;;;;;CCCCCCN1C[C@H](C)[C@@](C)(C[C@H]1CCC)c2cccc(O)c2;;Bioorg. Med. Chem. Lett.;2006;1;UO_0000065;False
CHEMBL242047;EC50;=;39;nM;7.41;;(-)3c;CHEMBL887396;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as maximal stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;0;382.55;;;;;4.65;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CCNC(=O)Oc1ccc2CC3C4CCCCC4(CCN3CC5CCC5)c2c1;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL242046;EC50;=;11;nM;7.96;;(-)3b;CHEMBL887396;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as maximal stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;0;368.52;;;;;4.26;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CNC(=O)Oc1ccc2CC3C4CCCCC4(CCN3CC5CCC5)c2c1;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL58646;IC50;=;21;nM;7.68;;1, 8-CAC;CHEMBL870418;Antagonist activity against human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1146899;Scientific Literature;0;0;298.43;;;;;2.72;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)N;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL2113382;EC50;=;5.33;nM;8.27;;5d;CHEMBL749736;Stimulation of [35S]GTP-gamma-S, binding to recombinant human Opioid receptor mu 1 expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144921;Scientific Literature;0;0;477.61;;;;;4.63;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(CC1[C@@]2(Cc6c4[nH]c7ccccc67)NCCc8ccccc8)c35;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL402116;IC50;=;48;nM;7.32;;26;CHEMBL948139;Binding affinity to mu opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1141623;Scientific Literature;0;0;249.35;29.35;0.56;4.68;17.64;2.64;;;;;;9606;BAO_0000357;;;;;CNC[C@H]1CCCC[C@]1(OC)c2cccc(O)c2;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL2113379;EC50;=;95;nM;7.02;;6d;CHEMBL749736;Stimulation of [35S]GTP-gamma-S, binding to recombinant human Opioid receptor mu 1 expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144921;Scientific Literature;0;0;491.59;;;;;4.16;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(CC1[C@@]2(Cc6c4[nH]c7ccccc67)NC(=O)Cc8ccccc8)c35;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL270570;IC50;=;97;nM;7.01;;11;CHEMBL948139;Binding affinity to mu opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1141623;Scientific Literature;0;0;305.46;22.96;0.44;2.85;21.45;4.16;;;;;;9606;BAO_0000357;;;;;CCCCO[C@@]1(CCCC[C@@H]1CN(C)C)c2cccc(O)c2;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL2113294;EC50;=;41.5;nM;7.38;;5a;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;500.64;;;;;3.97;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)[C@@]6(CC[C@@]35C[C@@H]6CNC(=O)\C=C\c7ccccc7)OC;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL2113314;EC50;=;14.4;nM;7.84;;18b;CHEMBL896951;Agonist activity at human delta opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;510.63;;;;;3.7;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12C=C[C@@]3([C@@H]4CN(C[C@H]14)C(=O)\C=C\c5ccc(C)cc5)[C@H]6Cc7ccc(O)c8O[C@@H]2[C@]3(CCN6C)c78;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL377069;EC50;=;2;nM;8.7;;4c;CHEMBL2163098;Agonist activity at mu opioid receptor expressed in CHO-hg cells by [35S]-GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2157906;Scientific Literature;0;0;418.54;20.78;0.38;4.68;9.13;4.02;;;;CHO-hg;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2CCCC[C@H]2c3nc(c[nH]3)c4ccccc4;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL3262545;EC50;=;81.4;nM;7.09;;5b, syn diastereomer;CHEMBL3270915;Agonist activity at human mu opioid receptor transfected in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259735;Scientific Literature;0;1;414.59;;;;;5.95;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CCC1C(=O)N(C2CCN(CC2)[C@@H]3CC[C@@H]4CCCc5cccc3c45)c6ccccc16;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL3262546;EC50;=;28.7;nM;7.54;;5c;CHEMBL3270915;Agonist activity at human mu opioid receptor transfected in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259735;Scientific Literature;0;1;374.53;;;;;5.07;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CCC1C(=O)N(C2CCN(CC2)C3CCCc4ccccc34)c5ccccc15;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL3262548;EC50;=;23.4;nM;7.63;;7e;CHEMBL3270915;Agonist activity at human mu opioid receptor transfected in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259735;Scientific Literature;0;0;373.5;;;;;4.67;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CCC1C(=O)N(C2CCN(Cc3cccc4[nH]ccc34)CC2)c5ccccc15;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL2113672;EC50;=;1.8;nM;8.74;;7d;CHEMBL749726;EC50 for binding of [35S]- GTPdeltaS in cloned human Opioid receptor mu 1 (DAMGO) transfected onto CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1132936;Scientific Literature;0;0;459.59;19.03;0.35;4.52;17.09;4.22;;;;CHO;;9606;BAO_0000219;;;;;CO[C@]12C=C[C@@]3(C[C@H]1[C@H](C)OCc4ccccc4)[C@H]5Cc6ccc(O)c7O[C@H]2C3(CCN5C)c67;;J. Med. Chem.;2000;1;UO_0000065;False
CHEMBL568877;EC50;=;6.8;nM;8.17;;3h, MCL-628;CHEMBL2050641;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;416.61;19.6;0.36;2.39;33.34;5.78;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc(CNc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4CC6CC6)c3c2)cc1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL399465;EC50;=;12;nM;7.92;;6;CHEMBL941715;Agonist activity at human mu opioid receptor expressed in CHO cell membrane by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140563;Scientific Literature;0;1;478.68;;;;;6.26;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)NCCc5ccccc5c6ccccc6;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL255467;EC50;=;28;nM;7.55;;Morphinone;CHEMBL925795;Activation of human mu opioid receptor expressed in HEK293a cells co-expressing YFP-labelled alphai1 and CFP-labelled beta1gamma2 Gi subunits assessed as Gi protein activation by fluorescence resonance energy transfer;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147037;Scientific Literature;0;0;283.33;26.66;0.49;6.14;15.18;1.41;Homo sapiens;;;HEK293-A;;9606;BAO_0000219;;;;;CN1CC[C@@]23[C@H]4C=CC(=O)[C@@H]2Oc5c(O)ccc(C[C@@H]14)c35;;J. Biol. Chem.;2007;1;UO_0000065;False
CHEMBL2096625;IC50;=;1;nM;9;;Morphine sulfate;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;0;0;668.77;31.54;0.59;7.8;17;1.2;;;;;;9606;BAO_0000357;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35.CN6CC[C@]78[C@H]9Oc%10c(O)ccc(C[C@@H]6[C@@H]7C=C[C@@H]9O)c8%10.OS(=O)(=O)O;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL2048764;IC50;=;94;nM;7.03;;3e, MCL-705;CHEMBL2050643;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;444.62;15.8;0.29;1.14;20.83;5.89;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C(Nc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)c6ccc7OCOc7c6;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL511816;IC50;=;4.4;nM;8.36;;13;CHEMBL958397;Antagonist activity against human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;0;0;327.42;;;;;2.35;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@]56[C@H](CCC[C@@]35O)Oc1c26;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL376355;EC50;=;2.6;nM;8.59;;22c;CHEMBL904888;Agonist activity at human mu opioid receptor expressed in CHO membrane assessed as stimulation of [35S]GTPgammaS binding;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1143667;Scientific Literature;0;0;381.55;;;;;3.51;Homo sapiens;;;;;9606;BAO_0000249;;;;;Nc1nc2C[C@]34CCN(CC5CCC5)[C@H](Cc6ccc(O)cc36)[C@@H]4Cc2s1;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL3086305;EC50;=;0.52;nM;9.28;;9, MCL-744;CHEMBL3090458;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085732;Scientific Literature;0;0;409.56;;;;;3.5;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(=O)Nc1nc2C[C@]34CCN(CC5CC5)[C@H](Cc6ccc(O)cc36)[C@@H]4Cc2s1;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3707094;IC50;=;53;nM;7.28;;15;CHEMBL753178;In vitro binding affinity against cloned human Opioid receptor mu 1 expressed in HEK 293S cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145019;Scientific Literature;0;0;445.66;16.33;0.3;4.03;44.91;3.25;;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H]1[C@H]2c3cc(ccc3C[C@H](N1C)c4ccc(cc24)N5CCN(C)CC5)N6CCN(C)CC6;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL2163912;EC50;=;0.72;nM;9.14;;8;CHEMBL2166341;Agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by liquid scintillation counter;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2163332;Scientific Literature;0;2;657.17;;;;;3.01;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](C(=C)C(=O)N)c5cccc(Cl)c5;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL3707080;IC50;=;44;nM;7.36;;12;CHEMBL753178;In vitro binding affinity against cloned human Opioid receptor mu 1 expressed in HEK 293S cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145019;Scientific Literature;0;0;405.49;18.14;0.33;2.98;13.17;4.38;;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H]1[C@H]2c3cc(OC(=O)C)ccc3C[C@H](N1CC4CC4)c5ccc(OC(=O)C)cc25;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL427862;IC50;=;10;nM;8;;(-)2c;CHEMBL887397;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as DAMGO-stimulated [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;0;368.52;;;;;4.26;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CCNC(=O)Oc1ccc2CC3C4CCCCC4(CCN3CC5CC5)c2c1;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL138036;IC50;=;2.1;nM;8.68;;5;CHEMBL754686;Concentration required to inhibit agonist (loperamide) stimulated [35S]GTP-gamma-S, binding to membranes containing the cloned human mu opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136497;Scientific Literature;0;0;323.48;;;;;4.02;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(CCc2ccccc2)CC[C@@]1(C)c3cccc(CO)c3;;Bioorg. Med. Chem. Lett.;2003;1;UO_0000065;False
CHEMBL376355;IC50;=;26;nM;7.58;;22c;CHEMBL904889;Antagonist activity at human mu opioid receptor expressed in CHO membrane assessed as inhibition of DAMGO-induced [35S]GTP-gamma-S binding;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1143667;Scientific Literature;0;0;381.55;;;;;3.51;Homo sapiens;;;;;9606;BAO_0000249;;;;;Nc1nc2C[C@]34CCN(CC5CCC5)[C@H](Cc6ccc(O)cc36)[C@@H]4Cc2s1;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL224014;EC50;=;4.4;nM;8.36;;7;CHEMBL919396;Agonist activity at human opioid gamma receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147138;Scientific Literature;0;2;819.1;;;;;8.31;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O[C@]12CCC(=O)[C@@H]3Oc4c(OC(=O)CCCCCCCCC(=O)Oc5ccc6C[C@@H]7C8CCCC[C@]8(CCN7CC9CCC9)c6c5)ccc%10C[C@H]1N(CC%11CC%11)CC[C@@]23c4%10;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL123693;IC50;=;14;nM;7.85;;Heptamine;CHEMBL757305;Antagonistic activity towards Opioid receptor mu 1;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1132386;Scientific Literature;0;0;115.22;;;;;1.91;;;;;;9606;BAO_0000019;;;;;CCCCCC(C)N;;J. Med. Chem.;1999;1;UO_0000065;False
CHEMBL218705;IC50;=;42;nM;7.38;;38;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;384.95;;;;;4.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3ccc(Cl)cc3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL373641;IC50;=;1.8;nM;8.74;;37;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;384.95;;;;;4.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3cccc(Cl)c3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL394573;EC50;=;63;nM;7.2;;12, MCL-447;CHEMBL893250;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding after 60 mins;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147995;Scientific Literature;0;0;353.51;;;;;4.04;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)Nc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1;;Bioorg. Med. Chem.;2007;1;UO_0000065;False
CHEMBL607017;EC50;=;0.5;nM;9.3;;7f;CHEMBL864218;Stimulation of [35S]GTPgammaS binding to human recombinant MOR;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1146036;Scientific Literature;0;0;458.56;;;;;3.19;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35NC(=O)\C=C\c6ccccc6C;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL435746;IC50;=;2.8;nM;8.55;;16;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;350.51;;;;;3.57;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2C[C@H](Cc3ccccc3)NC[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL2113671;EC50;=;0.6;nM;9.22;;5d;CHEMBL749726;EC50 for binding of [35S]- GTPdeltaS in cloned human Opioid receptor mu 1 (DAMGO) transfected onto CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1132936;Scientific Literature;0;0;459.59;20.07;0.37;5;18.03;4.22;;;;CHO;;9606;BAO_0000219;;;;;CO[C@]12C=C[C@@]3(C[C@H]1[C@@H](C)OCc4ccccc4)[C@H]5Cc6ccc(O)c7O[C@H]2C3(CCN5C)c67;;J. Med. Chem.;2000;1;UO_0000065;False
CHEMBL1169583;EC50;=;16.2;nM;7.79;;5b;CHEMBL749728;EC50 for binding of [35S]- GTPdeltaS in cloned human opioid mu receptor transfected onto CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1132936;Scientific Literature;0;0;383.49;20.31;0.38;5.14;15.23;2.65;;;;CHO;;9606;BAO_0000219;;;;;CO[C@H](C)[C@@H]1CC23C=C[C@]1(OC)[C@H]4Oc5c(O)ccc6CC2N(C)CCC34c56;;J. Med. Chem.;2000;1;UO_0000065;False
CHEMBL258294;IC50;=;16;nM;7.8;;10;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;0;478.63;;;;;4.32;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(CCC(=O)N(CC2CC2)[C@@H](Cc3ccccc3)C(=O)O)CC[C@@]1(C)c4cccc(O)c4;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL3580746;EC50;=;5.129;nM;8.29;;8;CHEMBL3584507;Agonist activity at human recombinant mu opioid receptor expressed in CHO cells co-expressing C-terminally modified GGalphaqi5 assessed as stimulation of calcium release by Fluo-4 AM dye-based fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3580572;Scientific Literature;0;2;763.84;10.85;0.21;7.53;3.53;0.76;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N[C@@H]2CCCCNC(=O)C[C@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc4ccc(F)cc4F)NC2=O)C(=O)N;;ACS Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL3580750;EC50;=;6.761;nM;8.17;;12;CHEMBL3584507;Agonist activity at human recombinant mu opioid receptor expressed in CHO cells co-expressing C-terminally modified GGalphaqi5 assessed as stimulation of calcium release by Fluo-4 AM dye-based fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3580572;Scientific Literature;0;2;795.86;10.27;0.2;6.67;3.48;1.5;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N[C@@H]2CCCCNC(=O)C[C@H](NC(=O)[C@H](Cc3ccc(cc3)C(F)(F)F)NC(=O)[C@H](Cc4ccccc4)NC2=O)C(=O)N;;ACS Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL607125;EC50;=;0.04;nM;10.4;;8f;CHEMBL864218;Stimulation of [35S]GTPgammaS binding to human recombinant MOR;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1146036;Scientific Literature;0;0;444.53;;;;;2.89;Homo sapiens;;;;;9606;BAO_0000019;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@]2(CCC4=O)NC(=O)\C=C\c6ccccc6C)c35;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL358104;IC50;=;90;nM;7.05;;11 MCL-136;CHEMBL754564;Inhibitory activity was determined in stimulating [35S]-GTP-gamma S binding mediated by the Opioid receptor mu 1 in chinese Hamster Ovary (CHO)membranes;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145905;Scientific Literature;0;2;761.1;9.26;0.17;-3.21;11.93;10.26;;;;;;9606;BAO_0000019;;;;;O=C(CCCCCCCCC(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CC%10)c7c6;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL325750;IC50;=;29.4;nM;7.53;;35;CHEMBL757059;Binding affinity against mu opiate receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134625;Scientific Literature;0;0;379.49;19.85;0.38;4.91;12.27;2.62;;;;;;9606;BAO_0000357;;;;;O=C1NCN(c2ccccc2)C13CCN(Cc4ccc5nsnc5c4)CC3;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL325945;IC50;=;6.3;nM;8.2;;14;CHEMBL757059;Binding affinity against mu opiate receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134625;Scientific Literature;0;0;413.86;19.82;0.39;5.29;10.71;2.91;;;;;;9606;BAO_0000357;;;;;Clc1cc2OCOc2cc1CN3CCC(CC3)N4C(=O)C(=O)Nc5ccccc45;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL1169584;EC50;=;13.5;nM;7.87;;7c;CHEMBL749726;EC50 for binding of [35S]- GTPdeltaS in cloned human Opioid receptor mu 1 (DAMGO) transfected onto CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1132936;Scientific Literature;0;0;397.52;19.8;0.37;4.83;15.38;3.04;;;;CHO;;9606;BAO_0000219;;;;;CCO[C@@H](C)[C@@H]1CC23C=C[C@]1(OC)[C@H]4Oc5c(O)ccc6CC2N(C)CCC34c56;;J. Med. Chem.;2000;1;UO_0000065;False
CHEMBL77804;IC50;=;1.1;nM;8.96;;30;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;1;530.71;16.88;0.31;4.86;8.32;4.1;;;;;;9606;BAO_0000357;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2CNC(=O)NC45CC6CC(CC(C6)C4)C5;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL35838;IC50;=;26.1;nM;7.58;;6;CHEMBL969341;Agonist activity at mu opioid receptor assessed as inhibition of forskolin-induced cAMP production in human SH-SY5Y cells pretreated for 24 hrs with DMEM medium after 15 mins;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149874;Scientific Literature;0;2;554.65;;;;;-0.76;Homo sapiens;;;SH-SY5Y;;9606;BAO_0000219;;;;;CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)N;;Bioorg. Med. Chem.;2008;1;UO_0000065;False
CHEMBL3262544;EC50;=;56.9;nM;7.25;;5a, anti diastereomer;CHEMBL3270915;Agonist activity at human mu opioid receptor transfected in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259735;Scientific Literature;0;1;414.59;;;;;5.95;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CCC1C(=O)N(C2CCN(CC2)[C@H]3CC[C@@H]4CCCc5cccc3c45)c6ccccc16;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL250993;EC50;=;5.6;nM;8.25;;8;CHEMBL941715;Agonist activity at human mu opioid receptor expressed in CHO cell membrane by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140563;Scientific Literature;0;1;481.48;;;;;5.36;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)NCCc5cccc(Br)c5;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL3262091;EC50;=;18.4;nM;7.74;;1f;CHEMBL3267139;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by beta-plate liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259633;Scientific Literature;0;1;501.67;;;;;4.91;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC[C@](O)([C@H]1C[C@]23CC[C@]1(OC)[C@@H]4Oc5c(O)ccc6C[C@H]2N(CC7CC7)CC[C@@]34c56)c8ccccc8;;J. Med. Chem.;2014;1;UO_0000065;False
CHEMBL2158958;IC50;=;45;nM;7.35;;5, diastereomer;CHEMBL2162350;Agonist activity at MOP receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2157899;Scientific Literature;0;;1228.57;;;;;;;;;CHO-K1;;9606;BAO_0000219;;;;;CCCCCCCCC(N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](Cc5ccccc5)C(=O)N[C@@H](Cc6ccccc6)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N;;Bioorg. Med. Chem.;2012;1;UO_0000065;False
CHEMBL511645;IC50;=;6.4;nM;8.19;;7;CHEMBL958397;Antagonist activity against human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;0;0;386.49;;;;;1.44;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(C[C@H](O)CC[C@@]35O)c2c1O;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL147511;EC50;=;1.3;nM;8.89;;10, MCL-144;CHEMBL1056145;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154777;Scientific Literature;0;2;789.16;;;;;11.04;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C(CCCCCCCCC(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6;;J. Med. Chem.;2009;1;UO_0000065;True
CHEMBL301160;IC50;=;20;nM;7.7;;MCL-101;CHEMBL1056147;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154777;Scientific Literature;0;0;311.47;;;;;4.25;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1;;J. Med. Chem.;2009;1;UO_0000065;True
CHEMBL38874;EC50;=;55;nM;7.26;;DAMGO;CHEMBL2050641;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;2;513.6;14.13;0.27;8.2;4.17;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Med. Chem.;2012;1;UO_0000065;True
CHEMBL2048773;IC50;=;7.6;nM;8.12;;4f, MCL-703;CHEMBL2050643;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;402.58;20.17;0.37;2.65;22.87;5.47;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc(CNc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4CC6CC6)c3c2)cc1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2048772;IC50;=;3.5;nM;8.46;;4e, MCL-701;CHEMBL2050643;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;402.58;21;0.38;2.99;23.82;5.47;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1cccc(CNc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4CC6CC6)c3c2)c1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2048766;IC50;=;0.21;nM;9.68;;3i, MCL-702;CHEMBL2050643;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;430.59;22.48;0.41;4.18;28.69;5.5;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C(Nc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1)c6ccc7OCOc7c6;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL568877;IC50;=;10;nM;8;;3h, MCL-628;CHEMBL2050643;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;416.61;19.2;0.35;2.22;32.65;5.78;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc(CNc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4CC6CC6)c3c2)cc1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2397017;EC50;=;38.85;nM;7.41;;6;CHEMBL2399071;Agonist activity at mu opioid receptor (unknown origin) expressed CHO cells assessed as stimulation of [35S]-GTP[gammaS] binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2396652;Scientific Literature;0;0;495.58;14.95;0.27;3.9;8.08;3.51;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)c7ccc8ccccc8n7;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL2397015;EC50;=;7.2;nM;8.14;;4;CHEMBL2399071;Agonist activity at mu opioid receptor (unknown origin) expressed CHO cells assessed as stimulation of [35S]-GTP[gammaS] binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2396652;Scientific Literature;0;0;444.53;18.32;0.34;5.18;10.32;2.96;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)c7ccccc7;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL2397022;EC50;=;1.67;nM;8.78;;3;CHEMBL2399071;Agonist activity at mu opioid receptor (unknown origin) expressed CHO cells assessed as stimulation of [35S]-GTP[gammaS] binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2396652;Scientific Literature;0;0;445.52;19.7;0.36;6.42;9.57;2.36;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)c7ccncc7;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL4108329;EC50;=;9.61;nM;8.02;412548;BDBM236845;CHEMBL3888720;"[35S]GTP?S Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared from a cell line expressing recombinant ? opioid receptor in a HEK-293, CHO or U-2 OS cell background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.; or DiscovRx, Fremont, Calif.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50� C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886801;BindingDB Database;0;0;440.58;18.2;0.34;5.33;8.92;2.69;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC(C)CCC(=O)N[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3CC5CC5)CC1=O;;;2016;37;UO_0000065;False
CHEMBL3928839;IC50;=;18;nM;7.75;326536;BDBM179890;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;468.65;16.53;0.3;2.76;12.69;4.98;Homo sapiens;;;;;9606;BAO_0000249;;;;;C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cc5)c6cn[nH]c6;;;2015;37;UO_0000065;False
CHEMBL3216476;EC50;=;0.69;nM;9.16;;17;CHEMBL1678401;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1671784;Scientific Literature;0;1;591.58;;;;;3.66;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cl.Cl.OC(=O)CN[C@H]1CC[C@@]2(OCCCc3ccccc3)[C@H]4Cc5ccc(O)c6O[C@@H]1[C@]2(CCN4CC7CC7)c56;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL4109400;IC50;=;85;nM;7.07;326531;BDBM179885;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;285.43;24.77;0.46;3.35;30.13;3.72;Homo sapiens;;;;;9606;BAO_0000249;;;;;CC1C2Cc3ccc(O)cc3[C@]1(C)CCN2CC4(C)CC4;;;2015;37;UO_0000065;False
CHEMBL4115016;IC50;=;38;nM;7.42;326546;BDBM179900;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;398.5;18.62;0.35;5.39;7.14;2.03;Homo sapiens;;;;;9606;BAO_0000249;;;;;C[C@H](C1CCC1)N2CC[C@]34CC(=O)CC[C@@]3(O)[C@H]2Cc5ccc(C(=O)N)c(O)c45;;;2015;37;UO_0000065;False
CHEMBL4065490;EC50;=;1.37;nM;8.86;;2a;CHEMBL4032004;Agonist activity at recombinant human MOR expressed in CHO cell membranes after 60 mins by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4028881;Scientific Literature;0;0;301.39;29.41;0.55;6.64;21.14;2.22;Homo sapiens;;;;;9606;BAO_0000219;;;;;CO[C@]12CCC[C@@H]3Oc4c(O)ccc5C[C@H]1N(C)CC[C@@]23c45;;J Med Chem;2017;1;UO_0000065;False
CHEMBL2347239;IC50;=;75;nM;7.12;;8;CHEMBL2353037;Partial agonist activity at human mu opioid receptor expressed in CHO cell membrane assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by liquid scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2346652;Scientific Literature;0;1;479.67;;;;;5.66;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cn5)c6ccccc6;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL4108846;EC50;=;1.1;nM;8.96;326555;BDBM179874;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;382.5;23.42;0.44;6.33;10.32;2.63;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(CC(=C)CC[C@@]35O)c2c1O;;;2015;37;UO_0000065;False
CHEMBL2347236;EC50;=;0.85;nM;9.07;;5;CHEMBL2353039;Partial agonist activity at human mu opioid receptor expressed in CHO cell membrane assessed as stimulation of [35S]GTPgammaS binding after 60 mins by liquid scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2346652;Scientific Literature;0;1;479.67;;;;;5.66;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cc5)c6cccnc6;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL370029;EC50;=;1;nM;9;326565;BDBM50165048;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;384.48;23.41;0.44;7.36;8.67;1.64;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(CC(=O)CC[C@@]35O)c2c1O;;;2015;37;UO_0000065;False
CHEMBL4113472;EC50;=;84;nM;7.08;326571;BDBM179886;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;289.42;24.45;0.46;4.39;16.19;2.69;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC1C2Cc3ccc(O)cc3[C@]1(C)CCN2CC(C)(C)O;;;2015;37;UO_0000065;False
CHEMBL3946804;EC50;=;20;nM;7.7;326579;BDBM179895;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;346.52;22.22;0.42;3.92;17.59;3.78;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CCCCCCN1CCC(CC1)(C(=O)N(C)CC)c2cccc(O)c2;;;2015;37;UO_0000065;False
CHEMBL3039334;EC50;=;21;nM;7.68;326585;BDBM179908;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;357.45;21.48;0.4;5.97;10.49;1.71;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC6CCC6)c45;;;2015;37;UO_0000065;False
CHEMBL3917891;EC50;=;0.3;nM;9.52;326586;BDBM179909;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;467.65;20.36;0.38;5.25;15.32;4.27;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@H]1C([C@H]2CC[C@@]13Oc4c(O)ccc5C[C@@H]6C2[C@@]3(CCN6CC7CC7)c45)[C@](C)(O)C(C)(C)C;;;2015;37;UO_0000065;False
CHEMBL3916122;EC50;=;10.78;nM;7.97;354836;BDBM4203;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;2;501.67;15.88;0.29;2.83;19.84;5.14;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@]7(CC[C@@]36C[C@@H]7COCc8ccccc8)OC;;;2015;37;UO_0000065;False
CHEMBL4111231;EC50;=;9.22;nM;8.04;354844;BDBM199357;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;0;433.55;18.53;0.34;4.33;13.4;3.71;Homo sapiens;;;;;9606;BAO_0000019;;;;;CO[C@]12CC[C@@]3(C[C@@H]1COCc4ccccc4)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5)c67;;;2015;37;UO_0000065;False
CHEMBL512150;EC50;=;2.8;nM;8.55;326566;BDBM50278335;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;386.49;22.13;0.42;7.11;7.99;1.44;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(C[C@@H](O)CC[C@@]35O)c2c1O;;;2015;37;UO_0000065;False
CHEMBL3971916;EC50;=;60;nM;7.22;326569;BDBM179884;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;285.43;25.3;0.47;3.51;30.77;3.71;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](C1CC1)N2CC[C@@]3(C)C(C)[C@H]2Cc4ccc(O)cc34;;;2015;37;UO_0000065;False
CHEMBL495402;IC50;=;25;nM;7.6;;7;CHEMBL953424;Agonist activity at human mu opioid receptor expressed in CHO cell membrane by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1150320;Scientific Literature;0;0;382.96;;;;;3.61;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN(CCO)CCN1c2cc3[nH]c(SC(C)(C)C)nc3cc2Cl;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL1743604;IC50;=;13;nM;7.89;;5, MCL-481;CHEMBL1670110;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1667791;Scientific Literature;0;1;893.88;;;;;4.03;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN(C)[C@@H](Cc1c(C)cc(O)cc1C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)OC4=C5O[C@H]6[C@@H](O)C=C[C@H]7[C@H]8CC(C=C4)C5[C@@]67CCN8C.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F;;Eur. J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL4061620;EC50;=;30;nM;7.52;;42;CHEMBL3992793;Agonist activity at human MOR expressed in CHO-K1 cells co-expressing Galpha 15 assessed as increase in intracellular calcium release incubated for 1 measured every 1.52 secs for 90 secs by FLIPR assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3992491;Scientific Literature;0;0;342.87;21.94;0.43;3.96;23.26;3.56;Homo sapiens;;;;;9606;BAO_0000219;;;;;Cc1ccc(cc1)C(=O)NCC2N(CCCl)CCc3ccccc23;;Eur J Med Chem;2017;1;UO_0000065;False
CHEMBL481366;EC50;=;23;nM;7.64;;21;CHEMBL993921;Agonist activity at human mu opioid receptor expressed in CHOK1 cells by [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1143349;Scientific Literature;0;1;408.63;;;;;5.64;Homo sapiens;;;CHO-K1;;9606;BAO_0000219;;;;;CC1(CCCCCCC1)N2CCC(CC2)n3c(nc4ccccc34)[C@H]5CCCNC5;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL4107821;EC50;=;96.55;nM;7.01;354880;BDBM199416;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;1;524.7;13.37;0.25;3.18;8.43;3.84;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@]7(CC[C@@]36C[C@@H]7COC(=O)[C@@H](N)CC(C)C)OC;;;2015;37;UO_0000065;False
CHEMBL4109220;EC50;=;60.48;nM;7.22;354887;BDBM199431;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;1;561.72;12.85;0.24;3.06;8.95;4.16;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@]7(CC[C@@]36C[C@@H]7COCc8ccc(cc8)C(O)CO)OC;;;2015;37;UO_0000065;False
CHEMBL1743605;EC50;=;29;nM;7.54;;4, MCL-480;CHEMBL1670104;Agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1667791;Scientific Literature;0;1;964.95;;;;;3.54;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN(C)[C@@H](Cc1c(C)cc(O)cc1C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)NCCC(=O)OC4=C5O[C@H]6[C@@H](O)C=C[C@H]7[C@H]8CC(C=C4)C5[C@@]67CCN8C.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F;;Eur. J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL56585;IC50;=;13;nM;7.89;;1a;CHEMBL1019888;Activity at human cloned mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;271.4;;;;;3.33;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1[C@H]2Cc3ccc(O)cc3[C@]1(C)CCN2CC4CC4;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;True
CHEMBL208454;EC50;=;27;nM;7.57;;4b;CHEMBL2163098;Agonist activity at mu opioid receptor expressed in CHO-hg cells by [35S]-GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2157906;Scientific Literature;0;0;466.59;16.22;0.3;2.97;7.95;4.6;;;;CHO-hg;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2c4nc(c[nH]4)c5ccccc5;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL2163914;EC50;=;10.91;nM;7.96;;10;CHEMBL2166341;Agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by liquid scintillation counter;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2163332;Scientific Literature;0;2;652.75;;;;;2.37;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;COc1ccc(cc1)[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]4CCCN4C(=O)[C@@H](N)Cc5ccc(O)cc5)C(=C)C(=O)N;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2163919;EC50;=;70.34;nM;7.15;;15;CHEMBL2166341;Agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by liquid scintillation counter;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2163332;Scientific Literature;0;2;672.79;;;;;3.51;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](C(=C)C(=O)N)c5ccc6ccccc6c5;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL4109142;EC50;=;59.95;nM;7.22;354871;BDBM199395;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;1;569.71;12.68;0.23;3;7.63;4.22;Homo sapiens;;;;;9606;BAO_0000019;;;;;CO[C@]12CC[C@@]3(C[C@@H]1COCc4ccccc4)[C@H]5Cc6ccc(OCc7nn[nH]n7)c8O[C@@H]2[C@]3(CCN5CC9CC9)c68;;;2015;37;UO_0000065;False
CHEMBL4107918;EC50;=;32.72;nM;7.49;354852;BDBM199366;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;2;517.74;14.46;0.28;1.64;24.2;5.85;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@]7(CC[C@@]36C[C@@H]7CSCc8ccccc8)OC;;;2015;37;UO_0000065;False
CHEMBL2178341;EC50;=;7.49;nM;8.13;;14;CHEMBL2184591;Agonist activity at mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTP-gammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2176919;Scientific Literature;0;0;448.52;18.12;0.34;6.59;7.54;1.54;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccncn7;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL4113124;EC50;=;6.76;nM;8.17;412572;BDBM236864;CHEMBL3888720;"[35S]GTP?S Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared from a cell line expressing recombinant ? opioid receptor in a HEK-293, CHO or U-2 OS cell background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.; or DiscovRx, Fremont, Calif.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50� C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886801;BindingDB Database;0;0;417.55;19.57;0.36;4.55;13.44;3.62;Homo sapiens;;;;;9606;BAO_0000019;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]5(CC(=O)[C@@H](Cc6ccccc6)C[C@@]35O)c2c1;;;2016;37;UO_0000065;False
CHEMBL19019;IC50;=;15.5;nM;7.81;;NTX;CHEMBL3405699;Antagonist activity at human MOR expressed in CHO cells assessed as inhibition of DAMGO-induced increase in intracellular Ca2+ level incubated for 15 mins prior to DAMGO addition by microplate reader analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3400112;Scientific Literature;4;0;341.41;22.87;0.43;6.28;11.16;1.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O;;Bioorg. Med. Chem.;2015;1;UO_0000065;False
CHEMBL2419121;IC50;=;23.7;nM;7.62;;4, NCQ;CHEMBL3405699;Antagonist activity at human MOR expressed in CHO cells assessed as inhibition of DAMGO-induced increase in intracellular Ca2+ level incubated for 15 mins prior to DAMGO addition by microplate reader analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3400112;Scientific Literature;0;1;562.07;13.57;0.26;3.66;7.32;3.97;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1c(nc(Cl)c2ccccc12)C(=O)N[C@H]3CC[C@@]4(O)[C@H]5Cc6ccc(O)c7O[C@@H]3[C@]4(CCN5CC8CC8)c67;;Bioorg. Med. Chem.;2015;1;UO_0000065;False
CHEMBL1852602;EC50;=;1.31;nM;8.88;;7;CHEMBL2184591;Agonist activity at mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTP-gammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2176919;Scientific Literature;0;1;526.43;16.87;0.36;5.97;9.36;2.91;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccncc7Br;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL1852558;EC50;=;1.13;nM;8.95;;4;CHEMBL2184591;Agonist activity at mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTP-gammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2176919;Scientific Literature;0;0;461.56;19.38;0.36;6.49;9.43;2.46;;;;CHO;;9606;BAO_0000219;;;;;Cc1cc(ccn1)C(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL4088589;EC50;=;2.95;nM;8.53;;4a;CHEMBL4032004;Agonist activity at recombinant human MOR expressed in CHO cell membranes after 60 mins by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4028881;Scientific Literature;0;0;315.41;27.04;0.51;5.92;20.34;2.61;Homo sapiens;;;;;9606;BAO_0000219;;;;;CO[C@]12CCC[C@]3(C)Oc4c(O)ccc5C[C@H]1N(C)CC[C@@]23c45;;J Med Chem;2017;1;UO_0000065;False
CHEMBL2179661;EC50;=;87;nM;7.06;;18e;CHEMBL2186797;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2177065;Scientific Literature;0;2;565.07;;;;;5.82;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@]2(Cc6cc(cnc46)c7ccc(Cl)cc7)OC(=O)Cc8ccccc8)c35;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL490665;EC50;=;1.7;nM;8.77;;TRK-820;CHEMBL4057025;Agonist activity at mu opioid receptor (unknown origin);single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4052747;Scientific Literature;3;0;513.03;18.4;0.34;5.68;10.15;3.09;Homo sapiens;;;;;9606;BAO_0000357;;;;;Cl.CN([C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CC6)c45)C(=O)\C=C\c7cocc7;;Bioorg Med Chem Lett;2017;1;UO_0000065;False
CHEMBL413512;IC50;=;1.8;nM;8.74;;10 MCL-135;CHEMBL754564;Inhibitory activity was determined in stimulating [35S]-GTP-gamma S binding mediated by the Opioid receptor mu 1 in chinese Hamster Ovary (CHO)membranes;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145905;Scientific Literature;0;2;676.94;12.92;0.24;0.83;14.8;7.91;;;;;;9606;BAO_0000019;;;;;O=C(CCC(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CC%10)c7c6;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL38874;EC50;=;1.7;nM;8.77;;DAMGO;CHEMBL970720;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1155897;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Med. Chem.;2008;1;UO_0000065;False
CHEMBL2347239;EC50;=;19;nM;7.72;;8;CHEMBL2353039;Partial agonist activity at human mu opioid receptor expressed in CHO cell membrane assessed as stimulation of [35S]GTPgammaS binding after 60 mins by liquid scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2346652;Scientific Literature;0;1;479.67;;;;;5.66;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cn5)c6ccccc6;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL412923;IC50;=;0.43;nM;9.37;;13;CHEMBL955670;Agonist activity at mu opioid receptor in human SHSY5Y cells assessed as inhibition of forskolin-stimulated cAMP production;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1150362;Scientific Literature;0;2;638.77;;;;;2.29;Homo sapiens;;;SH-SY5Y;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](Cc5ccccc5)C(=O)N;;Bioorg. Med. Chem.;2008;1;UO_0000065;False
CHEMBL2208351;EC50;=;0.15;nM;9.82;;18;CHEMBL2213832;Partial agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203245;Scientific Literature;0;2;522.69;;;;;5.99;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC1C2Cc3ccc(cc3C1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cc5)c6ccc7OCOc7c6;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL2208347;EC50;=;0.5;nM;9.3;;14;CHEMBL2213832;Partial agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203245;Scientific Literature;0;1;494.68;;;;;5.97;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1[C@H]2Cc3ccc(cc3[C@]1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cc5)c6ccc(O)cc6;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL511621;IC50;=;54;nM;7.27;;12;CHEMBL958397;Antagonist activity against human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;0;0;354.45;;;;;1.74;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CC4)CC[C@]56[C@H](CCC[C@@]35O)Oc1c26;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL2163920;EC50;=;36.5;nM;7.44;;3;CHEMBL2166341;Agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by liquid scintillation counter;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2163332;Scientific Literature;0;1;583.69;;;;;1.88;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=C)C(=O)N[C@@H](Cc3ccccc3)C(=O)N)c4ccccc4;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2159122;EC50;=;1;nM;9;;5l;CHEMBL2163098;Agonist activity at mu opioid receptor expressed in CHO-hg cells by [35S]-GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2157906;Scientific Literature;4;1;569.66;15.8;0.29;4.84;5.47;4.16;;;;CHO-hg;;9606;BAO_0000219;;;;;COc1ccc(CN([C@@H](C)c2nc(c[nH]2)c3ccccc3)C(=O)[C@@H](N)Cc4c(C)cc(cc4C)C(=O)N)cc1C(=O)O;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL3325714;EC50;=;41;nM;7.39;;19;CHEMBL3370190;Agonist activity at human mu opioid receptor expressed CHO-K1 cells coexpressing Galpha15 assessed as induction of intracellular calcium release by FLIPR calcium assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3351626;Scientific Literature;0;0;412.12;17.92;0.48;2.53;21.17;4.86;Homo sapiens;;;CHO-K1;;9606;BAO_0000219;;;;;Cc1nn(c2CC(C)(C)CC(=O)c12)c3ccc(Br)cc3Br;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL517166;IC50;=;58;nM;7.24;;8b;CHEMBL1019888;Activity at human cloned mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;328.46;;;;;2.49;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H]1[C@@H]2Cc3ccc(cc3[C@@]1(C)CCN2C[C@@H]4CCCO4)C(=O)N;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL38874;EC50;=;55;nM;7.26;;DAMGO;CHEMBL1019886;Activity at human cloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;True
CHEMBL49269;EC50;=;0.8;nM;9.1;;Cyclorphan;CHEMBL2050641;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;0;297.44;30.58;0.56;5.24;38.76;3.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL522201;IC50;=;5.42;nM;8.27;;9, NAQ;CHEMBL995937;Binding affinity to wild type mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140920;Scientific Literature;0;0;497.6;16.61;0.31;4.97;8.71;3.3;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@H](CC[C@@]36O)NC(=O)c7cc8ccccc8cn7;;J. Med. Chem.;2009;1;UO_0000065;True
CHEMBL201271;EC50;=;2.9;nM;8.54;;10 (MCL-195);CHEMBL863310;Activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148605;Scientific Literature;0;2;775.13;;;;;10.65;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C(CCCCCCCCC(=O)Oc1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC5CCC5)c2c1)Oc6ccc7C[C@@H]8C9CCCC[C@]9(CCN8CC%10CC%10)c7c6;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL49269;IC50;=;1.7;nM;8.77;;1c;CHEMBL863310;Activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148605;Scientific Literature;0;0;297.44;;;;;3.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1;;J. Med. Chem.;2006;1;UO_0000065;True
CHEMBL4110493;EC50;=;12.7;nM;7.9;412554;BDBM236851;CHEMBL3888720;"[35S]GTP?S Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared from a cell line expressing recombinant ? opioid receptor in a HEK-293, CHO or U-2 OS cell background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.; or DiscovRx, Fremont, Calif.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50� C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886801;BindingDB Database;0;0;446.55;17.68;0.33;5.34;8.79;2.56;Homo sapiens;;;;;9606;BAO_0000019;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]5(CC(=O)[C@H](C[C@@]35O)NC(=O)c6ccccc6)c2c1;;;2016;37;UO_0000065;False
CHEMBL38874;IC50;=;2.5;nM;8.6;;DAMGO;CHEMBL983893;Inhibition of human mu opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1155111;Scientific Literature;0;2;513.6;16.75;0.32;9.54;4.94;-0.94;Homo sapiens;;;;;9606;BAO_0000357;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Med. Chem.;2008;1;UO_0000065;True
CHEMBL4115318;EC50;=;54;nM;7.27;385614;BDBM220363;CHEMBL3888264;"In Vitro Mu-Opioid Receptor Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed membranes expressing human ?-receptors. Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; NEN). The prepared membrane solution (190 ?L/well) was transferred to 96-shallow well polypropylene plates containing 10 ?L of 20� concentrated stock solutions of the agonist DAMGO ([D-Ala2, N-methyl-Phe4 Gly-o15]-enkephalin) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25 �C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Packard, Meriden, Conn.) using a 96-well tissue harvester (Brandel, Gaithersburg, Md.) followed by three filtration washes with 200 ?L of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50 �C. for 2-3 hr. BetaScint scintillation cocktail (Wallas, Turku, Finland) was added (50 ?L/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886630;BindingDB Database;0;1;516.69;14.07;0.26;2.44;9.24;4.83;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC12C[C@H]3C[C@H](C[C@@H]1C[C@@H]2C3)N4[C@@H]5CCC[C@H]4C[C@H](C5)N6C(=O)C(=Nc7ccccc67)N8CC[C@@H]8C(=O)O;;;2016;37;UO_0000065;False
CHEMBL3275494;EC50;=;27;nM;7.57;;7a;CHEMBL1019886;Activity at human cloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;321.46;;;;;4.16;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(O)cc3[C@@]1(C)CCN2CCc4ccccc4;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL511691;EC50;=;4.2;nM;8.38;;10b;CHEMBL1019886;Activity at human cloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;312.41;;;;;2.36;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC1C2N(CC3CC3)CCC1(C)c4cc(ccc4C2=O)C(=O)N;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL1824514;EC50;=;2.32;nM;8.63;;4;CHEMBL1828464;Agonist activity against mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1821548;Scientific Literature;0;0;518.44;17.91;0.35;5.83;9.1;2.8;;;;CHO;;9606;BAO_0000219;;;;;Cl.Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccncc7Cl;;Bioorg. Med. Chem. Lett.;2011;1;UO_0000065;False
CHEMBL136421;IC50;=;24;nM;7.62;;7;CHEMBL754686;Concentration required to inhibit agonist (loperamide) stimulated [35S]GTP-gamma-S, binding to membranes containing the cloned human mu opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136497;Scientific Literature;0;0;350.51;;;;;3.89;Homo sapiens;;;;;9606;BAO_0000019;;;;;CNC(=O)c1cccc(c1)[C@]2(C)CCN(CCc3ccccc3)C[C@@H]2C;;Bioorg. Med. Chem. Lett.;2003;1;UO_0000065;False
CHEMBL2367604;EC50;=;2.7;nM;8.57;;8a, Mr2034;CHEMBL1019886;Activity at human cloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;301.43;;;;;3.1;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1[C@H]2Cc3ccc(O)cc3[C@@]1(C)CCN2C[C@@H]4CCCO4;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL459746;EC50;=;101;nM;7;;9b;CHEMBL1019886;Activity at human cloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;328.46;;;;;2.49;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H]1[C@@H]2Cc3ccc(cc3[C@@]1(C)CCN2C[C@H]4CCCO4)C(=O)N;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL1774947;EC50;=;1.8;nM;8.74;;9b, MCL-692;CHEMBL1777022;Agonist activity at human mu-opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1772956;Scientific Literature;0;2;849.21;;;;;10.57;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CCCC[C@@]13CCN(CC4CCC4)[C@@H]2Cc5ccc(OC(=O)CCCCCCCCC(=O)Oc6ccc7C[C@H]8N(CC9CCC9)CC[C@@]%10(CCCC[C@@]8%10OC)c7c6)cc35;;Bioorg. Med. Chem.;2011;1;UO_0000065;False
CHEMBL332947;EC50;=;75.2;nM;7.12;;2a;CHEMBL747703;Agonistic activity against human opioid Mu receptor transfected into Chinese hamster ovary (CHO) cells using [3H]-DAMGO as radioligand;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1131901;Scientific Literature;0;0;352.39;;;;;0.68;;;;CHO;;9606;BAO_0000219;;;;;CN1CCC23C4Oc5c(O)ccc(CC1C2(O)Cc6cnc(N)nc46)c35;;Bioorg. Med. Chem. Lett.;1999;1;UO_0000065;False
CHEMBL201271;IC50;=;96;nM;7.02;;10 (MCL-195);CHEMBL863310;Activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148605;Scientific Literature;0;2;775.13;;;;;10.65;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C(CCCCCCCCC(=O)Oc1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC5CCC5)c2c1)Oc6ccc7C[C@@H]8C9CCCC[C@]9(CCN8CC%10CC%10)c7c6;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL381750;EC50;=;19;nM;7.72;;6 (MCL-415);CHEMBL863310;Activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148605;Scientific Literature;0;2;729.02;;;;;9.03;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C(Oc1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC5CCC5)c2c1)\C=C\C=C\C(=O)Oc6ccc7C[C@@H]8C9CCCC[C@]9(CCN8CC%10CCC%10)c7c6;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL2443261;EC50;=;31.62;nM;7.5;;(R)-29;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;0;368.52;;;;;4.83;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Cc1oc(CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4)cc1C;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3325957;EC50;=;1.2;nM;8.92;;3a, cebranopadol;CHEMBL3366614;Agonist activity at human recombinant MOP receptor expressed in CHO-K1 cells assessed as stimulation of [35S]GTPgammaS binding by scintillation proximity assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3352090;Scientific Literature;0;1;570.61;;;;;5.11;Homo sapiens;;;CHO-K1;;9606;BAO_0000219;;;;;CN(C)[C@@]1(CC[C@]2(CC1)OCCc3c2[nH]c4ccc(F)cc34)c5ccccc5.OC(=O)CC(O)(CC(=O)O)C(=O)O;;ACS Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL1824516;EC50;=;2.32;nM;8.63;;7;CHEMBL1828464;Agonist activity against mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1821548;Scientific Literature;0;0;498.02;18.71;0.35;6.55;9.1;2.08;;;;CHO;;9606;BAO_0000219;;;;;Cl.Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)Cc7ccncc7;;Bioorg. Med. Chem. Lett.;2011;1;UO_0000065;False
CHEMBL1774949;IC50;=;3.4;nM;8.47;;15b, MCL-695;CHEMBL1777023;Antagonist activity at human mu-opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1772956;Scientific Literature;0;2;805.16;;;;;10.15;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O[C@@]12CCCC[C@@]13CCN(CC4CCC4)[C@@H]2Cc5ccc(OC(=O)CCCCCCCCC(=O)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6)cc35;;Bioorg. Med. Chem.;2011;1;UO_0000065;False
CHEMBL333357;EC50;=;0.04;nM;10.4;;6, Endomorphin-2;CHEMBL913686;Activity at mu opioid receptor assessed as increase in calcium level in CHO cells by aequorin luminescence based calcium assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1141402;Scientific Literature;0;1;571.68;;;;;1.19;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N;;J. Med. Chem.;2007;1;UO_0000065;True
CHEMBL611139;EC50;=;3.8;nM;8.42;;5e;CHEMBL864218;Stimulation of [35S]GTPgammaS binding to human recombinant MOR;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1146036;Scientific Literature;0;1;519.04;;;;;4.32;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)\C=C\c7ccccc7Cl;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL2443257;EC50;=;15.85;nM;7.8;;(R)-25;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;0;370.56;;;;;4.99;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Cc1ccc(CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4)s1;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL375025;EC50;=;2.35;nM;8.63;;8, cDADAE;CHEMBL889398;Agonist activity at human mu opioid receptor by [35S]GTP-gamma-S binding assay;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145383;Scientific Literature;0;2;551.6;;;;;-0.49;Homo sapiens;;;;;9606;BAO_0000019;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]2C\C=C/C[C@@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)CNC2=O)C(=O)O;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL3394748;IC50;=;80;nM;7.1;;10;CHEMBL3395052;Displacement of [3H]DAMGO from human Mu opioid receptor expressed in HEK293 cells after 2 hrs by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3393026;Scientific Literature;0;2;586.83;12.09;0.24;1.79;12.02;5.31;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;O[C@H](CNCc1cccs1)CN2CN(c3ccccc3)C4(CCN(CCc5ccccc5c6cccs6)CC4)C2=O;;Bioorg. Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL3394751;IC50;=;79;nM;7.1;;13;CHEMBL3395052;Displacement of [3H]DAMGO from human Mu opioid receptor expressed in HEK293 cells after 2 hrs by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3393026;Scientific Literature;0;2;654.88;10.85;0.21;1.79;9.16;5.31;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;COc1ccc(CCNC[C@@H](O)CN2CN(c3ccccc3)C4(CCN(CCc5ccccc5c6cccs6)CC4)C2=O)cc1OC;;Bioorg. Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL3394752;IC50;=;57;nM;7.24;;14;CHEMBL3395052;Displacement of [3H]DAMGO from human Mu opioid receptor expressed in HEK293 cells after 2 hrs by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3393026;Scientific Literature;0;1;546.78;13.25;0.25;2.39;12.27;4.85;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;CC(C)(C)NC[C@@H](O)CN1CN(c2ccccc2)C3(CCN(CCc4ccccc4c5cccs5)CC3)C1=O;;Bioorg. Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL3325961;EC50;=;1.2;nM;8.92;;48a;CHEMBL3366614;Agonist activity at human recombinant MOP receptor expressed in CHO-K1 cells assessed as stimulation of [35S]GTPgammaS binding by scintillation proximity assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3352090;Scientific Literature;0;0;568.62;;;;;4.67;Homo sapiens;;;CHO-K1;;9606;BAO_0000219;;;;;CN(C)[C@@]1(CC[C@]2(CC1)OCCc3c2[nH]c4ccc(O)cc34)c5ccccc5.OC(=O)CC(O)(CC(=O)O)C(=O)O;;ACS Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL2113380;EC50;=;21.5;nM;7.67;;9;CHEMBL749736;Stimulation of [35S]GTP-gamma-S, binding to recombinant human Opioid receptor mu 1 expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144921;Scientific Literature;0;1;476.62;;;;;6.07;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(CC1[C@]2(CCCc6ccccc6)Cc7c4[nH]c8ccccc78)c35;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL1169582;EC50;=;34.9;nM;7.46;;7b;CHEMBL749726;EC50 for binding of [35S]- GTPdeltaS in cloned human Opioid receptor mu 1 (DAMGO) transfected onto CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1132936;Scientific Literature;0;0;383.49;19.45;0.36;4.81;14.58;2.65;;;;CHO;;9606;BAO_0000219;;;;;CO[C@@H](C)[C@@H]1CC23C=C[C@]1(OC)[C@H]4Oc5c(O)ccc6CC2N(C)CCC34c56;;J. Med. Chem.;2000;1;UO_0000065;False
CHEMBL2113373;EC50;=;5.2;nM;8.28;;6e;CHEMBL749736;Stimulation of [35S]GTP-gamma-S, binding to recombinant human Opioid receptor mu 1 expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144921;Scientific Literature;0;1;505.62;;;;;4.55;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(CC1[C@@]2(Cc6c4[nH]c7ccccc67)NC(=O)CCc8ccccc8)c35;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL309307;IC50;=;0.98;nM;9.01;;34;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;457.57;19.69;0.36;5.75;9.42;3.26;;;;;;9606;BAO_0000357;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2CNC(=O)c4ccccc4;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL326962;IC50;=;16.7;nM;7.78;;41;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;0;0;365.43;21.28;0.39;5.44;14.39;2.34;;;;;;9606;BAO_0000357;;;;;O=C1NCN(c2ccccc2)C13CCN(Cc4ccc5OCOc5c4)CC3;;J. Med. Chem.;2001;1;UO_0000065;True
CHEMBL471243;IC50;=;0.88;nM;9.06;;1;CHEMBL958397;Antagonist activity against human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;0;0;406.91;;;;;1.25;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cl.NC(=O)c1ccc2C[C@H]3N(CC4CC4)CC[C@@]5(CC(=O)CC[C@@]35O)c2c1O;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL49269;IC50;=;1.7;nM;8.77;;1;CHEMBL754564;Inhibitory activity was determined in stimulating [35S]-GTP-gamma S binding mediated by the Opioid receptor mu 1 in chinese Hamster Ovary (CHO)membranes;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145905;Scientific Literature;0;0;297.44;29.48;0.54;4.91;37.36;3.86;;;;;;9606;BAO_0000019;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1;;J. Med. Chem.;2003;1;UO_0000065;True
CHEMBL405131;EC50;=;10;nM;8;;15 MCL-177;CHEMBL749732;Inhibitory activity in stimulating [35S]-GTP-gamma S binding mediated by the Opioid receptor mu 1 in chinese Hamster Ovary (CHO) cell membranes was determined;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145905;Scientific Literature;0;2;761.1;10.51;0.2;-2.26;13.54;10.26;;;;;;9606;BAO_0000019;;;;;O=C(CCCCCCC(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL4110146;EC50;=;23.55;nM;7.63;354863;BDBM199386;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;2;547.74;13.93;0.25;0.94;24.66;6.69;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@]7(CC[C@@]36C[C@@H]7COCc8ccccc8)c9ccccc9;;;2015;37;UO_0000065;False
CHEMBL4112287;EC50;=;5.85;nM;8.23;354874;BDBM199400;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;2;529.72;15.54;0.29;2.31;20.5;5.92;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@]7(CC[C@@]36C[C@@H]7C(C)(C)OCc8ccccc8)OC;;;2015;37;UO_0000065;False
CHEMBL357334;EC50;=;8;nM;8.1;;12 MCL-176;CHEMBL749732;Inhibitory activity in stimulating [35S]-GTP-gamma S binding mediated by the Opioid receptor mu 1 in chinese Hamster Ovary (CHO) cell membranes was determined;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145905;Scientific Literature;0;2;509.73;15.88;0.3;1.36;14.5;6.74;;;;;;9606;BAO_0000019;;;;;COC(=O)CCCCCCCCC(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL2163915;EC50;=;10.7;nM;7.97;;11;CHEMBL2166341;Agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by liquid scintillation counter;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2163332;Scientific Literature;0;2;666.74;;;;;2.09;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](C(=C)C(=O)N)c5ccc6OCOc6c5;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL301160;IC50;=;20;nM;7.7;;Butorphan;CHEMBL2050643;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;0;311.47;24.72;0.46;3.45;32.8;4.25;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2367916;EC50;=;15;nM;7.82;;(-)11;CHEMBL749733;Incorporation of [35S]- GTPgammaS into CHO membranes expressing human Opioid receptor mu 1;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145777;Scientific Literature;0;1;346.52;22.58;0.41;2.46;51.24;5.36;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1[C@H]2Cc3ccc(Nc4ccccc4)cc3[C@@]1(C)CCN2CC5CC5;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL352965;EC50;=;22;nM;7.66;;47;CHEMBL749733;Incorporation of [35S]- GTPgammaS into CHO membranes expressing human Opioid receptor mu 1;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145777;Scientific Literature;0;1;374.53;20.45;0.37;2.27;23.68;5.39;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC[C@]12CCN(CC3CC3)C([C@@H]1C)C(=O)c4ccc(Nc5ccccc5)cc24;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL522143;IC50;=;2.29;nM;8.64;;NAP;CHEMBL2444609;Binding affinity to wild type MOR (unknown origin) expressed in CHO cells after 15 mins by Ca2+ mobilization assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440098;Scientific Literature;0;0;447.54;19.31;0.36;6.49;9.1;2.15;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccncc7;;Bioorg. Med. Chem.;2013;1;UO_0000065;False
CHEMBL394624;EC50;=;7.1;nM;8.15;;(-)3e;CHEMBL887396;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as maximal stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;1;444.62;;;;;5.83;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C(NCc1ccccc1)Oc2ccc3CC4C5CCCCC5(CCN4CC6CCC6)c3c2;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL2113313;EC50;=;2.59;nM;8.59;;18a;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;510.63;;;;;3.7;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12C=C[C@@]3([C@@H]4CN(C[C@H]14)C(=O)\C=C\c5ccccc5C)[C@H]6Cc7ccc(O)c8O[C@@H]2[C@]3(CCN6C)c78;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL115229;IC50;=;19.3;nM;7.71;;13;CHEMBL757059;Binding affinity against mu opiate receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134625;Scientific Literature;0;0;394.39;19.56;0.36;4.58;7.5;3.13;;;;;;9606;BAO_0000357;;;;;Oc1nc2ccccc2n1C3=CCN(Cc4cc5OCOc5cc4[N+](=O)[O-])CC3;;J. Med. Chem.;2001;1;UO_0000065;True
CHEMBL382919;IC50;=;15;nM;7.82;;4;CHEMBL866455;Inhibition of loperamide-stimulated [35S]GTP-gamma-S binding to membranes containing mu opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149448;Scientific Literature;0;1;351.53;;;;;5.4;Homo sapiens;;;;;9606;BAO_0000019;;;;;CCC[C@@H]1C[C@](C)([C@@H](C)CN1CCc2ccccc2)c3cccc(O)c3;;Bioorg. Med. Chem. Lett.;2006;1;UO_0000065;False
CHEMBL281986;EC50;=;2.8;nM;8.55;;9b;CHEMBL749731;GTPgammaS binding in cloned human Opioid receptor mu 1 transfected into hamster ovary cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1133656;Scientific Literature;0;0;435.56;;;;;3.31;;;;ovary;;9606;BAO_0000219;;;;;CO[C@]12C=CC3(CC14CCC[C@H]4O)C5Cc6ccc(O)c7O[C@H]2C3(CCN5CC8CC8)c67;;J. Med. Chem.;2000;1;UO_0000065;False
CHEMBL200881;EC50;=;4.4;nM;8.36;;13 (MCL-414);CHEMBL863310;Activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148605;Scientific Literature;0;2;788.17;;;;;11.07;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C(CCCCCCCCC(=O)Oc1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC5CCC5)c2c1)Nc6ccc7C[C@@H]8C9CCCC[C@]9(CCN8CC%10CCC%10)c7c6;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL199827;EC50;=;5.1;nM;8.29;;12 (MCL-197);CHEMBL863310;Activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148605;Scientific Literature;0;2;571.8;;;;;8.18;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C(CCCCCCCCC(=O)Oc1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC5CCC5)c2c1)Oc6ccccc6;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL309236;IC50;=;12.8;nM;7.89;;23;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;395.51;19.96;0.37;6.78;6.03;1.11;;;;;;9606;BAO_0000357;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2CN=C(N)N;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL76846;IC50;=;94.6;nM;7.02;;17;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;379.46;18.51;0.34;3.88;6.09;3.14;;;;;;9606;BAO_0000357;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2CN=[N+]=[N-];;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL373925;IC50;=;28;nM;7.55;;12;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;1;453.63;;;;;5.01;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2C[C@@H](N(Cc3ccccc3)C[C@H]2C[C@@]1(C)c4cccc(c4)C(=O)N)c5ccccc5;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL438821;EC50;=;53;nM;7.28;;9;CHEMBL909319;Agonist activity at human cloned mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137299;Scientific Literature;0;0;335.49;;;;;4.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1[C@@H]2CC[C@H](CN2CC[C@@]1(C)c3cccc(O)c3)c4ccccc4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL384336;IC50;=;78;nM;7.11;;24;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;392.54;;;;;3.84;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(C[C@H]2C[C@@]1(C)c3cccc(O)c3)C(=O)CCc4ccccc4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL218909;IC50;=;4.5;nM;8.35;;40;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;366.51;;;;;3.58;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3cccc(O)c3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL375165;IC50;=;13;nM;7.89;;28;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;378.56;;;;;4.31;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(CCCc3ccccc3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL460631;IC50;=;100;nM;7;;(+/-)-6.3f;CHEMBL1030679;Displacement of [125I]FK33824 from human cloned mu opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1152717;Scientific Literature;0;2;508.09;13.78;0.27;1.55;19.43;5.45;Homo sapiens;;;;;9606;BAO_0000357;;;;;COCCN(C1C(C=Cc2ccccc12)N3CCN(CC3)c4ccccc4)C(=O)c5sccc5Cl;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL219108;EC50;=;82.1;nM;7.09;;2;CHEMBL913686;Activity at mu opioid receptor assessed as increase in calcium level in CHO cells by aequorin luminescence based calcium assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1141402;Scientific Literature;0;2;660.78;;;;;2.83;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](Cc5cccc6ccccc56)C(=O)N;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL1852458;EC50;=;2.84;nM;8.55;;12, NGP;CHEMBL2184591;Agonist activity at mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTP-gammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2176919;Scientific Literature;0;1;504.59;16.94;0.32;7.28;6.89;1.27;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)CNC(=O)c7ccncc7;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2113378;EC50;=;45.1;nM;7.35;;5e;CHEMBL749736;Stimulation of [35S]GTP-gamma-S, binding to recombinant human Opioid receptor mu 1 expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144921;Scientific Literature;0;1;491.64;;;;;5.02;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(CC1[C@@]2(Cc6c4[nH]c7ccccc67)NCCCc8ccccc8)c35;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL611400;EC50;=;2.6;nM;8.59;;5f;CHEMBL864218;Stimulation of [35S]GTPgammaS binding to human recombinant MOR;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1146036;Scientific Literature;0;0;498.62;;;;;3.97;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)\C=C\c7ccccc7C;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL1824510;EC50;=;1.19;nM;8.92;;2;CHEMBL1828464;Agonist activity against mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1821548;Scientific Literature;0;1;562.89;16.95;0.36;6.01;9.4;2.91;;;;CHO;;9606;BAO_0000219;;;;;Cl.Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccnc(Br)c7;;Bioorg. Med. Chem. Lett.;2011;1;UO_0000065;False
CHEMBL1824515;EC50;=;1.52;nM;8.82;;6, NMP;CHEMBL1828464;Agonist activity against mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1821548;Scientific Literature;0;0;498.02;19.11;0.35;6.36;9.29;2.46;;;;CHO;;9606;BAO_0000219;;;;;Cl.Cc1cnccc1C(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;Bioorg. Med. Chem. Lett.;2011;1;UO_0000065;False
CHEMBL1824517;EC50;=;2.84;nM;8.55;;9, NGP;CHEMBL1828464;Agonist activity against mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1821548;Scientific Literature;0;1;541.05;16.94;0.32;7.28;6.89;1.27;;;;CHO;;9606;BAO_0000219;;;;;Cl.Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)CNC(=O)c7ccncc7;;Bioorg. Med. Chem. Lett.;2011;1;UO_0000065;False
CHEMBL473699;EC50;=;18;nM;7.75;;14;CHEMBL1030613;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136834;Scientific Literature;0;0;309.46;;;;;3.81;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3cc4nc(C)[nH]c4cc3[C@@]1(C)CCN2CC5CC5;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL1834410;EC50;=;2.6;nM;8.59;;1c;CHEMBL1838554;Partial agonist activity at human MOP receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1833948;Scientific Literature;0;0;481.68;;;;;4.8;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)CC(C)(C)C)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL438389;IC50;=;19.95;nM;7.7;;"1; TY012";CHEMBL3738443;Binding affinity to mu opioid receptor (unknown origin);single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3734657;Scientific Literature;0;;1078.12;7.14;;;;;Homo sapiens;;;;;9606;BAO_0000357;;;;;CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc3ccc(O)cc3)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)NCc6cc(cc(c6)C(F)(F)F)C(F)(F)F;;J. Med. Chem.;2015;1;UO_0000065;False
CHEMBL574142;IC50;=;0.11;nM;9.96;;2;CHEMBL1058518;Displacement of [3H]DAMGO from mu opioid receptor expressed in CHO cells after 90 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154775;Scientific Literature;0;;1088.8;9.15;;;;;;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCN(C(=O)CBr)C(=O)CBr)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)O;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL328443;IC50;=;1.3;nM;8.89;;6;CHEMBL744603;In vitro binding affinity towards mu opioid receptors was determined using [3H][p-Cl-Phe]- 4] DPDPE or [3H]deltorphin II;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1131989;Scientific Literature;0;2;583.69;15.22;0.29;9.61;4.08;-0.72;;;;;;9606;BAO_0000357;;;;;CCCC[C@H](N)C(=O)NNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc2ccc(O)cc2;;Bioorg. Med. Chem. Lett.;1999;1;UO_0000065;False
CHEMBL322796;EC50;=;20.3;nM;7.69;;1 (Cyprodime);CHEMBL749655;Concentration necessary to produce 50% of the Emax value, i.e. to stimulate [35S]GTP-gamma-S, binding to recombinant human Opioid receptor mu 1 expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148330;Scientific Literature;0;0;355.48;;;;;3.11;;;;CHO;;9606;BAO_0000219;;;;;COc1cccc2C[C@H]3N(CC4CC4)CC[C@@]5(CC(=O)CC[C@@]35OC)c12;;J. Med. Chem.;2004;1;UO_0000065;False
CHEMBL49269;EC50;=;0.8;nM;9.1;;1;CHEMBL893250;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding after 60 mins;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147995;Scientific Literature;0;0;297.44;;;;;3.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1;;Bioorg. Med. Chem.;2007;1;UO_0000065;True
CHEMBL430397;EC50;=;24;nM;7.62;;16;CHEMBL941715;Agonist activity at human mu opioid receptor expressed in CHO cell membrane by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140563;Scientific Literature;0;1;466.67;;;;;6.14;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)NCCCc5ccc6ccccc6c5;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL416765;EC50;=;3.7;nM;8.43;;9a;CHEMBL749731;GTPgammaS binding in cloned human Opioid receptor mu 1 transfected into hamster ovary cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1133656;Scientific Literature;0;0;395.5;;;;;2.53;;;;ovary;;9606;BAO_0000219;;;;;CO[C@]12C=CC3(CC14CCC[C@H]4O)C5Cc6ccc(O)c7O[C@H]2C3(CCN5C)c67;;J. Med. Chem.;2000;1;UO_0000065;False
CHEMBL475108;IC50;=;99;nM;7;;19;CHEMBL1030612;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136834;Scientific Literature;0;0;296.42;;;;;2.89;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc4[nH]nnc4c3[C@@]1(C)CCN2CC5CC5;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL2113313;EC50;=;1.8;nM;8.74;;18a;CHEMBL896951;Agonist activity at human delta opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;510.63;;;;;3.7;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12C=C[C@@]3([C@@H]4CN(C[C@H]14)C(=O)\C=C\c5ccccc5C)[C@H]6Cc7ccc(O)c8O[C@@H]2[C@]3(CCN6C)c78;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL80823;IC50;=;16.1;nM;7.79;;33;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;395.5;19.7;0.37;5.82;8.15;1.97;;;;;;9606;BAO_0000357;;;;;CC(=O)NC[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc3c(C)cc(O)cc3C;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL2163910;EC50;=;7.35;nM;8.13;;6;CHEMBL2166341;Agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by liquid scintillation counter;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2163332;Scientific Literature;0;2;640.72;;;;;2.5;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](C(=C)C(=O)N)c5ccc(F)cc5;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL205049;EC50;=;9;nM;8.05;;4e;CHEMBL2163098;Agonist activity at mu opioid receptor expressed in CHO-hg cells by [35S]-GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2157906;Scientific Literature;0;0;445.57;18.06;0.33;4.63;6.81;3.42;;;;CHO-hg;;9606;BAO_0000219;;;;;Cc1cc(cc(C)c1C[C@H](N)C(=O)N2CCCC[C@H]2c3nc(c[nH]3)c4ccccc4)C(=O)N;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL582930;EC50;=;7.1;nM;8.15;;4a;CHEMBL1056145;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154777;Scientific Literature;0;2;817.21;;;;;11.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(CCCCCCC(C)C(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)C(=O)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL435746;IC50;=;29;nM;7.54;223804;BDBM50199907;CHEMBL3705131;Binding Assay: The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994).;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3638450;BindingDB Database;0;0;350.51;21.5;0.4;3.97;21.23;3.57;Homo sapiens;;;;;9606;BAO_0000357;;;;;C[C@H]1CN2C[C@H](Cc3ccccc3)NC[C@H]2C[C@@]1(C)c4cccc(O)c4;;;2013;37;UO_0000065;False
CHEMBL3309507;EC50;=;4.97;nM;8.3;;5b;CHEMBL3361835;Agonist activity at human recombinant mu opioid receptor expressed in CHO cell membranes after 60 mins by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3352469;Scientific Literature;0;0;444.53;;;;;2.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@]2(O)CC6=C4N(Cc7ccccc7)C(=O)CC6)c35;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL70;EC50;=;3.7;nM;8.43;;Morphine;CHEMBL2051429;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 1 hr by HTRF assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046316;Scientific Literature;4;0;285.34;;;;;1.2;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35;;ACS Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL1852393;EC50;=;1.52;nM;8.82;;8, NMP;CHEMBL2184591;Agonist activity at mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTP-gammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2176919;Scientific Literature;0;0;461.56;19.11;0.35;6.36;9.29;2.46;;;;CHO;;9606;BAO_0000219;;;;;Cc1cnccc1C(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2178338;EC50;=;7.89;nM;8.1;;5;CHEMBL2184591;Agonist activity at mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTP-gammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2176919;Scientific Literature;0;0;477.56;16.97;0.32;5.94;7.78;2.16;;;;CHO;;9606;BAO_0000219;;;;;COc1cc(ccn1)C(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2334768;EC50;=;0.057;nM;10.24;;3;CHEMBL2341394;Agonist activity at FLAG-tagged mu-type opioid receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins by liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2331515;Scientific Literature;0;2;622.73;;;;;2.22;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CC[C@@H](C2)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](C(=C)C(=O)N)c5ccccc5;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL2048769;IC50;=;4.8;nM;8.32;;4b, MCL-683;CHEMBL2050643;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;416.61;19.97;0.37;2.46;23.43;5.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1cccc(CNc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4CC6CCC6)c3c2)c1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL1766024;EC50;=;47;nM;7.33;;13a;CHEMBL1769433;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1765082;Scientific Literature;0;0;367.56;;;;;4.81;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CNc1nc2cc3c(C[C@@H]4[C@@H]5CCCC[C@]35CCN4CC6CC6)cc2s1;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL2347235;EC50;=;2.2;nM;8.66;;4;CHEMBL2353039;Partial agonist activity at human mu opioid receptor expressed in CHO cell membrane assessed as stimulation of [35S]GTPgammaS binding after 60 mins by liquid scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2346652;Scientific Literature;0;1;479.67;;;;;5.66;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cc5)c6ccncc6;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL257661;EC50;=;40;nM;7.4;;6a;CHEMBL1019886;Activity at human cloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;231.34;;;;;2.55;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1[C@@H]2Cc3ccc(O)cc3[C@]1(C)CCN2C;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL1927270;EC50;=;2.042;nM;8.69;;1;CHEMBL3762660;Agonist activity at human recombinant MOR expressed in CHO cells assessed as calcium mobilization by Fluo-4 AM based fluorescence analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3758180;Scientific Literature;0;2;699.81;12.42;0.23;8.83;3.7;-0.14;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]2CCCCNC(=O)C[C@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc4ccccc4)NC2=O)C(=O)N;;Eur. J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL501331;EC50;=;71;nM;7.15;;22;CHEMBL993921;Agonist activity at human mu opioid receptor expressed in CHOK1 cells by [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1143349;Scientific Literature;0;1;422.66;;;;;5.99;Homo sapiens;;;CHO-K1;;9606;BAO_0000219;;;;;CN1CCC[C@@H](C1)c2nc3ccccc3n2C4CCN(CC4)C5(C)CCCCCCC5;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL511884;EC50;=;24;nM;7.62;;6b;CHEMBL1019886;Activity at human cloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;258.36;;;;;1.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC1C2Cc3ccc(cc3C1(C)CCN2C)C(=O)N;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL3309506;EC50;=;80;nM;7.1;;5a;CHEMBL3361835;Agonist activity at human recombinant mu opioid receptor expressed in CHO cell membranes after 60 mins by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3352469;Scientific Literature;0;0;368.43;;;;;1.29;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@]2(O)CC6=C4N(C)C(=O)CC6)c35;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL3262092;EC50;=;1.55;nM;8.81;;1g;CHEMBL3267139;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by beta-plate liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259633;Scientific Literature;0;0;473.61;;;;;4.35;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@]12CC[C@@]3(C[C@@H]1[C@@H](O)c4ccccc4)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5CC8CC8)c67;;J. Med. Chem.;2014;1;UO_0000065;False
CHEMBL2113307;EC50;=;2.46;nM;8.61;;6e;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;521.06;;;;;4.32;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1CNC(=O)\C=C\c4ccc(Cl)cc4)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5C)c67;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL387101;IC50;=;3.73;nM;8.43;;5l;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;0;493.05;;;;;4.32;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NCCc7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL217790;IC50;=;12.1;nM;7.92;;5e;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;0;1;533.07;;;;;4.4;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)\C=C\Cc7ccc(Cl)cc7;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL512394;IC50;=;5.3;nM;8.28;;(S)-(S)-5.2a;CHEMBL1030679;Displacement of [125I]FK33824 from human cloned mu opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1152717;Scientific Literature;0;0;287.43;28.79;0.57;4.52;38.93;3.76;Homo sapiens;;;;;9606;BAO_0000357;;;;;COCCN[C@H]1[C@@H](CCc2ccccc12)c3ccsc3;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL401245;EC50;=;43;nM;7.37;;11;CHEMBL897687;Agonist activity at human mu opioid receptor expressed in CHO membrane by [35S]GTP-gamma-S binding assay;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149641;Scientific Literature;0;0;387.48;;;;;1.19;Homo sapiens;;;;;9606;BAO_0000249;;;;;CO[C@]12C(O)C[C@@]3(C[C@@H]1[C@@H](C)O)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4C)c56;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL114379;IC50;=;1.2;nM;8.92;;10;CHEMBL757059;Binding affinity against mu opiate receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134625;Scientific Literature;0;0;385.85;23.12;0.45;4.96;14.93;3.96;;;;;;9606;BAO_0000357;;;;;Oc1nc2ccccc2n1C3CCN(Cc4cc5OCOc5cc4Cl)CC3;;J. Med. Chem.;2001;1;UO_0000065;True
CHEMBL310842;IC50;=;61.8;nM;7.21;;29;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;452.6;15.93;0.3;4.28;6.69;2.93;;;;;;9606;BAO_0000357;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2CNC(=O)NC(C)(C)C;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL3264742;EC50;=;1.8;nM;8.74;;4a;CHEMBL3271443;Agonist activity at human mu opioid receptor expressed in HEK293 cells by CellKey method;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259551;Scientific Literature;0;1;500.6;17.47;0.32;5.42;12.24;3.32;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@]56[C@@H]7[C@@H]8O[C@]35CC[C@@]7(OCOc1c26)N(Cc9ccccc9)C8=O;;ACS Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL523382;EC50;=;2.29;nM;8.64;;13;CHEMBL1007140;Activity at monocloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140920;Scientific Literature;0;0;497.6;;;;;3.3;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@H](CC[C@@]36O)NC(=O)c7cnc8ccccc8c7;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL494853;EC50;=;0.09;nM;10.05;;11;CHEMBL1007140;Activity at monocloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140920;Scientific Literature;0;0;497.6;;;;;3.3;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@H](CC[C@@]36O)NC(=O)c7ccc8ccccc8n7;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL472937;EC50;=;0.33;nM;9.48;;4;CHEMBL1007140;Activity at monocloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140920;Scientific Literature;0;0;447.54;;;;;2.15;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7cccnc7;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL514781;EC50;=;23.9;nM;7.62;;1;CHEMBL1007140;Activity at monocloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140920;Scientific Literature;0;0;447.54;;;;;2.15;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@H](CC[C@@]36O)NC(=O)c7ccccn7;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL169552;EC50;=;1.2;nM;8.92;;6;CHEMBL843115;Activity was evaluated in human mu opioid receptors transfected with CHO cells by [35S]GTP-gamma-S, assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1132136;Scientific Literature;0;0;427.59;;;;;3.63;;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CCC3(C[C@H]1[C@@](C)(O)C(C)(C)C)[C@H]4Cc5ccc(O)c6O[C@@H]2C3(CCN4C)c56;;Bioorg. Med. Chem. Lett.;1999;1;UO_0000065;False
CHEMBL38874;IC50;=;5;nM;8.3;;DAMGO;CHEMBL3370192;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP production after 30 mins by HTRF assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3351626;Scientific Literature;0;2;513.6;16.16;0.31;9.24;4.77;-0.94;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem.;2014;1;UO_0000065;True
CHEMBL3264748;EC50;=;5.2;nM;8.28;;4i;CHEMBL3271443;Agonist activity at human mu opioid receptor expressed in HEK293 cells by CellKey method;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259551;Scientific Literature;0;1;514.62;16.1;0.3;4.91;11.59;3.37;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@]56[C@@H]7[C@@H]8O[C@]35CC[C@@]7(OCOc1c26)N(CCc9ccccc9)C8=O;;ACS Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL38874;EC50;=;8.2;nM;8.09;;11, DAMGO;CHEMBL1071838;Activity at mu opioid receptor expressed in HEK293 cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1152554;Scientific Literature;0;2;513.6;;;;;-0.94;;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem.;2009;1;UO_0000065;False
CHEMBL2163917;EC50;=;0.0342;nM;10.47;;13;CHEMBL2166341;Agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by liquid scintillation counter;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2163332;Scientific Literature;0;2;612.69;;;;;1.95;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](C(=C)C(=O)N)c5cocc5;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL1824512;EC50;=;1.13;nM;8.95;;3;CHEMBL1828464;Agonist activity against mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1821548;Scientific Literature;0;0;498.02;19.38;0.36;6.49;9.43;2.46;;;;CHO;;9606;BAO_0000219;;;;;Cl.Cc1cc(ccn1)C(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;Bioorg. Med. Chem. Lett.;2011;1;UO_0000065;False
CHEMBL1824511;EC50;=;1.46;nM;8.84;;8;CHEMBL1828464;Agonist activity against mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1821548;Scientific Literature;0;0;512.05;18.58;0.34;6.37;9.31;2.47;;;;CHO;;9606;BAO_0000219;;;;;Cl.Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)CCc7ccncc7;;Bioorg. Med. Chem. Lett.;2011;1;UO_0000065;False
CHEMBL521854;EC50;=;0.27;nM;9.57;;10;CHEMBL1007140;Activity at monocloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140920;Scientific Literature;0;0;497.6;;;;;3.3;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7cc8ccccc8cn7;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL260528;EC50;=;26.28;nM;7.58;;2;CHEMBL1007140;Activity at monocloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140920;Scientific Literature;0;0;447.54;;;;;2.15;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccccn7;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL38874;EC50;=;45.06;nM;7.35;;DAMGO;CHEMBL1007140;Activity at monocloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140920;Scientific Literature;0;2;513.6;;;;;-0.94;;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Med. Chem.;2009;1;UO_0000065;True
CHEMBL3357966;EC50;=;70.5;nM;7.15;;4a;CHEMBL3361835;Agonist activity at human recombinant mu opioid receptor expressed in CHO cell membranes after 60 mins by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3352469;Scientific Literature;0;1;516.59;;;;;2.97;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CCOC(=O)Cc1c(O)n(Cc2ccccc2)c3[C@@H]4Oc5c(O)ccc6C[C@H]7N(C)CC[C@@]4(c56)[C@@]7(O)Cc13;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL2113312;EC50;=;62.5;nM;7.2;;8b;CHEMBL896951;Agonist activity at human delta opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;507.07;;;;;4.79;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1CNC\C=C\c4ccc(Cl)cc4)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5C)c67;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL2113311;EC50;=;26.2;nM;7.58;;8a;CHEMBL896951;Agonist activity at human delta opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;0;472.63;;;;;4.14;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1CNC\C=C\c4ccccc4)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5C)c67;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL2113305;EC50;=;3.36;nM;8.47;;6c;CHEMBL896951;Agonist activity at human delta opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;521.06;;;;;4.32;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1CNC(=O)\C=C\c4ccccc4Cl)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5C)c67;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL219044;IC50;=;6.9;nM;8.16;;43;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;408.54;;;;;3.66;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COC(=O)c1cccc(CN2CCN3C[C@H](C)[C@@](C)(C[C@@H]3C2)c4cccc(O)c4)c1;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL375803;IC50;=;5.7;nM;8.24;;41;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;366.51;;;;;3.58;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3ccc(O)cc3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL217998;IC50;=;1.5;nM;8.82;;34;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;364.53;;;;;4.18;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3cccc(C)c3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL219099;IC50;=;7.5;nM;8.12;;50;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;351.49;;;;;3.27;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3cccnc3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL219154;IC50;=;9.7;nM;8.01;;44;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;1;442.6;;;;;5.67;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2CCN(Cc3cccc(Oc4ccccc4)c3)C[C@H]2C[C@@]1(C)c5cccc(O)c5;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL3216841;EC50;=;15.29;nM;7.82;;SYK-352;CHEMBL3097535;Agonist activity at human recombinant mu opioid receptor expressed in CHO cells after 2 hrs by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3091434;Scientific Literature;0;0;515.48;;;;;3.52;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cl.Cl.Oc1ccc2CC3N(C[C@@H]4CCCO4)CC[C@@]5(Cc6nc7ccccc7cc6C[C@@]35O)c2c1;;Bioorg. Med. Chem.;2013;1;UO_0000065;False
CHEMBL38874;IC50;=;1.1;nM;8.96;;DAMGO;CHEMBL947370;Displacement of radiolabeled DAMGO from human mu-type opioid receptor agonist site;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140203;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Med. Chem.;2008;1;UO_0000065;False
CHEMBL241824;EC50;=;14;nM;7.85;;(-)2b;CHEMBL887396;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as maximal stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;0;354.49;;;;;3.87;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CNC(=O)Oc1ccc2CC3C4CCCCC4(CCN3CC5CC5)c2c1;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL2443260;EC50;=;5.012;nM;8.3;;(R)-28;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;1;384.59;;;;;5.3;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Cc1cc(CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4)sc1C;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3262090;EC50;=;10.4;nM;7.98;;1e;CHEMBL3267139;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by beta-plate liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259633;Scientific Literature;0;0;473.61;;;;;4.35;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@]12CC[C@@]3(C[C@@H]1[C@H](O)c4ccccc4)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5CC8CC8)c67;;J. Med. Chem.;2014;1;UO_0000065;False
CHEMBL2178731;IC50;=;37;nM;7.43;;2;CHEMBL2183870;Agonist activity at human MOR expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 15 mins by cAMP EIA;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2177066;Scientific Literature;0;2;518.57;;;;;-0.2;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;NC(=O)[C@H]1CC(=O)NCCC(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](Cc4ccccc4)C(=O)N1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL511645;EC50;=;0.86;nM;9.07;;7;CHEMBL958391;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;0;0;386.49;;;;;1.44;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(C[C@H](O)CC[C@@]35O)c2c1O;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL38874;EC50;=;3.18;nM;8.5;;DAMGO;CHEMBL2156219;Agonist activity at human MOR expressed in HEK293 cell membrane assessed as inhibition of forskolin-induced cAMP accumulation by by liquid scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2150869;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL2048768;EC50;=;38;nM;7.42;;4a, MCL-682;CHEMBL2050641;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;416.61;17.81;0.33;1.56;20.9;5.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccccc1CNc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4CC6CCC6)c3c2;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL56585;EC50;=;4;nM;8.4;;1;CHEMBL1030613;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136834;Scientific Literature;0;0;271.4;;;;;3.33;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1[C@H]2Cc3ccc(O)cc3[C@]1(C)CCN2CC4CC4;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL242048;EC50;=;1.3;nM;8.89;;(-)3d;CHEMBL887396;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as maximal stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;1;430.59;;;;;6.16;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C(Nc1ccccc1)Oc2ccc3CC4C5CCCCC5(CCN4CC6CCC6)c3c2;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL397035;EC50;=;0.44;nM;9.36;;(-)2d;CHEMBL887396;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as maximal stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;1;416.57;;;;;5.77;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C(Nc1ccccc1)Oc2ccc3CC4C5CCCCC5(CCN4CC6CC6)c3c2;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL38874;EC50;=;55;nM;7.26;;DAMGO;CHEMBL973306;Activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1150274;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem.;2008;1;UO_0000065;True
CHEMBL226113;EC50;=;1.7;nM;8.77;;20b;CHEMBL904888;Agonist activity at human mu opioid receptor expressed in CHO membrane assessed as stimulation of [35S]GTPgammaS binding;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1143667;Scientific Literature;0;0;398.55;;;;;4.87;Homo sapiens;;;;;9606;BAO_0000249;;;;;COc1ccc2C[C@@H]3[C@@H]4Cc5c(C[C@]4(CCN3CC6CC6)c2c1)[nH]c7ccccc57;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL242048;IC50;=;22;nM;7.66;;(-)3d;CHEMBL887397;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as DAMGO-stimulated [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;1;430.59;;;;;6.16;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C(Nc1ccccc1)Oc2ccc3CC4C5CCCCC5(CCN4CC6CCC6)c3c2;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;False
CHEMBL2113275;EC50;=;2;nM;8.7;;8;CHEMBL919396;Agonist activity at human opioid gamma receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147138;Scientific Literature;0;2;805.07;;;;;8.09;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O[C@]12CCC(=O)[C@@H]3Oc4c(OC(=O)CCCCCCCCC(=O)Oc5ccc6C[C@@H]7C8CCCC[C@]8(CCN7CC9CCC9)c6c5)ccc%10C[C@H]1N(CC=C)CC[C@@]23c4%10;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL424328;IC50;=;100;nM;7;;18 MCL-178;CHEMBL754564;Inhibitory activity was determined in stimulating [35S]-GTP-gamma S binding mediated by the Opioid receptor mu 1 in chinese Hamster Ovary (CHO)membranes;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145905;Scientific Literature;0;2;817.21;8.57;0.16;-4.82;11.85;11.82;;;;;;9606;BAO_0000019;;;;;O=C(CCCCCCCCCCC(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL242756;EC50;=;73;nM;7.14;;3, ATPM;CHEMBL1769433;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1765082;Scientific Literature;0;0;353.54;;;;;4.35;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Nc1nc2cc3c(C[C@@H]4[C@@H]5CCCC[C@]35CCN4CC6CC6)cc2s1;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL1774949;EC50;=;1.2;nM;8.92;;15b, MCL-695;CHEMBL1777022;Agonist activity at human mu-opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1772956;Scientific Literature;0;2;805.16;;;;;10.15;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O[C@@]12CCCC[C@@]13CCN(CC4CCC4)[C@@H]2Cc5ccc(OC(=O)CCCCCCCCC(=O)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6)cc35;;Bioorg. Med. Chem.;2011;1;UO_0000065;False
CHEMBL3758969;EC50;=;19.95;nM;7.7;;2;CHEMBL3762660;Agonist activity at human recombinant MOR expressed in CHO cells assessed as calcium mobilization by Fluo-4 AM based fluorescence analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3758180;Scientific Literature;0;2;777.92;9.9;0.18;6.07;3.28;1.63;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N[C@@H]2CCCCNC(=O)C[C@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc4cccc5ccccc45)NC2=O)C(=O)N;;Eur. J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL1852385;EC50;=;1.19;nM;8.92;;2;CHEMBL2184591;Agonist activity at mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTP-gammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2176919;Scientific Literature;0;1;526.43;16.95;0.36;6.01;9.4;2.91;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccnc(Br)c7;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL101454;EC50;=;99;nM;7;;1;CHEMBL2389089;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2385080;Scientific Literature;0;0;326.48;;;;;4.15;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C1Cc2ccccc2N1C3CCN(CC3)C4CCCCCCC4;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL2387198;EC50;=;68;nM;7.17;;15;CHEMBL2389089;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2385080;Scientific Literature;0;0;354.54;;;;;4.65;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(C)C1CCC(CC1)N2CCC(CC2)N3C(=O)CCc4ccccc34;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL2387192;EC50;=;50.6;nM;7.3;;9;CHEMBL2389089;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2385080;Scientific Literature;0;0;320.44;;;;;3.8;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(N1CCC(CC1)N2C(=O)Cc3ccccc23)c4ccccc4;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL405131;IC50;=;90;nM;7.05;;15 MCL-177;CHEMBL754564;Inhibitory activity was determined in stimulating [35S]-GTP-gamma S binding mediated by the Opioid receptor mu 1 in chinese Hamster Ovary (CHO)membranes;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145905;Scientific Literature;0;2;761.1;9.26;0.17;-3.21;11.93;10.26;;;;;;9606;BAO_0000019;;;;;O=C(CCCCCCC(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL1254685;IC50;=;4.8;nM;8.32;;12, LPI;CHEMBL1252310;Agonist activity at mu opioid expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1250436;Scientific Literature;0;0;364.49;;;;;3.95;;;;HEK293;;9606;BAO_0000219;;;;;C[C@H]1CN(CCC(=O)Nc2ccccc2)[C@@H]3Cc4ccc(O)cc4[C@]1(C)C3;;Bioorg. Med. Chem.;2010;1;UO_0000065;False
CHEMBL499595;IC50;=;48;nM;7.32;;12;CHEMBL1000649;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of 100 nM loperamide-stimulated GTPgammaS binding by cell based assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136971;Scientific Literature;0;1;501.59;14.59;0.27;5.89;5.93;1.43;Homo sapiens;;;;;9606;BAO_0000219;;;;;C[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H]5CCCN5C1=O;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL2179655;EC50;=;4.27;nM;8.37;;17g;CHEMBL2186797;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2177065;Scientific Literature;0;2;563.1;;;;;6.76;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@]2(Cc6cc(cnc46)c7ccc(Cl)cc7)OC\C=C\c8ccccc8)c35;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL3707087;IC50;=;59;nM;7.23;;32a;CHEMBL753178;In vitro binding affinity against cloned human Opioid receptor mu 1 expressed in HEK 293S cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145019;Scientific Literature;0;0;261.37;27.66;0.49;3.34;223.12;3.89;;;;HEK293;;9606;BAO_0000219;;;;;C1C[C@H]2[C@H]3c4ccccc4C[C@H](N2C1)c5ccccc35;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL77001;IC50;=;0.65;nM;9.19;;25;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;443.59;20.71;0.38;5.57;11.69;3.62;;;;;;9606;BAO_0000357;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2CNCc4ccccc4;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL1161419;EC50;=;31;nM;7.51;;1;CHEMBL749654;Compound tested at 10 uM for the ability to induce Opioid receptor mu 1-mediated binding of [35S]GTP-gamma-S to G proteins in CHO membrane preparations;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145973;Scientific Literature;0;1;555.68;;;;;1.49;;;;;;9606;BAO_0000249;;;;;N[C@@H](Cc1ccccc1)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL325347;EC50;=;3.47;nM;8.46;;7;CHEMBL749655;Concentration necessary to produce 50% of the Emax value, i.e. to stimulate [35S]GTP-gamma-S, binding to recombinant human Opioid receptor mu 1 expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148330;Scientific Literature;0;0;445.6;;;;;4.81;;;;CHO;;9606;BAO_0000219;;;;;Oc1cccc2C[C@H]3N(CC4CC4)CCC5(CC(=O)CC[C@@]35OCCCc6ccccc6)c12;;J. Med. Chem.;2004;1;UO_0000065;False
CHEMBL431074;EC50;=;71.95;nM;7.14;;2b;CHEMBL747703;Agonistic activity against human opioid Mu receptor transfected into Chinese hamster ovary (CHO) cells using [3H]-DAMGO as radioligand;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1131901;Scientific Literature;0;0;351.41;;;;;1.41;;;;CHO;;9606;BAO_0000219;;;;;CN1CCC23C4Oc5c(O)ccc(CC1C2(O)Cc6cnc(C)nc46)c35;;Bioorg. Med. Chem. Lett.;1999;1;UO_0000065;False
CHEMBL91760;IC50;=;4.7;nM;8.33;;2;CHEMBL744603;In vitro binding affinity towards mu opioid receptors was determined using [3H][p-Cl-Phe]- 4] DPDPE or [3H]deltorphin II;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1131989;Scientific Literature;0;1;470.53;17.7;0.33;9.73;4.41;-1.4;;;;;;9606;BAO_0000357;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)NN;;Bioorg. Med. Chem. Lett.;1999;1;UO_0000065;False
CHEMBL76089;IC50;=;12.5;nM;7.9;;15;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;444.58;17.78;0.33;3.85;10.43;4.05;;;;;;9606;BAO_0000357;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2COCc4ccccc4;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL3394745;IC50;=;36;nM;7.44;;7;CHEMBL3395052;Displacement of [3H]DAMGO from human Mu opioid receptor expressed in HEK293 cells after 2 hrs by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3393026;Scientific Literature;0;2;636.91;11.69;0.22;0.68;14.81;6.76;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;CCCCN(C[C@H](O)CN1CN(c2ccccc2)C3(CCN(CCc4ccccc4c5cccs5)CC3)C1=O)Cc6ccccc6;;Bioorg. Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL2048767;IC50;=;6.8;nM;8.17;;3k, MCL-731;CHEMBL2050643;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;445.61;18.33;0.34;2.1;13.98;6.07;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;[O-][N+](=O)c1cccc(CNc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4CC6CCC6)c3c2)c1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2048761;IC50;=;80;nM;7.1;;3b, MCL-665;CHEMBL2050643;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;430.64;16.48;0.3;0.93;28.97;6.17;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1cccc(CNc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4CC6CCC6)c3c2)c1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL257895;IC50;=;13;nM;7.89;;25;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;0;496.6;;;;;3.28;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)N[C@@H](CCC(=O)O)C(=O)O)CC[C@@]1(C)c3cccc(O)c3;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL270187;IC50;=;6.2;nM;8.21;;21;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;0;2;564.73;;;;;5.82;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)N[C@@H](Cc3ccc4ccccc4c3)C(=O)O)CC[C@@]1(C)c5cccc(O)c5;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL420863;IC50;=;2.4;nM;8.62;;15;CHEMBL757059;Binding affinity against mu opiate receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134625;Scientific Literature;0;0;399.88;21.56;0.42;4.35;14.43;4.27;;;;;;9606;BAO_0000357;;;;;Cc1ccc2nc(O)n(C3CCN(Cc4cc5OCOc5cc4Cl)CC3)c2c1;;J. Med. Chem.;2001;1;UO_0000065;True
CHEMBL421520;IC50;=;36;nM;7.44;;32;CHEMBL757823;Binding affinity at cloned human mu-opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134689;Scientific Literature;0;0;468.67;15.88;0.31;3.93;8.18;3.51;;;;;;9606;BAO_0000357;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2C\N=C(\S)/NC(C)(C)C;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL3217272;EC50;=;15;nM;7.82;;5b;CHEMBL3089286;Agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085655;Scientific Literature;0;0;451.48;;;;;4.36;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cl.Cl.CN[C@H]1C[C@H]2C[C@@](C1)([C@H](C)CN2CCCc3ccccc3)c4cccc(O)c4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL108608;EC50;=;44.7;nM;7.35;;4a;CHEMBL749730;Effective concentration agonistic activity towards Opioid receptor mu 1;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145844;Scientific Literature;0;1;488.63;;;;;6.19;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2CC3N(C)CC[C@@]4([C@@H]5\C(=C\c6ccccc6)\C[C@]34Cc7c5[nH]c8ccccc78)c2c1O;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL2208358;EC50;=;0.22;nM;9.66;;5;CHEMBL2213832;Partial agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203245;Scientific Literature;0;2;508.71;;;;;6.27;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1cccc(c1)c2ccc(CCNC(=O)c3ccc4CC5C(C)C(C)(CCN5CC6CC6)c4c3)cc2;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL2367604;IC50;=;17;nM;7.77;;8a, Mr2034;CHEMBL1019888;Activity at human cloned mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;301.43;;;;;3.1;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1[C@H]2Cc3ccc(O)cc3[C@@]1(C)CCN2C[C@@H]4CCCO4;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL584790;EC50;=;11;nM;7.96;;4b;CHEMBL1056145;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154777;Scientific Literature;0;2;845.27;;;;;12.31;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(C)(CCCCCCC(C)(C)C(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)C(=O)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL114484;IC50;=;16;nM;7.8;;16;CHEMBL757059;Binding affinity against mu opiate receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134625;Scientific Literature;0;0;355.87;21.91;0.43;3.26;18.88;4.54;;;;;;9606;BAO_0000357;;;;;Cc1ccc(CN2CCC(CC2)n3c(O)nc4ccccc34)c(Cl)c1;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL201556;IC50;=;43;nM;7.37;;8, D6 M1;CHEMBL865906;Inhibition of mu opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149431;Scientific Literature;0;0;255.39;29.54;0.56;5.04;16.86;2.33;Homo sapiens;;;;;9606;BAO_0000357;;;;;[2H]C([2H])([2H])N(C[C@H]1CCCC[C@]1(O)c2cccc(O)c2)C([2H])([2H])[2H];;Bioorg. Med. Chem. Lett.;2006;1;UO_0000065;False
CHEMBL242968;EC50;=;31;nM;7.51;;11, MCL-448;CHEMBL893250;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding after 60 mins;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147995;Scientific Literature;0;0;339.48;;;;;3.65;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)Nc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1;;Bioorg. Med. Chem.;2007;1;UO_0000065;False
CHEMBL319822;IC50;=;8.3;nM;8.08;;9;CHEMBL744603;In vitro binding affinity towards mu opioid receptors was determined using [3H][p-Cl-Phe]- 4] DPDPE or [3H]deltorphin II;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1131989;Scientific Literature;0;2;656.74;12.3;0.23;8.27;3.46;-0.19;;;;;;9606;BAO_0000357;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)NNC(=O)[C@H](N)Cc4ccccc4;;Bioorg. Med. Chem. Lett.;1999;1;UO_0000065;False
CHEMBL3233197;EC50;=;6.3;nM;8.2;;8;CHEMBL3239402;Agonist activity at GFP-fused mu opioid receptor (unknown origin) expressed in HEK293 cells assessed as recruitment of beta-arrestin-2 after 10 mins by BRET assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3232856;Scientific Literature;0;0;491.59;;;;;1.56;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL2177697;EC50;=;10;nM;8;;3;CHEMBL2184591;Agonist activity at mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTP-gammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2176919;Scientific Literature;0;0;472.55;16.93;0.31;5.98;6.74;2.02;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccnc(c7)C#N;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL1852475;EC50;=;5.08;nM;8.29;;15;CHEMBL2184591;Agonist activity at mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTP-gammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2176919;Scientific Literature;0;0;467.61;17.74;0.33;6.51;9.73;1.78;;;;CHO;;9606;BAO_0000219;;;;;CN1CCC(CC1)C(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2178340;EC50;=;28.3;nM;7.55;;13;CHEMBL2184591;Agonist activity at mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTP-gammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2176919;Scientific Literature;0;0;448.52;16.83;0.31;6.01;7;1.54;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccnnc7;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL1852672;EC50;=;2.32;nM;8.63;;6;CHEMBL2184591;Agonist activity at mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTP-gammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2176919;Scientific Literature;0;0;481.98;17.91;0.35;5.83;9.1;2.8;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccncc7Cl;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL285479;EC50;=;3.981;nM;8.4;;Dermorphin;CHEMBL3766803;Agonist activity at human recombinant MOR expressed in CHO cells by calcium mobilization assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3763121;Scientific Literature;0;3;802.89;10.46;0.2;10.4;2.84;-2;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)N;;Bioorg. Med. Chem.;2016;1;UO_0000065;False
CHEMBL584791;EC50;=;2;nM;8.7;;11;CHEMBL1056145;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154777;Scientific Literature;0;2;775.09;;;;;9.79;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C=CCN1CC[C@]23[C@@H]4CCC[C@H]2[C@H]1Cc5ccc(OC(=O)CCCCCCCCC(=O)Oc6ccc7CC8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6)c(O4)c35;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL584791;IC50;=;25;nM;7.6;;11;CHEMBL1056147;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154777;Scientific Literature;0;2;775.09;;;;;9.79;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C=CCN1CC[C@]23[C@@H]4CCC[C@H]2[C@H]1Cc5ccc(OC(=O)CCCCCCCCC(=O)Oc6ccc7CC8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6)c(O4)c35;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL2443255;EC50;=;6.31;nM;8.2;;(R)-23;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;0;370.56;;;;;4.99;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Cc1ccsc1CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL2443271;EC50;=;10;nM;8;;(R)-12;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;1;384.95;;;;;5.28;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Clc1ccccc1CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL2443263;EC50;=;31.62;nM;7.5;;(R)-6;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;1;367.51;;;;;5.37;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Fc1ccc(cc1)[C@]2(CCNCc3ccccc3)CCOC4(CCCC4)C2;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3580749;EC50;=;1.66;nM;8.78;;11;CHEMBL3584507;Agonist activity at human recombinant mu opioid receptor expressed in CHO cells co-expressing C-terminally modified GGalphaqi5 assessed as stimulation of calcium release by Fluo-4 AM dye-based fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3580572;Scientific Literature;0;2;763.84;11.49;0.22;8.02;3.74;0.76;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N[C@@H]2CCCCNC(=O)C[C@H](NC(=O)[C@H](Cc3ccc(F)cc3F)NC(=O)[C@H](Cc4ccccc4)NC2=O)C(=O)N;;ACS Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL522201;IC50;=;5.42;nM;8.27;;NAQ;CHEMBL2444609;Binding affinity to wild type MOR (unknown origin) expressed in CHO cells after 15 mins by Ca2+ mobilization assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440098;Scientific Literature;0;0;497.6;16.61;0.31;4.97;8.71;3.3;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@H](CC[C@@]36O)NC(=O)c7cc8ccccc8cn7;;Bioorg. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3217271;EC50;=;2.7;nM;8.57;;5h;CHEMBL3089286;Agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085655;Scientific Literature;0;1;505.57;;;;;5.48;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cl.Cl.C[C@@H]1CN(CCCc2ccccc2)[C@H]3C[C@@H](C[C@@]1(C3)c4cccc(O)c4)N(C)CC5CC5;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3217051;EC50;=;33;nM;7.48;;5c;CHEMBL3089286;Agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085655;Scientific Literature;0;0;465.51;;;;;4.75;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cl.Cl.CCN[C@H]1C[C@H]2C[C@@](C1)([C@H](C)CN2CCCc3ccccc3)c4cccc(O)c4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL2443272;EC50;=;50.12;nM;7.3;;(R)-13;CHEMBL2445992;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as beta-arrestin recruitment by chemiluminescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;1;384.95;18.96;0.37;2.02;21.38;5.28;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Clc1cccc(CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4)c1;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3580745;EC50;=;2.512;nM;8.6;;7;CHEMBL3584507;Agonist activity at human recombinant mu opioid receptor expressed in CHO cells co-expressing C-terminally modified GGalphaqi5 assessed as stimulation of calcium release by Fluo-4 AM dye-based fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3580572;Scientific Literature;0;2;745.85;11.53;0.22;7.98;3.66;0.62;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N[C@@H]2CCCCNC(=O)C[C@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc4ccc(F)cc4)NC2=O)C(=O)N;;ACS Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL2443285;EC50;=;79.43;nM;7.1;;6;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;1;367.51;;;;;5.37;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Fc1ccc(cc1)C2(CCNCc3ccccc3)CCOC4(CCCC4)C2;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL2443282;EC50;=;39.81;nM;7.4;;3;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;0;371.5;;;;;4.93;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;CC[C@]1(C)CC(CCNCc2ccccc2O)(CCO1)c3ccc(F)cc3;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3580743;EC50;=;6.31;nM;8.2;;5;CHEMBL3584507;Agonist activity at human recombinant mu opioid receptor expressed in CHO cells co-expressing C-terminally modified GGalphaqi5 assessed as stimulation of calcium release by Fluo-4 AM dye-based fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3580572;Scientific Literature;0;2;735.79;11.14;0.21;8.06;3.49;0.14;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]2CCCCNC(=O)C[C@H](NC(=O)[C@H](Cc3ccc(F)cc3F)NC(=O)[C@H](Cc4ccccc4)NC2=O)C(=O)N;;ACS Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL3086308;IC50;=;2.8;nM;8.55;;12, MCL-742;CHEMBL3090455;Antagonist activity at human mu opioid receptor transfected in CHO cells assessed as inhibition of U50488-induced [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085732;Scientific Literature;0;0;462.46;;;;;3.58;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Br.CNc1nc2C[C@]34CCN(CC5CC5)[C@H](Cc6ccc(O)cc36)[C@@H]4Cc2s1;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL38874;EC50;=;7.57;nM;8.12;;DAMGO;CHEMBL3381489;Agonist activity at human MOR expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3352005;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem. Lett.;2014;1;UO_0000065;True
CHEMBL3580748;EC50;=;2.754;nM;8.56;;10;CHEMBL3584507;Agonist activity at human recombinant mu opioid receptor expressed in CHO cells co-expressing C-terminally modified GGalphaqi5 assessed as stimulation of calcium release by Fluo-4 AM dye-based fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3580572;Scientific Literature;0;2;745.85;11.48;0.22;7.94;3.65;0.62;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N[C@@H]2CCCCNC(=O)C[C@H](NC(=O)[C@H](Cc3ccc(F)cc3)NC(=O)[C@H](Cc4ccccc4)NC2=O)C(=O)N;;ACS Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL3627737;EC50;=;0.0643;nM;10.19;;2;CHEMBL3630378;Agonist activity at mu opioid receptor (unknown origin) transfected in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP production;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3627650;Scientific Literature;0;2;628.75;16.21;0.31;7.77;5.55;2.42;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](C(=C)C(=O)N)c5ccsc5;;Bioorg. Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL575349;IC50;=;5.23;nM;8.28;;5;CHEMBL1058518;Displacement of [3H]DAMGO from mu opioid receptor expressed in CHO cells after 90 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154775;Scientific Literature;0;;1102.83;7.51;;;;;;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCCN(C(=O)CBr)C(=O)CBr)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)O;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL38874;IC50;=;0.43;nM;9.37;;DAMGO;CHEMBL3779735;Displacement of [3H]DAMGO from human recombinant Mu-type opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3774372;Scientific Literature;0;2;513.6;18.24;0.35;10.31;5.38;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem.;2016;1;UO_0000065;True
CHEMBL3216613;EC50;=;6.5;nM;8.19;;5f;CHEMBL3089286;Agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085655;Scientific Literature;0;0;465.51;;;;;4.7;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cl.Cl.C[C@@H]1CN(CCCc2ccccc2)[C@H]3C[C@@H](C[C@@]1(C3)c4cccc(O)c4)N(C)C;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL140278;EC50;=;1.2;nM;8.92;;2;CHEMBL2161464;Inverse agonist activity at human recombinant mu opioid receptor expressed in CHO cells after 3 hrs by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2157973;Scientific Literature;0;0;343.42;;;;;1.32;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CC6)c45;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL3086305;IC50;=;12;nM;7.92;;9, MCL-744;CHEMBL3090455;Antagonist activity at human mu opioid receptor transfected in CHO cells assessed as inhibition of U50488-induced [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085732;Scientific Literature;0;0;409.56;;;;;3.5;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(=O)Nc1nc2C[C@]34CCN(CC5CC5)[C@H](Cc6ccc(O)cc36)[C@@H]4Cc2s1;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3086304;IC50;=;1.8;nM;8.74;;8, MCL-420;CHEMBL3090455;Antagonist activity at human mu opioid receptor transfected in CHO cells assessed as inhibition of U50488-induced [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085732;Scientific Literature;0;0;448.43;;;;;3.12;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Br.Nc1nc2C[C@]34CCN(CC5CC5)[C@H](Cc6ccc(O)cc36)[C@@H]4Cc2s1;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3325841;EC50;=;100;nM;7;;29;CHEMBL3370190;Agonist activity at human mu opioid receptor expressed CHO-K1 cells coexpressing Galpha15 assessed as induction of intracellular calcium release by FLIPR calcium assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3351626;Scientific Literature;0;0;414.14;16.9;0.46;2.29;18.4;4.71;Homo sapiens;;;CHO-K1;;9606;BAO_0000219;;;;;Cc1nn(c2CC(C)(C)CC(O)c12)c3ccc(Br)cc3Br;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL3325716;EC50;=;41;nM;7.39;;21;CHEMBL3370190;Agonist activity at human mu opioid receptor expressed CHO-K1 cells coexpressing Galpha15 assessed as induction of intracellular calcium release by FLIPR calcium assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3351626;Scientific Literature;0;0;347.26;21.27;0.48;2.98;21.17;4.41;Homo sapiens;;;CHO-K1;;9606;BAO_0000219;;;;;Cc1ccc(c(Br)c1)n2nc(C)c3C(=O)CC(C)(C)Cc23;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL3758348;EC50;=;35;nM;7.46;;"63; UMB 425";CHEMBL3762574;Agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3758122;Scientific Literature;0;0;331.37;22.5;0.42;7.35;8.26;0.11;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@@]23c4c5C[C@@H]1[C@]2(O)CCC(=O)[C@]3(CO)Oc4c(O)cc5;;Eur. J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL3759660;EC50;=;73;nM;7.14;;"75; ATPM";CHEMBL3760684;Partial agonist activity at mu opioid receptor (unknown origin) expressed in CHO cell membrane assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3758122;Scientific Literature;0;0;353.54;20.19;0.39;2.79;16.93;4.35;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Nc1nc2cc3c(CC4[C@@H]5CCCC[C@]35CCN4CC6CC6)cc2s1;;Eur. J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL147511;EC50;=;1.3;nM;8.89;;"51; MCL-144";CHEMBL3760689;Partial agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3758122;Scientific Literature;0;2;789.16;11.26;0.21;-2.15;15.04;11.04;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O=C(CCCCCCCCC(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6;;Eur. J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL494350;IC50;=;97;nM;7.01;;8;CHEMBL953424;Agonist activity at human mu opioid receptor expressed in CHO cell membrane by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1150320;Scientific Literature;0;0;382.96;;;;;3.61;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H]1CN(CCO)CCN1c2cc3[nH]c(SC(C)(C)C)nc3cc2Cl;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL38874;EC50;=;45.1;nM;7.35;;DAMGO;CHEMBL993517;Agonist activity against mu opioid receptor expressed in CHO cells assessed as stimulation [35S]GTPgammaS binding relative to basal level;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153911;Scientific Literature;0;2;513.6;;;;;-0.94;;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL1766041;EC50;=;29;nM;7.54;;13c;CHEMBL1769433;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1765082;Scientific Literature;0;0;373.54;;;;;4.76;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CNc1nc2cc3c(C[C@@H]4[C@@H]5CCCC[C@]35CCN4CCCF)cc2s1;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL2387187;EC50;=;73.5;nM;7.13;;3;CHEMBL2389089;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2385080;Scientific Literature;0;0;340.51;;;;;4.25;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(C)C1CCC(CC1)N2CCC(CC2)N3C(=O)Cc4ccccc34;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL316446;IC50;=;65.4;nM;7.18;;1;CHEMBL2161363;Agonist activity at mu-opioid receptor in human SH-SY5Y cells assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins by immunoassay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2157939;Scientific Literature;0;2;610.72;;;;;1.67;Homo sapiens;;;SH-SY5Y;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](Cc5ccccc5)C(=O)N;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL13470;EC50;=;0.14;nM;9.85;;SNC80;CHEMBL3271443;Agonist activity at human mu opioid receptor expressed in HEK293 cells by CellKey method;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259551;Scientific Literature;0;0;449.64;21.92;0.41;5;27.36;4.85;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;CCN(CC)C(=O)c1ccc(cc1)[C@@H](N2C[C@@H](C)N(CC=C)C[C@@H]2C)c3cccc(OC)c3;;ACS Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL316446;IC50;=;3.2;nM;8.49;;1;CHEMBL2162350;Agonist activity at MOP receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2157899;Scientific Literature;0;2;610.72;;;;;1.67;;;;CHO-K1;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](Cc5ccccc5)C(=O)N;;Bioorg. Med. Chem.;2012;1;UO_0000065;False
CHEMBL4071332;EC50;=;10;nM;8;;45;CHEMBL3992793;Agonist activity at human MOR expressed in CHO-K1 cells co-expressing Galpha 15 assessed as increase in intracellular calcium release incubated for 1 measured every 1.52 secs for 90 secs by FLIPR assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3992491;Scientific Literature;0;0;308.43;25.94;0.48;4.74;24.74;3.26;Homo sapiens;;;;;9606;BAO_0000219;;;;;CN1CCc2ccccc2C1CNC(=O)c3ccc(C)c(C)c3;;Eur J Med Chem;2017;1;UO_0000065;False
CHEMBL1400;IC50;=;47;nM;7.33;;metabolite M1;CHEMBL865906;Inhibition of mu opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149431;Scientific Literature;0;0;249.35;29.39;0.56;5;16.77;2.33;Homo sapiens;;;;;9606;BAO_0000357;;;;;CN(C)C[C@H]1CCCC[C@]1(O)c2cccc(O)c2;;Bioorg. Med. Chem. Lett.;2006;1;UO_0000065;True
CHEMBL38874;EC50;=;55;nM;7.26;;DAMGO;CHEMBL2213836;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203245;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;True
CHEMBL2048774;EC50;=;6.5;nM;8.19;;4g, MCL-725;CHEMBL2050641;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;0;362.52;22.58;0.41;3.5;23.06;4.69;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23CCCC[C@H]2[C@H]1Cc4ccc(NCc5cccc(O)c5)cc34;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL38874;EC50;=;55;nM;7.26;;DAMGO;CHEMBL2353043;Agonist activity at human mu opioid receptor expressed in CHO cell membrane assessed as stimulation of [35S]GTPgammaS binding after 60 mins by liquid scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2346652;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL1834409;EC50;=;6;nM;8.22;;1b;CHEMBL1838554;Partial agonist activity at human MOP receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1833948;Scientific Literature;0;0;481.68;;;;;4.8;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CCC(C)(C)[C@](C)(O)[C@H]1C[C@]23CC[C@]1(OC)[C@@H]4Oc5c(O)ccc6C[C@H]2N(CC7CC7)CC[C@@]34c56;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL1824518;EC50;=;5.08;nM;8.29;;10;CHEMBL1828464;Agonist activity against mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1821548;Scientific Literature;0;0;504.07;17.74;0.33;6.51;9.73;1.78;;;;CHO;;9606;BAO_0000219;;;;;Cl.CN1CCC(CC1)C(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;Bioorg. Med. Chem. Lett.;2011;1;UO_0000065;False
CHEMBL1834250;IC50;=;20.8;nM;7.68;;page no 6539, R62C1;CHEMBL1837092;Agonist activity at Mu-type opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1833812;Scientific Literature;0;0;479.54;;;;;-0.45;;;;;;9606;BAO_0000019;;;;;C[C@@H](N1Cc2cc(O)ccc2CC(N)C1=O)C(=O)NC3Cc4ccccc4CN(CC(=O)N)C3=O;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL3339378;EC50;=;0.4;nM;9.4;;4b;CHEMBL3385713;Agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3351376;Scientific Literature;0;0;485.58;;;;;2.47;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2CC3N(CC4CC4)CCC56C(Oc1c25)[C@@]7(O)CC[C@@]36N=C7C(=O)NCc8ccccc8;;Bioorg. Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL3339379;EC50;=;1.09;nM;8.96;;4c;CHEMBL3385713;Agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3351376;Scientific Literature;0;0;499.61;;;;;2.51;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2CC3N(CC4CC4)CCC56C(Oc1c25)[C@@]7(O)CC[C@@]36N=C7C(=O)NCCc8ccccc8;;Bioorg. Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL1824509;EC50;=;0.83;nM;9.08;;1;CHEMBL1828464;Agonist activity against mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1821548;Scientific Literature;0;0;518.44;18.84;0.36;6.28;9.57;2.8;;;;CHO;;9606;BAO_0000219;;;;;Cl.Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccnc(Cl)c7;;Bioorg. Med. Chem. Lett.;2011;1;UO_0000065;False
CHEMBL2163913;EC50;=;0.84;nM;9.08;;9;CHEMBL2166341;Agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by liquid scintillation counter;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2163332;Scientific Literature;0;2;657.17;;;;;3.01;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](C(=C)C(=O)N)c5ccccc5Cl;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2163922;EC50;=;45.09;nM;7.35;;5;CHEMBL2166341;Agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by liquid scintillation counter;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2163332;Scientific Literature;0;1;595.7;;;;;2.57;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=C)C(=O)N[C@H](C(=C)C(=O)N)c3ccccc3)c4ccccc4;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL3763905;IC50;=;70.4;nM;7.15;;2;CHEMBL3766870;Agonist activity at human MOR expressed in CHO cells assessed as induction of membrane potential change measured every 3 secs for 30 secs by fluorescent membrane potential assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3763066;Scientific Literature;0;2;674.76;10.6;0.2;7.12;3.08;0.03;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]2CCCCNC(=O)CNC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](Cc4ccc(O)cc4)NC2=O;;J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL56585;EC50;=;4.5;nM;8.35;;17(1R,5R,9R);CHEMBL749733;Incorporation of [35S]- GTPgammaS into CHO membranes expressing human Opioid receptor mu 1;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145777;Scientific Literature;0;0;271.4;30.75;0.57;5.02;35.56;3.33;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1[C@H]2Cc3ccc(O)cc3[C@]1(C)CCN2CC4CC4;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL1766023;EC50;=;71;nM;7.15;;12;CHEMBL1769433;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1765082;Scientific Literature;0;0;383.56;;;;;4.12;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Nc1nc2cc3c(C[C@@H]4[C@@H]5CCCC[C@]35CCN4C[C@@H]6CCCO6)cc2s1;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL2179662;EC50;=;48;nM;7.32;;18f;CHEMBL2186797;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2177065;Scientific Literature;0;2;579.1;;;;;6.21;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@]2(Cc6cc(cnc46)c7ccc(Cl)cc7)OC(=O)CCc8ccccc8)c35;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL70;EC50;=;39.81;nM;7.4;;Morphine;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;4;0;285.34;;;;;1.2;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL2418739;EC50;=;20;nM;7.7;;13;CHEMBL2423628;Agonist activity at human MOR assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins by cell based TR-FRET assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2417445;Scientific Literature;0;0;301.39;;;;;1.67;Homo sapiens;;;;;9606;BAO_0000219;;;;;C[C@@H]1C[C@H]2[C@H]3Cc4ccc(O)c5O[C@@H]([C@H]1O)[C@]2(CCN3C)c45;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL464230;EC50;=;5.3;nM;8.28;;7b;CHEMBL1019886;Activity at human cloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;348.49;;;;;3.55;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC1C2Cc3ccc(cc3C1(C)CCN2CCc4ccccc4)C(=O)N;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL2334769;EC50;=;0.0933;nM;10.03;;4;CHEMBL2341394;Agonist activity at FLAG-tagged mu-type opioid receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins by liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2331515;Scientific Literature;0;2;612.69;;;;;1.81;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CC[C@@H](C2)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](C(=C)C(=O)N)c5occc5;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL2113314;EC50;=;3.1;nM;8.51;;18b;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;510.63;;;;;3.7;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12C=C[C@@]3([C@@H]4CN(C[C@H]14)C(=O)\C=C\c5ccc(C)cc5)[C@H]6Cc7ccc(O)c8O[C@@H]2[C@]3(CCN6C)c78;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL2113312;EC50;=;5.37;nM;8.27;;8b;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;507.07;;;;;4.79;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1CNC\C=C\c4ccc(Cl)cc4)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5C)c67;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL2113304;EC50;=;0.25;nM;9.6;;6b;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;500.64;;;;;3.97;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1CNC(=O)\C=C\c4ccccc4C)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5C)c67;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL19019;IC50;=;8.9;nM;8.05;;NALTREXONE;CHEMBL3227490;Antagonist activity at human mu opioid receptor expressed in Gqi5 transfected CHO cells assessed as inhibition of DAMGO-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3217593;Scientific Literature;4;0;341.41;23.58;0.44;6.52;11.5;1.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O;;MedChemComm;2013;1;UO_0000065;True
CHEMBL407563;IC50;=;84;nM;7.08;;27;CHEMBL948139;Binding affinity to mu opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1141623;Scientific Literature;0;0;249.35;28.38;0.54;4.44;17.05;2.64;;;;;;9606;BAO_0000357;;;;;CNC[C@@H]1CCCC[C@@]1(OC)c2cccc(O)c2;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL3582485;EC50;=;4.074;nM;8.39;;2;CHEMBL3584507;Agonist activity at human recombinant mu opioid receptor expressed in CHO cells co-expressing C-terminally modified GGalphaqi5 assessed as stimulation of calcium release by Fluo-4 AM dye-based fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3580572;Scientific Literature;0;2;735.79;11.4;0.22;8.25;3.57;0.14;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]2CCCCNC(=O)C[C@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc4ccc(F)cc4F)NC2=O)C(=O)N;;ACS Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL3394746;IC50;=;47;nM;7.33;;8;CHEMBL3395052;Displacement of [3H]DAMGO from human Mu opioid receptor expressed in HEK293 cells after 2 hrs by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3393026;Scientific Literature;0;2;636.91;11.51;0.22;0.57;14.58;6.76;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;CCCCN(C[C@@H](O)CN1CN(c2ccccc2)C3(CCN(CCc4ccccc4c5cccs5)CC3)C1=O)Cc6ccccc6;;Bioorg. Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL3394747;IC50;=;29;nM;7.54;;9;CHEMBL3395052;Displacement of [3H]DAMGO from human Mu opioid receptor expressed in HEK293 cells after 2 hrs by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3393026;Scientific Literature;0;2;586.83;12.84;0.25;2.23;12.76;5.31;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;O[C@@H](CNCc1cccs1)CN2CN(c3ccccc3)C4(CCN(CCc5ccccc5c6cccs6)CC4)C2=O;;Bioorg. Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL2113311;EC50;=;5.51;nM;8.26;;8a;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;0;472.63;;;;;4.14;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1CNC\C=C\c4ccccc4)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5C)c67;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL2113308;EC50;=;1.3;nM;8.89;;6f;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;531.61;;;;;3.57;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1CNC(=O)\C=C\c4ccc(cc4)[N+](=O)[O-])[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5C)c67;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL2113303;EC50;=;3.12;nM;8.51;;6a;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;0;486.61;;;;;3.67;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1CNC(=O)\C=C\c4ccccc4)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5C)c67;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL4111934;EC50;=;53;nM;7.28;340496;BDBM190229;CHEMBL3887475;"GTPgammaS Functional Assay (U-2): [35S]GTPgammaS functional assays were conducted using freshly thawed pt-receptor membranes prepared in-house from a cell line expressing recombinant mu opioid receptor in a U-2 OS cell background, or purchased from a commercial source (Perkin Elmer, Shelton, Conn.; or DiscovRx, Fremont, Calif.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2,20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886333;BindingDB Database;0;1;557.74;13.05;0.24;3.16;8.46;4.12;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@]7(CC[C@@]36C[C@@H]7C(NC(C)C(=O)N)c8ccccc8)OC;;;2015;37;UO_0000065;False
CHEMBL3764157;IC50;=;66.9;nM;7.17;;9;CHEMBL3766870;Agonist activity at human MOR expressed in CHO cells assessed as induction of membrane potential change measured every 3 secs for 30 secs by fluorescent membrane potential assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3763066;Scientific Literature;0;2;668.75;10.73;0.2;8.64;2.69;-1.47;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]2CCCCNC(=O)CNC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](CCCNC(=O)N)NC2=O;;J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL3763985;IC50;=;32;nM;7.5;;7;CHEMBL3766870;Agonist activity at human MOR expressed in CHO cells assessed as induction of membrane potential change measured every 3 secs for 30 secs by fluorescent membrane potential assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3763066;Scientific Literature;0;2;659.74;11.36;0.21;7.77;3.33;-0.28;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]2CCCCNC(=O)CNC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](Cc4ccncc4)NC2=O;;J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL3264745;EC50;=;2.7;nM;8.57;;4e;CHEMBL3271437;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]-GTP[gammaS] binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259551;Scientific Literature;0;0;486.57;17.61;0.33;5.47;11.99;3.1;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC=C)CC[C@]45[C@@H]6[C@@H]7O[C@]34CC[C@@]6(OCOc1c25)N(Cc8ccccc8)C7=O;;ACS Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL3264748;EC50;=;2.1;nM;8.68;;4i;CHEMBL3271437;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]-GTP[gammaS] binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259551;Scientific Literature;0;1;514.62;16.86;0.31;5.31;12.14;3.37;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@]56[C@@H]7[C@@H]8O[C@]35CC[C@@]7(OCOc1c26)N(CCc9ccccc9)C8=O;;ACS Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL38874;IC50;=;0.43;nM;9.37;;DAMGO;CHEMBL3876380;Displacement of [3H]DAMGO from human recombinant mu-opioid receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3875185;Scientific Literature;0;2;513.6;18.24;0.35;10.31;5.38;-0.94;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg Med Chem;2017;1;UO_0000065;False
CHEMBL4108290;EC50;=;79.27;nM;7.1;354879;BDBM199414;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;1;512.65;13.85;0.26;4.93;6.86;2.17;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@]7(CC[C@@]36C[C@@H]7COC(=O)[C@@H](N)C(C)O)OC;;;2015;37;UO_0000065;False
CHEMBL3787016;EC50;=;6.23;nM;8.21;;8;CHEMBL3787931;Agonist activity at human mu opioid receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3785070;Scientific Literature;0;0;414.55;19.79;0.36;4.14;13.79;4.07;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]5(Cc6[nH]c7ccccc7c6CC[C@@]35O)c2c1;;Bioorg. Med. Chem.;2016;1;UO_0000065;False
CHEMBL3787663;EC50;=;11.6;nM;7.94;;9;CHEMBL3787931;Agonist activity at human mu opioid receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3785070;Scientific Literature;0;0;426.56;18.6;0.34;3.8;14.02;4.14;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]5(Cc6nc7ccccc7cc6CC[C@@]35O)c2c1;;Bioorg. Med. Chem.;2016;1;UO_0000065;False
CHEMBL3786083;EC50;=;19.2;nM;7.72;;14;CHEMBL3787931;Agonist activity at human mu opioid receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3785070;Scientific Literature;0;0;429.56;17.96;0.33;3.48;12.7;4.24;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]5(CC(=O)\C(=C/c6ccccc6)\CC[C@@]35O)c2c1;;Bioorg. Med. Chem.;2016;1;UO_0000065;False
CHEMBL4111936;EC50;=;2.31;nM;8.64;412537;BDBM236867;CHEMBL3888720;"[35S]GTP?S Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared from a cell line expressing recombinant ? opioid receptor in a HEK-293, CHO or U-2 OS cell background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.; or DiscovRx, Fremont, Calif.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50� C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886801;BindingDB Database;0;0;353.51;24.43;0.45;4.72;21.3;3.92;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC(C)[C@H]1C[C@H]2[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3CC5CC5)CC1=O;;;2016;37;UO_0000065;False
CHEMBL4110274;IC50;=;3.3;nM;8.48;326529;BDBM179883;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;285.43;29.71;0.55;4.77;36.14;3.71;Homo sapiens;;;;;9606;BAO_0000249;;;;;C[C@H](C1CC1)N2CC[C@@]3(C)C(C)[C@H]2Cc4ccc(O)cc34;;;2015;37;UO_0000065;False
CHEMBL285479;IC50;=;36.7;nM;7.43;;Dermorphin;CHEMBL3762577;Binding affinity at mu opioid receptor (unknown origin);single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3758122;Scientific Literature;0;3;802.89;9.26;0.18;9.44;2.52;-2;Homo sapiens;;;;;9606;BAO_0000357;;;;;C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)N;;Eur. J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL4107680;EC50;=;55.91;nM;7.25;354831;BDBM199338;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;0;446.59;16.24;0.3;3.32;12.73;3.93;Homo sapiens;;;;;9606;BAO_0000019;;;;;CO[C@]12CC[C@@]3(C[C@@H]1COCc4ccccc4)[C@H]5Cc6ccc(N)c7O[C@@H]2[C@]3(CCN5C)c67;;;2015;37;UO_0000065;False
CHEMBL3736013;IC50;=;59;nM;7.23;;"5; AKG127";CHEMBL3738454;Agonist activity at mu opioid receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation by bioluminescent assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3734657;Scientific Literature;0;;1124.17;6.43;;;;;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2ccc(F)cc2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc3c(C)cc(O)cc3C)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)NCc6cc(cc(c6)C(F)(F)F)C(F)(F)F;;J. Med. Chem.;2015;1;UO_0000065;False
CHEMBL4114707;EC50;=;15;nM;7.82;326562;BDBM179881;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;382.5;20.45;0.38;5.02;9.01;2.8;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(=CCN1CC[C@]23CC(=C)CC[C@@]2(O)[C@H]1Cc4ccc(C(=O)N)c(O)c34)C;;;2015;37;UO_0000065;False
CHEMBL3958318;IC50;=;26;nM;7.58;326533;BDBM179887;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;275.39;27.54;0.52;5.03;23.2;2.56;Homo sapiens;;;;;9606;BAO_0000249;;;;;COCCN1CC[C@]2(C)[C@@H](C)[C@H]1Cc3ccc(O)cc23;;;2015;37;UO_0000065;False
CHEMBL4114524;EC50;=;1.5;nM;8.82;326560;BDBM179879;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;370.49;23.82;0.45;6.5;10.17;2.32;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@@H]3[C@@H]4CC[C@@H](O)C[C@]4(CCN3CC5CCC5)c2c1O;;;2015;37;UO_0000065;False
CHEMBL4114055;EC50;=;2.5;nM;8.6;326582;BDBM179902;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;338.5;25.41;0.47;4.96;18.57;3.64;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC5CCC5)c2c1;;;2015;37;UO_0000065;False
CHEMBL3582484;EC50;=;2.57;nM;8.59;;1;CHEMBL3584507;Agonist activity at human recombinant mu opioid receptor expressed in CHO cells co-expressing C-terminally modified GGalphaqi5 assessed as stimulation of calcium release by Fluo-4 AM dye-based fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3580572;Scientific Literature;0;2;717.8;11.97;0.23;;3.66;0;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]2CCCCNC(=O)C[C@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc4ccc(F)cc4)NC2=O)C(=O)N;;ACS Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL3923831;EC50;=;28.5;nM;7.54;369596;BDBM208981;CHEMBL3888047;"HiRange Homogenous Time-Resolved Fluorescence (HTRF) Assay: Briefly, suspensions of cells expressing either the mu, kappa or delta opioid receptors were prepared in buffer containing 0.5 mM isobutyl-methyl xanthine (IBMX). Cells were incubated with varying concentrations of PEG-opioid conjugates and 3 uM forskolin for 30 minutes at room temperature. cAMP was detected following a two-step assay protocol per the manufacturer's instructions and time resolved fluorescence was measured with the following settings: 330 nm excitation; 620 nm and 665 nm emission; 380 nm dichroic mirror. The 665 nm/620 nm ratio is expressed as Delta F % and test compound-related data is expressed as a percentage of average maximum response in wells without forskolin. EC50 values were calculated for each compound from a sigmoidal dose-response plot of concentrations versus maximum response.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886551;BindingDB Database;0;0;299.37;25.2;0.47;5.7;17.99;1.85;Homo sapiens;;;;;9606;BAO_0000019;;;;;CO[C@H]1C=CC2C3Cc4ccc(O)c5OC1[C@]2(CCN3C)c45;;;2016;37;UO_0000065;False
CHEMBL4110373;EC50;=;85;nM;7.07;369597;BDBM208982;CHEMBL3888047;"HiRange Homogenous Time-Resolved Fluorescence (HTRF) Assay: Briefly, suspensions of cells expressing either the mu, kappa or delta opioid receptors were prepared in buffer containing 0.5 mM isobutyl-methyl xanthine (IBMX). Cells were incubated with varying concentrations of PEG-opioid conjugates and 3 uM forskolin for 30 minutes at room temperature. cAMP was detected following a two-step assay protocol per the manufacturer's instructions and time resolved fluorescence was measured with the following settings: 330 nm excitation; 620 nm and 665 nm emission; 380 nm dichroic mirror. The 665 nm/620 nm ratio is expressed as Delta F % and test compound-related data is expressed as a percentage of average maximum response in wells without forskolin. EC50 values were calculated for each compound from a sigmoidal dose-response plot of concentrations versus maximum response.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886551;BindingDB Database;0;0;361.44;19.56;0.37;5.86;9.9;1.21;Homo sapiens;;;;;9606;BAO_0000019;;;;;COCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45;;;2016;37;UO_0000065;False
CHEMBL226217;EC50;=;0.4;nM;9.4;;22b;CHEMBL904888;Agonist activity at human mu opioid receptor expressed in CHO membrane assessed as stimulation of [35S]GTPgammaS binding;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1143667;Scientific Literature;0;0;367.52;;;;;3.12;Homo sapiens;;;;;9606;BAO_0000249;;;;;Nc1nc2C[C@]34CCN(CC5CC5)[C@H](Cc6ccc(O)cc36)[C@@H]4Cc2s1;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL373984;IC50;=;97;nM;7.01;;MCL-450;CHEMBL870440;Antagonist activity against human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1146900;Scientific Literature;0;2;732.97;;;;;5.8;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@H]2C(=O)NCCC(=O)Oc4ccc5C[C@@H]6[C@@H]7CCCC[C@]7(CCN6CC8CCC8)c5c4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL58646;IC50;=;5.6;nM;8.25;;2, 8-CAC;CHEMBL2353037;Partial agonist activity at human mu opioid receptor expressed in CHO cell membrane assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by liquid scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2346652;Scientific Literature;0;0;298.43;;;;;2.72;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)N;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL2113295;EC50;=;15.1;nM;7.82;;5b;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;1;514.67;;;;;4.28;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)[C@@]6(CC[C@@]35C[C@@H]6CNC(=O)\C=C\c7ccccc7C)OC;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL2113303;EC50;=;59.2;nM;7.23;;6a;CHEMBL896951;Agonist activity at human delta opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;0;0;486.61;;;;;3.67;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1CNC(=O)\C=C\c4ccccc4)[C@H]5Cc6ccc(O)c7O[C@@H]2[C@]3(CCN5C)c67;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL301160;EC50;=;1.6;nM;8.8;;(-)3a;CHEMBL887396;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as maximal stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;0;311.47;;;;;4.25;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;True
CHEMBL1774946;IC50;=;9.3;nM;8.03;;8, MCL-691;CHEMBL1777023;Antagonist activity at human mu-opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1772956;Scientific Literature;0;0;341.5;;;;;4.02;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CCCC[C@@]13CCN(CC4CCC4)[C@@H]2Cc5ccc(O)cc35;;Bioorg. Med. Chem.;2011;1;UO_0000065;False
CHEMBL1774946;EC50;=;3.6;nM;8.44;;8, MCL-691;CHEMBL1777022;Agonist activity at human mu-opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1772956;Scientific Literature;0;0;341.5;;;;;4.02;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CCCC[C@@]13CCN(CC4CCC4)[C@@H]2Cc5ccc(O)cc35;;Bioorg. Med. Chem.;2011;1;UO_0000065;False
CHEMBL301160;EC50;=;1.6;nM;8.8;;1, butorphan;CHEMBL919396;Agonist activity at human opioid gamma receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147138;Scientific Literature;0;0;311.47;;;;;4.25;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1;;J. Med. Chem.;2007;1;UO_0000065;True
CHEMBL301160;IC50;=;20;nM;7.7;;1, butorphan;CHEMBL919398;Agonist activity at human opioid gamma receptor expressed in CHO cells assessed as inhibition of DAGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147138;Scientific Literature;0;0;311.47;;;;;4.25;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1;;J. Med. Chem.;2007;1;UO_0000065;True
CHEMBL2347238;EC50;=;4.5;nM;8.35;;7;CHEMBL2353039;Partial agonist activity at human mu opioid receptor expressed in CHO cell membrane assessed as stimulation of [35S]GTPgammaS binding after 60 mins by liquid scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2346652;Scientific Literature;0;1;479.67;;;;;5.66;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)NCCc5ccc(nc5)c6ccccc6;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL426523;IC50;=;0.53;nM;9.28;223798;BDBM50199896;CHEMBL3705131;Binding Assay: The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994).;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3638450;BindingDB Database;0;0;335.49;27.65;0.51;4.34;39.52;4.94;Homo sapiens;;;;;9606;BAO_0000357;;;;;C[C@H]1CN2C[C@@H](CC[C@H]2C[C@@]1(C)c3cccc(O)c3)c4ccccc4;;;2013;37;UO_0000065;False
CHEMBL219495;IC50;=;21;nM;7.68;223799;BDBM50199934;CHEMBL3705131;Binding Assay: The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994).;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3638450;BindingDB Database;0;0;364.53;21.06;0.39;3.76;28.74;3.92;Homo sapiens;;;;;9606;BAO_0000357;;;;;C[C@H]1CN2CCN(CCc3ccccc3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;;2013;37;UO_0000065;False
CHEMBL218404;IC50;=;21;nM;7.68;223800;BDBM50199913;CHEMBL3705131;Binding Assay: The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994).;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3638450;BindingDB Database;0;0;364.49;21.06;0.39;4.16;17.54;3.52;Homo sapiens;;;;;9606;BAO_0000357;;;;;C[C@H]1CN2CCN(C[C@H]2C[C@@]1(C)c3cccc(O)c3)C(=O)c4ccccc4;;;2013;37;UO_0000065;False
CHEMBL3215943;EC50;=;1.199;nM;8.92;;SYK-372;CHEMBL3097535;Agonist activity at human recombinant mu opioid receptor expressed in CHO cells after 2 hrs by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3091434;Scientific Literature;0;0;511.45;;;;;4.13;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cl.Cl.Oc1ccc2CC3N(Cc4occc4)CC[C@@]5(Cc6nc7ccccc7cc6C[C@@]35O)c2c1;;Bioorg. Med. Chem.;2013;1;UO_0000065;False
CHEMBL4109061;EC50;=;12.31;nM;7.91;354872;BDBM199396;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;1;544.69;14.52;0.27;3.92;9.5;3.99;Homo sapiens;;;;;9606;BAO_0000019;;;;;CO[C@]12CC[C@@]3(C[C@@H]1COCc4ccccc4)[C@H]5Cc6ccc(OCC(=O)N)c7O[C@@H]2[C@]3(CCN5CC8CC8)c67;;;2015;37;UO_0000065;False
CHEMBL3394749;IC50;=;69;nM;7.16;;11;CHEMBL3395052;Displacement of [3H]DAMGO from human Mu opioid receptor expressed in HEK293 cells after 2 hrs by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3393026;Scientific Literature;0;2;594.83;12.04;0.23;1.6;12.13;5.56;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Cc1ccccc1CNC[C@H](O)CN2CN(c3ccccc3)C4(CCN(CCc5ccccc5c6cccs6)CC4)C2=O;;Bioorg. Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL2163911;EC50;=;12;nM;7.92;;7;CHEMBL2166341;Agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by liquid scintillation counter;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2163332;Scientific Literature;0;2;657.17;;;;;3.01;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](C(=C)C(=O)N)c5ccc(Cl)cc5;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL70;EC50;=;15.6;nM;7.81;;morphine;CHEMBL864218;Stimulation of [35S]GTPgammaS binding to human recombinant MOR;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1146036;Scientific Literature;4;0;285.34;;;;;1.2;Homo sapiens;;;;;9606;BAO_0000019;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35;;J. Med. Chem.;2006;1;UO_0000065;True
CHEMBL38874;EC50;=;3.04;nM;8.52;;DAMGO;CHEMBL2341394;Agonist activity at FLAG-tagged mu-type opioid receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins by liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2331515;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL1852788;EC50;=;0.83;nM;9.08;;1;CHEMBL2184591;Agonist activity at mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTP-gammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2176919;Scientific Literature;0;0;481.98;18.84;0.36;6.28;9.57;2.8;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccnc(Cl)c7;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL1774948;EC50;=;10;nM;8;;15c, MCL-694;CHEMBL1777022;Agonist activity at human mu-opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1772956;Scientific Literature;0;2;835.09;;;;;7.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CCCC[C@@]13CCN(CC4CCC4)[C@@H]2Cc5ccc(OC(=O)CCCCCCCCC(=O)Oc6ccc7C[C@H]8N(CC=C)CC[C@@]9%10[C@@H](Oc6c79)C(=O)CC[C@@]8%10O)cc35;;Bioorg. Med. Chem.;2011;1;UO_0000065;False
CHEMBL1773091;EC50;=;1.7;nM;8.77;;13b, MCL-693;CHEMBL1777022;Agonist activity at human mu-opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1772956;Scientific Literature;0;2;615.86;;;;;8.08;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CCCC[C@@]13CCN(CC4CCC4)[C@@H]2Cc5ccc(OC(=O)CCCCCCCCC(=O)OCc6ccccc6)cc35;;Bioorg. Med. Chem.;2011;1;UO_0000065;False
CHEMBL1774950;IC50;=;34;nM;7.47;;15a, MCL-696;CHEMBL1777023;Antagonist activity at human mu-opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1772956;Scientific Literature;0;2;821.07;;;;;7.2;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O[C@@]12CCCC[C@@]13CCN(CC4CCC4)[C@@H]2Cc5ccc(OC(=O)CCCCCCCCC(=O)Oc6ccc7C[C@H]8N(CC=C)CC[C@@]9%10[C@@H](Oc6c79)C(=O)CC[C@@]8%10O)cc35;;Bioorg. Med. Chem.;2011;1;UO_0000065;False
CHEMBL1774948;IC50;=;19;nM;7.72;;15c, MCL-694;CHEMBL1777023;Antagonist activity at human mu-opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1772956;Scientific Literature;0;2;835.09;;;;;7.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CCCC[C@@]13CCN(CC4CCC4)[C@@H]2Cc5ccc(OC(=O)CCCCCCCCC(=O)Oc6ccc7C[C@H]8N(CC=C)CC[C@@]9%10[C@@H](Oc6c79)C(=O)CC[C@@]8%10O)cc35;;Bioorg. Med. Chem.;2011;1;UO_0000065;False
CHEMBL301160;IC50;=;20;nM;7.7;;1b;CHEMBL863310;Activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148605;Scientific Literature;0;0;311.47;;;;;4.25;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1;;J. Med. Chem.;2006;1;UO_0000065;True
CHEMBL49269;EC50;=;0.8;nM;9.1;;1c;CHEMBL863310;Activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148605;Scientific Literature;0;0;297.44;;;;;3.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1;;J. Med. Chem.;2006;1;UO_0000065;True
CHEMBL2163918;EC50;=;72.3;nM;7.14;;14;CHEMBL2166341;Agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by liquid scintillation counter;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2163332;Scientific Literature;0;2;672.79;;;;;3.51;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](C(=C)C(=O)N)c5cccc6ccccc56;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2163921;EC50;=;0.16;nM;9.8;;4;CHEMBL2166341;Agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by liquid scintillation counter;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2163332;Scientific Literature;0;2;622.73;;;;;2.36;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](C(=C)C(=O)N)c5ccccc5;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL3233014;EC50;=;18.6;nM;7.73;;11;CHEMBL3239402;Agonist activity at GFP-fused mu opioid receptor (unknown origin) expressed in HEK293 cells assessed as recruitment of beta-arrestin-2 after 10 mins by BRET assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3232856;Scientific Literature;0;0;494.64;;;;;2.01;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Cc1cc(C)c(C[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)Cc3c(C)cc(O)cc3C)C(=O)N)c(C)c1;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL3923032;EC50;=;43.75;nM;7.36;412525;BDBM236823;CHEMBL3888720;"[35S]GTP?S Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared from a cell line expressing recombinant ? opioid receptor in a HEK-293, CHO or U-2 OS cell background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.; or DiscovRx, Fremont, Calif.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50� C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886801;BindingDB Database;0;0;456.54;16.12;0.3;6;5.79;1.36;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H](NC(=O)C[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3CC5CC5)CC1=O)C(=O)O;;;2016;37;UO_0000065;False
CHEMBL278789;IC50;=;1.82;nM;8.74;;dermorphin;CHEMBL756438;Agonist activity for Opioid receptor mu 1;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1130156;Scientific Literature;0;3;802.89;;;;;-2;;;;;;9606;BAO_0000019;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)N;;J. Med. Chem.;1997;1;UO_0000065;False
CHEMBL3309510;EC50;=;94.9;nM;7.02;;5f;CHEMBL3361835;Agonist activity at human recombinant mu opioid receptor expressed in CHO cell membranes after 60 mins by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3352469;Scientific Literature;0;0;488.58;;;;;2.47;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@]2(O)CC6=C4N(Cc7ccccc7)C(=O)[C@@H](CCO)C6)c35;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL4109805;EC50;=;1.56;nM;8.81;389735;BDBM222963;CHEMBL3888318;"?-Opioid Receptor Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared in-house from a cell line expressing recombinant ? opioid receptor in a HEK293 background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25 �C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50 �C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886656;BindingDB Database;0;0;463.62;19;0.35;4.25;17.21;4.56;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC(C)(C)[C@@]1(C)OCO[C@]23C=C[C@@]4(C[C@H]12)[C@H]5Cc6ccc(O)c7O[C@@H]3[C@]4(CCN5CC8CC8)c67;;;2016;37;UO_0000065;False
CHEMBL38874;EC50;=;30;nM;7.52;;DAMGO;CHEMBL3812007;Agonist activity at human MOR expressed in CHO cell membranes after 60 mins by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3808393;Scientific Literature;0;2;513.6;14.65;0.28;8.46;4.32;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;ACS Med. Chem. Lett.;2016;1;UO_0000065;False
CHEMBL4114524;IC50;=;3.7;nM;8.43;326521;BDBM179879;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;370.49;22.76;0.43;6.11;9.72;2.32;Homo sapiens;;;;;9606;BAO_0000249;;;;;NC(=O)c1ccc2C[C@@H]3[C@@H]4CC[C@@H](O)C[C@]4(CCN3CC5CCC5)c2c1O;;;2015;37;UO_0000065;False
CHEMBL3911427;IC50;=;14;nM;7.85;326547;BDBM179901;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;302.42;25.97;0.49;5.89;14.14;1.96;Homo sapiens;;;;;9606;BAO_0000249;;;;;COCCN1CC[C@]2(C)[C@@H](C)[C@H]1Cc3ccc(cc23)C(=O)N;;;2015;37;UO_0000065;False
CHEMBL3039334;IC50;=;88;nM;7.06;326552;BDBM179908;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;357.45;19.74;0.37;5.35;9.64;1.71;Homo sapiens;;;;;9606;BAO_0000249;;;;;O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC6CCC6)c45;;;2015;37;UO_0000065;False
CHEMBL4106879;IC50;=;1.5;nM;8.82;326537;BDBM179891;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;1;551.69;15.99;0.29;4.63;8.59;4.19;Homo sapiens;;;;;9606;BAO_0000249;;;;;Oc1c(ccc2C[C@H]3N(CC4CC4)CC[C@@]5(CC(=O)CC[C@@]35O)c12)C(=O)NCCc6ccc(cc6)c7cccnc7;;;2015;37;UO_0000065;False
CHEMBL4099423;EC50;=;10.23;nM;7.99;;2;CHEMBL4011280;Agonist activity at human recombinant MOR expressed in CHO cells assessed as calcium mobilization by Fluo-4 AM based fluorescence analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4007500;Scientific Literature;0;2;727.86;10.98;0.21;7.52;3.77;0.47;Homo sapiens;;;;;9606;BAO_0000219;;;;;CN[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]2CCCCNC(=O)C[C@H](NC(=O)[C@H](Cc3ccccc3)N(C)C(=O)[C@H](Cc4ccccc4)NC2=O)C(=O)N;;Bioorg Med Chem Lett;2017;1;UO_0000065;False
CHEMBL38874;EC50;=;7.5;nM;8.12;;DAMGO;CHEMBL3405698;Agonist activity at human MOR expressed in CHO cells assessed as increase in intracellular Ca2+ level after 30 mins by microplate reader analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3400112;Scientific Literature;0;2;513.6;15.82;0.3;9.06;4.67;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem.;2015;1;UO_0000065;False
CHEMBL38874;EC50;=;9.61;nM;8.02;;DAMGO;CHEMBL3405700;Agonist activity at human MOR expressed in CHO cells assessed as increase in intracellular Ca2+ level after 30 mins by cytosensor micrometer;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3400112;Scientific Literature;0;2;513.6;15.61;0.3;8.96;4.61;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem.;2015;1;UO_0000065;False
CHEMBL383539;IC50;=;41;nM;7.39;;3;CHEMBL864595;Displacement of [3H]naloxone from human mu opioid receptor expressed in BHK cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148567;Scientific Literature;0;0;389.54;18.96;0.35;3.25;20.76;4.14;Homo sapiens;;;BHK;;9606;BAO_0000219;;;;;O=C1NCN(c2ccccc2)C13CCN(CC3)[C@@H]4CCCC[C@@H]4c5ccccc5;;Bioorg. Med. Chem. Lett.;2006;1;UO_0000065;False
CHEMBL19019;IC50;=;8.9;nM;8.05;304254;BDBM60212;CHEMBL3706101;Flux Assay: As Ca2+ flux is associated with the activation of the MOR, the functional activity of bivalent ligand 1, monovalent ligand 2, and naltrexone was then evaluated in a Ca2+ mobilization assay in hMORCHO cells transfected with chimeric Ca2+ following a published protocol.23 No agonism was observed for any of the tested compounds (data not shown). Thus, they were further assessed for their antagonist properties as the ability to inhibit DAMGO (a MOR agonist) induced Ca2+ flux.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3638635;BindingDB Database;4;0;341.41;23.58;0.44;6.52;11.5;1.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O;;;2015;37;UO_0000065;False
CHEMBL504973;IC50;=;27.5;nM;7.56;;7;CHEMBL969341;Agonist activity at mu opioid receptor assessed as inhibition of forskolin-induced cAMP production in human SH-SY5Y cells pretreated for 24 hrs with DMEM medium after 15 mins;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149874;Scientific Literature;0;2;593.69;;;;;-0.28;Homo sapiens;;;SH-SY5Y;;9606;BAO_0000219;;;;;CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc3ccc(O)cc3)C(=O)N;;Bioorg. Med. Chem.;2008;1;UO_0000065;False
CHEMBL3582487;EC50;=;3.236;nM;8.49;;4;CHEMBL3584507;Agonist activity at human recombinant mu opioid receptor expressed in CHO cells co-expressing C-terminally modified GGalphaqi5 assessed as stimulation of calcium release by Fluo-4 AM dye-based fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3580572;Scientific Literature;0;2;717.8;11.83;0.22;;3.62;0;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]2CCCCNC(=O)C[C@H](NC(=O)[C@H](Cc3ccc(F)cc3)NC(=O)[C@H](Cc4ccccc4)NC2=O)C(=O)N;;ACS Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL2443262;EC50;=;50.12;nM;7.3;;(R)-30, TRV130;CHEMBL2445992;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as beta-arrestin recruitment by chemiluminescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;3;0;386.56;18.88;0.37;2.61;16.83;4.69;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;COc1ccsc1CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3785265;EC50;=;54.6;nM;7.26;;13;CHEMBL3787931;Agonist activity at human mu opioid receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3785070;Scientific Literature;0;0;415.53;17.48;0.32;3.41;11.95;3.85;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]5(CC(=O)\C(=C/c6ccccc6)\C[C@@]35O)c2c1;;Bioorg. Med. Chem.;2016;1;UO_0000065;False
CHEMBL4081856;EC50;=;2.5;nM;8.6;;3a;CHEMBL4035930;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by Eu-cAMP tracer based TR-FRET assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4033703;Scientific Literature;0;0;492.64;17.46;0.34;5.31;12.27;3.29;Homo sapiens;;;;;9606;BAO_0000219;;;;;Oc1ccc2CC3N(CC4CC4)CCC5(C6[C@H]7CN(C6CCC35O7)S(=O)(=O)c8ccccc8)c2c1;;Bioorg Med Chem Lett;2017;1;UO_0000065;False
CHEMBL2443262;EC50;=;7.943;nM;8.1;;(R)-30, TRV130;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;3;0;386.56;;;;;4.69;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;COc1ccsc1CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL493846;EC50;=;0.3;nM;9.52;;50;CHEMBL4029370;Agonist activity at human mu-opioid receptor expressed in HEK293 cell membranes after 1 hr by [35S]-GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4028804;Scientific Literature;0;0;496.61;19.18;0.35;5.61;11.61;3.91;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccc8ccccc8c7;;J Med Chem;2017;1;UO_0000065;False
CHEMBL4097865;EC50;=;60;nM;7.22;;36;CHEMBL3992793;Agonist activity at human MOR expressed in CHO-K1 cells co-expressing Galpha 15 assessed as increase in intracellular calcium release incubated for 1 measured every 1.52 secs for 90 secs by FLIPR assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3992491;Scientific Literature;0;0;294.4;24.53;0.45;4.35;17.56;2.87;Homo sapiens;;;;;9606;BAO_0000219;;;;;CCc1ccc(cc1)C(=O)NCC2NCCc3ccccc23;;Eur J Med Chem;2017;1;UO_0000065;False
CHEMBL3215960;EC50;=;18;nM;7.75;;5d;CHEMBL3089286;Agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085655;Scientific Literature;0;1;479.54;;;;;5.14;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cl.Cl.CCCN[C@H]1C[C@H]2C[C@@](C1)([C@H](C)CN2CCCc3ccccc3)c4cccc(O)c4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL354172;EC50;=;21;nM;7.68;;48;CHEMBL749733;Incorporation of [35S]- GTPgammaS into CHO membranes expressing human Opioid receptor mu 1;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145777;Scientific Literature;0;0;285.39;26.9;0.5;4.71;18.94;2.97;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1C2N(CC3CC3)CC[C@]1(C)c4cc(O)ccc4C2=O;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL3948892;EC50;=;0.53;nM;9.28;326556;BDBM179875;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;366.51;25.31;0.47;5.76;13.94;3.52;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@@H]3[C@@H]4CCC(=C)C[C@]4(CCN3CC5CCC5)c2c1O;;;2015;37;UO_0000065;False
CHEMBL376690;IC50;=;11;nM;7.96;223801;BDBM50199914;CHEMBL3705131;Binding Assay: The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994).;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3638450;BindingDB Database;0;0;350.51;22.71;0.42;4.08;29.8;3.88;Homo sapiens;;;;;9606;BAO_0000357;;;;;C[C@H]1CN2CCN(Cc3ccccc3)C[C@H]2C[C@@]1(C)c4cccc(O)c4;;;2013;37;UO_0000065;False
CHEMBL3971169;EC50;=;14.2;nM;7.85;412533;BDBM236832;CHEMBL3888720;"[35S]GTP?S Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared from a cell line expressing recombinant ? opioid receptor in a HEK-293, CHO or U-2 OS cell background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.; or DiscovRx, Fremont, Calif.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50� C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886801;BindingDB Database;0;0;371.48;21.13;0.4;6.09;9.69;1.76;Homo sapiens;;;;;9606;BAO_0000019;;;;;OCC[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3CC5CC5)CC1=O;;;2016;37;UO_0000065;False
CHEMBL270190;IC50;=;3;nM;8.52;;1;CHEMBL4040566;Antagonist activity at recombinant human MOR expressed in HEK293T cells assessed as reduction in DAMGO-induced inhibition of forskolin-stimulated cAMP level preincubated for 15 to 20 mins followed by DAMGO and forskolin addition by GloSensor assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4038325;Scientific Literature;4;0;424.54;20.08;0.38;5.47;9.48;3.05;Homo sapiens;;;HEK-293T;;9606;BAO_0000219;;;;;C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c3cccc(O)c3;;J Med Chem;2017;1;UO_0000065;False
CHEMBL80;IC50;=;45;nM;7.35;;Naloxone;CHEMBL4040566;Antagonist activity at recombinant human MOR expressed in HEK293T cells assessed as reduction in DAMGO-induced inhibition of forskolin-stimulated cAMP level preincubated for 15 to 20 mins followed by DAMGO and forskolin addition by GloSensor assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4038325;Scientific Literature;4;0;327.38;22.44;0.42;6.05;10.5;1.3;Homo sapiens;;;HEK-293T;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O;;J Med Chem;2017;1;UO_0000065;False
CHEMBL4114055;IC50;=;7.8;nM;8.11;326548;BDBM179902;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;338.5;23.95;0.44;4.47;17.5;3.64;Homo sapiens;;;;;9606;BAO_0000249;;;;;NC(=O)c1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC5CCC5)c2c1;;;2015;37;UO_0000065;False
CHEMBL4108288;IC50;=;1.5;nM;8.82;326549;BDBM179903;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;324.47;27.19;0.5;5.57;19.05;3.25;Homo sapiens;;;;;9606;BAO_0000249;;;;;NC(=O)c1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC5CC5)c2c1;;;2015;37;UO_0000065;False
CHEMBL3948713;EC50;=;2.85;nM;8.54;412536;BDBM236866;CHEMBL3888720;"[35S]GTP?S Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared from a cell line expressing recombinant ? opioid receptor in a HEK-293, CHO or U-2 OS cell background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.; or DiscovRx, Fremont, Calif.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50� C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886801;BindingDB Database;0;0;353.51;24.17;0.45;4.63;21.08;3.92;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC(C)[C@@H]1C[C@H]2[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3CC5CC5)CC1=O;;;2016;37;UO_0000065;False
CHEMBL80;IC50;=;7.3;nM;8.14;;naloxone;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;4;0;327.38;;;;;1.3;Homo sapiens;;;;;9606;BAO_0000019;;;;;Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL522143;IC50;=;2.29;nM;8.64;;6, NAP;CHEMBL995937;Binding affinity to wild type mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140920;Scientific Literature;0;0;447.54;19.31;0.36;6.49;9.1;2.15;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccncc7;;J. Med. Chem.;2009;1;UO_0000065;True
CHEMBL2208361;IC50;=;13;nM;7.89;;8;CHEMBL2213834;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203245;Scientific Literature;0;2;536.76;;;;;7.05;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(C)Oc1ccc(cc1)c2ccc(CCNC(=O)c3ccc4CC5C(C)C(C)(CCN5CC6CC6)c4c3)cc2;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL1824513;EC50;=;1.31;nM;8.88;;5;CHEMBL1828464;Agonist activity against mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1821548;Scientific Literature;0;1;562.89;16.87;0.36;5.97;9.36;2.91;;;;CHO;;9606;BAO_0000219;;;;;Cl.Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccncc7Br;;Bioorg. Med. Chem. Lett.;2011;1;UO_0000065;False
CHEMBL4107642;EC50;=;93.3;nM;7.03;369598;BDBM208983;CHEMBL3888047;"HiRange Homogenous Time-Resolved Fluorescence (HTRF) Assay: Briefly, suspensions of cells expressing either the mu, kappa or delta opioid receptors were prepared in buffer containing 0.5 mM isobutyl-methyl xanthine (IBMX). Cells were incubated with varying concentrations of PEG-opioid conjugates and 3 uM forskolin for 30 minutes at room temperature. cAMP was detected following a two-step assay protocol per the manufacturer's instructions and time resolved fluorescence was measured with the following settings: 330 nm excitation; 620 nm and 665 nm emission; 380 nm dichroic mirror. The 665 nm/620 nm ratio is expressed as Delta F % and test compound-related data is expressed as a percentage of average maximum response in wells without forskolin. EC50 values were calculated for each compound from a sigmoidal dose-response plot of concentrations versus maximum response.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886551;BindingDB Database;0;0;405.49;17.34;0.33;5.81;8.72;1.22;Homo sapiens;;;;;9606;BAO_0000019;;;;;COCCOCCO[C@H]1CC[C@@]2(O)C3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3C)c45;;;2016;37;UO_0000065;False
CHEMBL3629337;EC50;=;0.0629;nM;10.2;;1;CHEMBL3630378;Agonist activity at mu opioid receptor (unknown origin) transfected in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP production;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3627650;Scientific Literature;0;2;628.75;16.22;0.31;7.78;5.56;2.42;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](C(=C)C(=O)N)c5cccs5;;Bioorg. Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL218520;IC50;=;26;nM;7.58;223803;BDBM50199912;CHEMBL3705131;Binding Assay: The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994).;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3638450;BindingDB Database;0;0;350.51;21.64;0.4;3.54;28.4;4.05;Homo sapiens;;;;;9606;BAO_0000357;;;;;C[C@H]1CN2C[C@@H](N(C)C[C@H]2C[C@@]1(C)c3cccc(O)c3)c4ccccc4;;;2013;37;UO_0000065;False
CHEMBL3325715;EC50;=;100;nM;7;;20;CHEMBL3370199;Agonist activity at myc-tagged mu opioid receptor (unknown origin) expressed in AtT-20 cells assessed as induction of membrane potential hyperpolarization;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3351626;Scientific Literature;0;0;367.67;19.04;0.46;2.25;20.06;4.75;Homo sapiens;;;AtT20;;9606;BAO_0000219;;;;;Cc1nn(c2CC(C)(C)CC(=O)c12)c3ccc(Cl)cc3Br;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL2347237;EC50;=;1.7;nM;8.77;;6;CHEMBL2353039;Partial agonist activity at human mu opioid receptor expressed in CHO cell membrane assessed as stimulation of [35S]GTPgammaS binding after 60 mins by liquid scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2346652;Scientific Literature;0;1;479.67;;;;;5.66;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1C2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cc5)c6ccccn6;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL4114285;EC50;=;1.3;nM;8.89;326580;BDBM179897;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;338.5;26.25;0.49;5.25;19.18;3.64;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H](C1CC1)N2CC[C@]34CCCC[C@H]3[C@H]2Cc5ccc(cc45)C(=O)N;;;2015;37;UO_0000065;False
CHEMBL301160;EC50;=;1.6;nM;8.8;;MCL-101;CHEMBL1056145;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1154777;Scientific Literature;0;0;311.47;;;;;4.25;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1;;J. Med. Chem.;2009;1;UO_0000065;True
CHEMBL4106746;EC50;=;0.62;nM;9.21;354878;BDBM199411;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;1;514.67;17.89;0.33;4.98;12.44;4.23;Homo sapiens;;;;;9606;BAO_0000019;;;;;CO[C@]12CC[C@@]3(C[C@@H]1COCc4ccccc4)[C@H]5Cc6ccc(C(=O)N)c7O[C@@H]2[C@]3(CCN5CC8CC8)c67;;;2015;37;UO_0000065;False
CHEMBL3903900;IC50;=;14;nM;7.85;326524;BDBM179882;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;312.46;25.14;0.47;4.74;16.95;3.11;Homo sapiens;;;;;9606;BAO_0000249;;;;;C[C@H]1[C@H]2Cc3ccc(cc3[C@]1(C)CCN2CC4CCC4)C(=O)N;;;2015;37;UO_0000065;False
CHEMBL3906641;EC50;=;49.72;nM;7.3;412529;BDBM236827;CHEMBL3888720;"[35S]GTP?S Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared from a cell line expressing recombinant ? opioid receptor in a HEK-293, CHO or U-2 OS cell background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.; or DiscovRx, Fremont, Calif.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50� C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886801;BindingDB Database;0;0;498.62;14.65;0.28;4.91;5.74;2.39;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC(C)C[C@H](NC(=O)C[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3CC5CC5)CC1=O)C(=O)O;;;2016;37;UO_0000065;False
CHEMBL4110274;EC50;=;3.5;nM;8.46;326568;BDBM179883;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;285.43;29.63;0.55;4.75;36.03;3.71;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H](C1CC1)N2CC[C@@]3(C)C(C)[C@H]2Cc4ccc(O)cc34;;;2015;37;UO_0000065;False
CHEMBL4108288;EC50;=;0.89;nM;9.05;326583;BDBM179903;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;324.47;27.89;0.52;5.8;19.54;3.25;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC5CC5)c2c1;;;2015;37;UO_0000065;False
CHEMBL3917891;IC50;=;0.45;nM;9.35;326553;BDBM179909;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;467.65;19.99;0.38;5.08;15.04;4.27;Homo sapiens;;;;;9606;BAO_0000249;;;;;CO[C@@H]1C([C@H]2CC[C@@]13Oc4c(O)ccc5C[C@@H]6C2[C@@]3(CCN6CC7CC7)c45)[C@](C)(O)C(C)(C)C;;;2015;37;UO_0000065;False
CHEMBL963;EC50;=;7.8;nM;8.11;;1;CHEMBL4032004;Agonist activity at recombinant human MOR expressed in CHO cell membranes after 60 mins by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4028881;Scientific Literature;4;0;301.34;26.91;0.5;7.36;11.58;0.75;Homo sapiens;;;;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@]2(O)CCC4=O)c35;;J Med Chem;2017;1;UO_0000065;False
CHEMBL511645;EC50;=;0.98;nM;9.01;326567;BDBM50278263;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;386.49;23.31;0.44;7.57;8.42;1.44;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(C[C@H](O)CC[C@@]35O)c2c1O;;;2015;37;UO_0000065;False
CHEMBL3986245;EC50;=;3.3;nM;8.48;326557;BDBM179876;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;370.49;22.89;0.43;6.16;9.77;2.32;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@@H]3[C@@H]4CC[C@H](O)C[C@]4(CCN3CC5CCC5)c2c1O;;;2015;37;UO_0000065;False
CHEMBL4097466;EC50;=;40;nM;7.4;;43;CHEMBL3992793;Agonist activity at human MOR expressed in CHO-K1 cells co-expressing Galpha 15 assessed as increase in intracellular calcium release incubated for 1 measured every 1.52 secs for 90 secs by FLIPR assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3992491;Scientific Literature;0;0;294.4;25.13;0.46;4.45;22.88;2.95;Homo sapiens;;;;;9606;BAO_0000219;;;;;CN1CCc2ccccc2C1CNC(=O)c3ccc(C)cc3;;Eur J Med Chem;2017;1;UO_0000065;False
CHEMBL4070288;EC50;=;10;nM;8;;44;CHEMBL3992793;Agonist activity at human MOR expressed in CHO-K1 cells co-expressing Galpha 15 assessed as increase in intracellular calcium release incubated for 1 measured every 1.52 secs for 90 secs by FLIPR assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3992491;Scientific Literature;0;0;308.43;25.94;0.48;4.79;24.74;3.21;Homo sapiens;;;;;9606;BAO_0000219;;;;;CCc1ccc(cc1)C(=O)NCC2N(C)CCc3ccccc23;;Eur J Med Chem;2017;1;UO_0000065;False
CHEMBL4076673;EC50;=;22;nM;7.66;;2g;CHEMBL4035930;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by Eu-cAMP tracer based TR-FRET assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4033703;Scientific Literature;0;0;474.6;16.13;0.3;4.29;12.3;3.37;Homo sapiens;;;;;9606;BAO_0000219;;;;;COCCCN1CCC23C4[C@H]5CN(C4CCC2(O5)C1Cc6ccc(O)cc36)C(=O)c7ccccc7;;Bioorg Med Chem Lett;2017;1;UO_0000065;False
CHEMBL3219777;IC50;=;40;nM;7.4;304255;BDBM160931;CHEMBL3706101;Flux Assay: As Ca2+ flux is associated with the activation of the MOR, the functional activity of bivalent ligand 1, monovalent ligand 2, and naltrexone was then evaluated in a Ca2+ mobilization assay in hMORCHO cells transfected with chimeric Ca2+ following a published protocol.23 No agonism was observed for any of the tested compounds (data not shown). Thus, they were further assessed for their antagonist properties as the ability to inhibit DAMGO (a MOR agonist) induced Ca2+ flux.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3638635;BindingDB Database;0;;1197.48;6.18;;;;;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(C)c1nnc(C)n1C2CC3CCC(C2)N3CC[C@H](NC(=O)C4CCC(F)(F)CC4)c5ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]6CC[C@@]7(O)[C@H]8Cc9ccc(O)c%10O[C@@H]6[C@]7(CCN8CC%11CC%11)c9%10)cc5;;;2015;37;UO_0000065;False
CHEMBL4115660;IC50;=;4.2;nM;8.38;326515;BDBM179873;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;370.49;22.61;0.42;5.92;9.65;2.46;Homo sapiens;;;;;9606;BAO_0000249;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(CCCC[C@@]35O)c2c1O;;;2015;37;UO_0000065;False
CHEMBL4108846;IC50;=;2;nM;8.7;326516;BDBM179874;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;382.5;22.74;0.42;6.07;10.02;2.63;Homo sapiens;;;;;9606;BAO_0000249;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(CC(=C)CC[C@@]35O)c2c1O;;;2015;37;UO_0000065;False
CHEMBL38874;IC50;=;0.68;nM;9.17;;DAMGO;CHEMBL2394939;Binding affinity to human mu-type opioid receptor by radioligand displacement assay;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2390830;Scientific Literature;0;2;513.6;17.85;0.34;10.11;5.27;-0.94;Homo sapiens;;;;;9606;BAO_0000357;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Eur. J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3759179;EC50;=;3.631;nM;8.44;;5;CHEMBL3762660;Agonist activity at human recombinant MOR expressed in CHO cells assessed as calcium mobilization by Fluo-4 AM based fluorescence analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3758180;Scientific Literature;0;2;777.92;10.85;0.2;6.81;3.59;1.63;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N[C@@H]2CCCCNC(=O)C[C@H](NC(=O)[C@@H](Cc3ccc4ccccc4c3)NC(=O)[C@H](Cc5ccccc5)NC2=O)C(=O)N;;Eur. J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL4108042;IC50;=;44;nM;7.36;326542;BDBM179896;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;312.46;23.54;0.44;4.25;15.88;3.11;Homo sapiens;;;;;9606;BAO_0000249;;;;;CC1C2Cc3ccc(cc3[C@]1(C)CCN2CC4(C)CC4)C(=O)N;;;2015;37;UO_0000065;False
CHEMBL3939227;IC50;=;58;nM;7.24;326550;BDBM179904;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;328.46;22.03;0.41;4.75;13.02;2.49;Homo sapiens;;;;;9606;BAO_0000249;;;;;C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2C[C@H]4CCCO4)C(=O)N;;;2015;37;UO_0000065;False
CHEMBL38874;IC50;=;0.74;nM;9.13;;DAMGO;CHEMBL2394995;Binding affinity to mu opioid receptor (unknown origin) by radioligand displacement assay;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2390917;Scientific Literature;0;2;513.6;17.78;0.34;10.07;5.24;-0.94;Homo sapiens;;;;;9606;BAO_0000357;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3948892;IC50;=;1.3;nM;8.89;326517;BDBM179875;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;366.51;24.25;0.45;5.37;13.35;3.52;Homo sapiens;;;;;9606;BAO_0000249;;;;;NC(=O)c1ccc2C[C@@H]3[C@@H]4CCC(=C)C[C@]4(CCN3CC5CCC5)c2c1O;;;2015;37;UO_0000065;False
CHEMBL3954177;IC50;=;1.1;nM;8.96;326519;BDBM179877;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;368.48;24.31;0.45;6.43;10.71;2.53;Homo sapiens;;;;;9606;BAO_0000249;;;;;NC(=O)c1ccc2C[C@@H]3[C@@H]4CCC(=O)C[C@]4(CCN3CC5CCC5)c2c1O;;;2015;37;UO_0000065;False
CHEMBL4113014;EC50;=;64;nM;7.19;385616;BDBM220365;CHEMBL3888264;"In Vitro Mu-Opioid Receptor Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed membranes expressing human ?-receptors. Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; NEN). The prepared membrane solution (190 ?L/well) was transferred to 96-shallow well polypropylene plates containing 10 ?L of 20� concentrated stock solutions of the agonist DAMGO ([D-Ala2, N-methyl-Phe4 Gly-o15]-enkephalin) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25 �C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Packard, Meriden, Conn.) using a 96-well tissue harvester (Brandel, Gaithersburg, Md.) followed by three filtration washes with 200 ?L of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50 �C. for 2-3 hr. BetaScint scintillation cocktail (Wallas, Turku, Finland) was added (50 ?L/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886630;BindingDB Database;0;1;516.69;13.92;0.26;2.5;9.14;4.69;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC12C[C@H]3C[C@H](C[C@@H]1C[C@@H]2C3)N4[C@@H]5CCC[C@H]4C[C@H](C5)N6C(=O)C(=Nc7ccccc67)N8CC(C8)C(=O)O;;;2016;37;UO_0000065;False
CHEMBL2048765;IC50;=;2;nM;8.7;;3g, MCL-700;CHEMBL2050643;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;416.61;20.88;0.38;2.92;35.51;5.78;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1cccc(CNc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4CC6CC6)c3c2)c1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL19019;IC50;=;4.8;nM;8.32;;3, NTRX;CHEMBL958397;Antagonist activity against human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;4;0;341.41;;;;;1.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL3736364;IC50;=;46;nM;7.34;;"4; AKG116";CHEMBL3738454;Agonist activity at mu opioid receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation by bioluminescent assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3734657;Scientific Literature;0;;1106.18;6.63;;;;;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc3c(C)cc(O)cc3C)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)NCc6cc(cc(c6)C(F)(F)F)C(F)(F)F;;J. Med. Chem.;2015;1;UO_0000065;False
CHEMBL3736013;IC50;=;1.905;nM;8.72;;"5; AKG127";CHEMBL3738443;Binding affinity to mu opioid receptor (unknown origin);single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3734657;Scientific Literature;0;;1124.17;7.76;;;;;Homo sapiens;;;;;9606;BAO_0000357;;;;;CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2ccc(F)cc2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc3c(C)cc(O)cc3C)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)NCc6cc(cc(c6)C(F)(F)F)C(F)(F)F;;J. Med. Chem.;2015;1;UO_0000065;False
CHEMBL3735298;IC50;=;2.818;nM;8.55;;"6; AKG128";CHEMBL3738443;Binding affinity to mu opioid receptor (unknown origin);single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3734657;Scientific Literature;0;;1138.2;7.51;;;;;Homo sapiens;;;;;9606;BAO_0000357;;;;;CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2ccc(F)cc2)N(C)C(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc3c(C)cc(O)cc3C)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)NCc6cc(cc(c6)C(F)(F)F)C(F)(F)F;;J. Med. Chem.;2015;1;UO_0000065;False
CHEMBL3735476;IC50;=;8.318;nM;8.08;;"7; AKG190";CHEMBL3738443;Binding affinity to mu opioid receptor (unknown origin);single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3734657;Scientific Literature;0;;1096.12;7.37;;;;;Homo sapiens;;;;;9606;BAO_0000357;;;;;CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2ccc(F)cc2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc3ccc(O)cc3)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)NCc6cc(cc(c6)C(F)(F)F)C(F)(F)F;;J. Med. Chem.;2015;1;UO_0000065;False
CHEMBL3736420;IC50;=;4.677;nM;8.33;;"8; AKG191";CHEMBL3738443;Binding affinity to mu opioid receptor (unknown origin);single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3734657;Scientific Literature;0;;1140.62;7.3;;;;;Homo sapiens;;;;;9606;BAO_0000357;;;;;CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc3c(C)cc(O)cc3C)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)NCc6cc(cc(c6)C(F)(F)F)C(F)(F)F;;J. Med. Chem.;2015;1;UO_0000065;False
CHEMBL370029;IC50;=;2.2;nM;8.66;326526;BDBM50165048;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;384.48;22.52;0.42;7.02;8.34;1.64;Homo sapiens;;;;;9606;BAO_0000249;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(CC(=O)CC[C@@]35O)c2c1O;;;2015;37;UO_0000065;False
CHEMBL3895359;IC50;=;0.65;nM;9.19;326544;BDBM179898;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;384.48;23.89;0.45;7.55;8.85;1.64;Homo sapiens;;;;;9606;BAO_0000249;;;;;C[C@@H](C1CC1)N2CC[C@]34CC(=O)CC[C@@]3(O)[C@H]2Cc5ccc(C(=O)N)c(O)c45;;;2015;37;UO_0000065;False
CHEMBL3262549;EC50;=;39.5;nM;7.4;;7f;CHEMBL3270915;Agonist activity at human mu opioid receptor transfected in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259735;Scientific Literature;0;1;438.62;;;;;6.21;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CCC1C(=O)N(C2CCN(CCC(c3ccccc3)c4ccccc4)CC2)c5ccccc15;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL267495;EC50;=;0.72;nM;9.14;;Nalfurafine;CHEMBL3385713;Agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3351376;Scientific Literature;3;0;476.57;;;;;3.09;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN([C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CC6)c45)C(=O)\C=C\c7cocc7;;Bioorg. Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL70;IC50;=;6.3;nM;8.2;;Morphine;CHEMBL3766870;Agonist activity at human MOR expressed in CHO cells assessed as induction of membrane potential change measured every 3 secs for 30 secs by fluorescent membrane potential assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3763066;Scientific Literature;4;0;285.34;28.74;0.53;7;15.49;1.2;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35;;J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL38874;IC50;=;2.5;nM;8.6;;DAMGO;CHEMBL3766870;Agonist activity at human MOR expressed in CHO cells assessed as induction of membrane potential change measured every 3 secs for 30 secs by fluorescent membrane potential assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3763066;Scientific Literature;0;2;513.6;16.75;0.32;9.54;4.94;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL4074110;EC50;=;8.99;nM;8.05;;1a;CHEMBL4032004;Agonist activity at recombinant human MOR expressed in CHO cell membranes after 60 mins by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4028881;Scientific Literature;0;0;287.36;28;0.52;6.48;15.2;1.57;Homo sapiens;;;;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@@H]4CCC[C@@]2(O)[C@H]1Cc5ccc(O)c(O4)c35;;J Med Chem;2017;1;UO_0000065;False
CHEMBL607351;EC50;=;0.32;nM;9.49;;3;CHEMBL4032004;Agonist activity at recombinant human MOR expressed in CHO cell membranes after 60 mins by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4028881;Scientific Literature;0;0;391.47;24.25;0.45;6.52;16.09;2.97;Homo sapiens;;;;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@]2(CCC4=O)OCc6ccccc6)c35;;J Med Chem;2017;1;UO_0000065;False
CHEMBL3264746;EC50;=;2.3;nM;8.64;;4f;CHEMBL3271437;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]-GTP[gammaS] binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259551;Scientific Literature;0;1;550.66;15.69;0.29;4.48;12.09;4.16;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CCc4ccccc4)CC[C@]56[C@@H]7[C@@H]8O[C@]35CC[C@@]7(OCOc1c26)N(Cc9ccccc9)C8=O;;ACS Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL80;IC50;=;20;nM;7.7;;NALOXONE;CHEMBL1909182;DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine);cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1909046;DrugMatrix;4;0;327.38;23.52;0.44;6.4;11;1.3;;;;CHO-K1;Membrane;9606;BAO_0000249;;;;;Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O;;;;15;UO_0000065;False
CHEMBL3262088;EC50;=;50.2;nM;7.3;;1c;CHEMBL3267139;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by beta-plate liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259633;Scientific Literature;0;0;481.68;;;;;4.8;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC[C@](O)([C@H]1C[C@]23CC[C@]1(OC)[C@@H]4Oc5c(O)ccc6C[C@H]2N(CC7CC7)CC[C@@]34c56)C(C)(C)C;;J. Med. Chem.;2014;1;UO_0000065;False
CHEMBL3262361;EC50;=;31.8;nM;7.5;;2c;CHEMBL3267139;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by beta-plate liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259633;Scientific Literature;0;0;499.65;;;;;4.69;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC[C@](O)([C@H]1C[C@]23C=C[C@]1(OC)[C@@H]4Oc5c(O)ccc6C[C@H]2N(CC7CC7)CC[C@@]34c56)c8ccccc8;;J. Med. Chem.;2014;1;UO_0000065;False
CHEMBL4100902;IC50;=;76.56;nM;7.12;;26b;CHEMBL4040566;Antagonist activity at recombinant human MOR expressed in HEK293T cells assessed as reduction in DAMGO-induced inhibition of forskolin-stimulated cAMP level preincubated for 15 to 20 mins followed by DAMGO and forskolin addition by GloSensor assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4038325;Scientific Literature;0;0;351.45;20.25;0.37;3.21;11.71;3.91;Homo sapiens;;;HEK-293T;;9606;BAO_0000219;;;;;CC1(CCN(C\C(=C/c2ccccc2)\C(=O)O)CC1)c3cccc(O)c3;;J Med Chem;2017;1;UO_0000065;False
CHEMBL4115660;EC50;=;1.4;nM;8.85;326554;BDBM179873;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;370.49;23.9;0.45;6.39;10.2;2.46;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(CCCC[C@@]35O)c2c1O;;;2015;37;UO_0000065;False
CHEMBL512150;IC50;=;47;nM;7.33;326527;BDBM50278335;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;386.49;18.96;0.36;5.89;6.85;1.44;Homo sapiens;;;;;9606;BAO_0000249;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(C[C@@H](O)CC[C@@]35O)c2c1O;;;2015;37;UO_0000065;False
CHEMBL4067629;EC50;=;10;nM;8;;3h;CHEMBL4036559;Agonist activity at human recombinant MOR expressed in CHO cells assessed as cAMP accumulation;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4033739;Scientific Literature;0;0;426.6;18.75;0.34;3.02;29.95;4.98;Homo sapiens;;;;;9606;BAO_0000219;;;;;Oc1ccc2CC3N(CC4CC4)CCC5(C6[C@H]7CN(C6CCC35C7)c8ccccc8)c2c1;;Bioorg Med Chem Lett;2017;1;UO_0000065;False
CHEMBL3765406;EC50;=;4.677;nM;8.33;;4;CHEMBL3766803;Agonist activity at human recombinant MOR expressed in CHO cells by calcium mobilization assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3763121;Scientific Literature;0;1;593.58;14.03;0.27;7.38;5.24;0.95;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CC(F)(F)C[C@H]2C(=O)N[C@@H](Cc3ccccc3)C(=O)N4CC(F)(F)C[C@@H]4C(=O)N;;Bioorg. Med. Chem.;2016;1;UO_0000065;False
CHEMBL4107906;EC50;=;8.03;nM;8.1;354833;BDBM199340;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;0;449.57;18.01;0.34;3.61;26.17;4.49;Homo sapiens;;;;;9606;BAO_0000019;;;;;CO[C@]12CC[C@@]3(C[C@@H]1COCc4ccccc4)[C@H]5Cc6ccc(F)c7O[C@@H]2[C@]3(CCN5C)c67;;;2015;37;UO_0000065;False
CHEMBL4076303;EC50;=;5.9;nM;8.23;;2c;CHEMBL4035930;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by Eu-cAMP tracer based TR-FRET assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4033703;Scientific Literature;0;0;416.52;19.76;0.36;5.27;15.52;2.96;Homo sapiens;;;;;9606;BAO_0000219;;;;;CN1CCC23C4[C@H]5CN(C4CCC2(O5)C1Cc6ccc(O)cc36)C(=O)c7ccccc7;;Bioorg Med Chem Lett;2017;1;UO_0000065;False
CHEMBL4111233;EC50;=;79.4;nM;7.1;354838;BDBM199351;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;1;524.68;13.53;0.26;3.38;9.21;3.72;Homo sapiens;;;;;9606;BAO_0000019;;;;;CO[C@]12CC[C@@]3(C[C@@H]1COCc4ccccc4)[C@H]5Cc6ccc(NS(=O)(=O)C)c7O[C@@H]2[C@]3(CCN5C)c67;;;2015;37;UO_0000065;False
CHEMBL3763920;IC50;=;11.1;nM;7.96;;6;CHEMBL3766870;Agonist activity at human MOR expressed in CHO cells assessed as induction of membrane potential change measured every 3 secs for 30 secs by fluorescent membrane potential assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3763066;Scientific Literature;0;2;659.74;12.06;0.23;8.23;3.54;-0.28;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]2CCCCNC(=O)CNC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](Cc4cccnc4)NC2=O;;J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL3736287;IC50;=;39;nM;7.41;;"3; AKG115";CHEMBL3738454;Agonist activity at mu opioid receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation by bioluminescent assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3734657;Scientific Literature;0;;1120.21;6.61;;;;;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2ccccc2)N(C)C(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc3c(C)cc(O)cc3C)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)NCc6cc(cc(c6)C(F)(F)F)C(F)(F)F;;J. Med. Chem.;2015;1;UO_0000065;False
CHEMBL3736287;IC50;=;1.66;nM;8.78;;"3; AKG115";CHEMBL3738443;Binding affinity to mu opioid receptor (unknown origin);single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3734657;Scientific Literature;0;;1120.21;7.84;;;;;Homo sapiens;;;;;9606;BAO_0000357;;;;;CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2ccccc2)N(C)C(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc3c(C)cc(O)cc3C)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)NCc6cc(cc(c6)C(F)(F)F)C(F)(F)F;;J. Med. Chem.;2015;1;UO_0000065;False
CHEMBL3764556;IC50;=;24;nM;7.62;;3;CHEMBL3766870;Agonist activity at human MOR expressed in CHO cells assessed as induction of membrane potential change measured every 3 secs for 30 secs by fluorescent membrane potential assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3763066;Scientific Literature;0;2;697.79;10.92;0.2;6.81;3.35;0.81;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]2CCCCNC(=O)CNC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC2=O;;J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL4100902;IC50;=;18;nM;7.75;;26b;CHEMBL4040566;Antagonist activity at recombinant human MOR expressed in HEK293T cells assessed as reduction in DAMGO-induced inhibition of forskolin-stimulated cAMP level preincubated for 15 to 20 mins followed by DAMGO and forskolin addition by GloSensor assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4038325;Scientific Literature;0;0;351.45;22.04;0.41;3.83;12.74;3.91;Homo sapiens;;;HEK-293T;;9606;BAO_0000219;;;;;CC1(CCN(C\C(=C/c2ccccc2)\C(=O)O)CC1)c3cccc(O)c3;;J Med Chem;2017;1;UO_0000065;False
CHEMBL3765059;IC50;=;2.3;nM;8.64;;1;CHEMBL3766870;Agonist activity at human MOR expressed in CHO cells assessed as induction of membrane potential change measured every 3 secs for 30 secs by fluorescent membrane potential assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3763066;Scientific Literature;0;2;658.76;13.11;0.25;8.32;4.08;0.32;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]2CCCCNC(=O)CNC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](Cc4ccccc4)NC2=O;;J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL38874;IC50;=;2;nM;8.7;;DAMGO;CHEMBL1114660;Displacement of [3H]naloxone from mu opioid receptor expressed in CHO cell membrane;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1157800;Scientific Literature;0;2;513.6;16.94;0.32;9.64;5;-0.94;;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Nat. Prod.;2010;1;UO_0000065;False
CHEMBL4092125;IC50;=;50;nM;7.3;;46;CHEMBL3992795;Agonist activity at human MOR expressed in HEK293 cells assessed as inhibition of forskolin-induced adenylyl cyclase-mediated cAMP accumulation after 30 mins by HTRF assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3992491;Scientific Literature;0;0;349.26;20.9;0.43;3.35;22.58;3.95;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;CN1CCc2ccccc2C1CNC(=O)c3ccc(Cl)c(Cl)c3;;Eur J Med Chem;2017;1;UO_0000065;False
CHEMBL3736364;IC50;=;2.344;nM;8.63;;"4; AKG116";CHEMBL3738443;Binding affinity to mu opioid receptor (unknown origin);single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3734657;Scientific Literature;0;;1106.18;7.8;;;;;Homo sapiens;;;;;9606;BAO_0000357;;;;;CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc3c(C)cc(O)cc3C)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)NCc6cc(cc(c6)C(F)(F)F)C(F)(F)F;;J. Med. Chem.;2015;1;UO_0000065;False
CHEMBL2048767;EC50;=;1.1;nM;8.96;;3k, MCL-731;CHEMBL2050641;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;445.61;20.1;0.37;2.89;15.34;6.07;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;[O-][N+](=O)c1cccc(CNc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4CC6CCC6)c3c2)c1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL316446;EC50;=;14.4;nM;7.84;;1, EM-1,endomorphin-1;CHEMBL3630378;Agonist activity at mu opioid receptor (unknown origin) transfected in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP production;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3627650;Scientific Literature;0;2;610.72;12.84;0.24;6.17;4.27;1.67;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](Cc5ccccc5)C(=O)N;;Bioorg. Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL2159120;EC50;=;61;nM;7.21;;5k;CHEMBL2163098;Agonist activity at mu opioid receptor expressed in CHO-hg cells by [35S]-GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2157906;Scientific Literature;0;1;539.64;13.37;0.25;3.06;4.64;4.15;;;;CHO-hg;;9606;BAO_0000219;;;;;C[C@H](N(Cc1cccc(c1)C(=O)O)C(=O)[C@@H](N)Cc2c(C)cc(cc2C)C(=O)N)c3nc(c[nH]3)c4ccccc4;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL2048770;EC50;=;3.6;nM;8.44;;4c, MCL-706;CHEMBL2050641;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;416.61;20.27;0.37;2.58;23.79;5.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc(CNc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4CC6CCC6)c3c2)cc1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL4096314;EC50;=;5.3;nM;8.28;;2f;CHEMBL4035930;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by Eu-cAMP tracer based TR-FRET assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4033703;Scientific Literature;0;1;506.65;16.33;0.3;3.7;15.61;4.58;Homo sapiens;;;;;9606;BAO_0000219;;;;;Oc1ccc2CC3N(CCc4ccccc4)CCC5(C6[C@H]7CN(C6CCC35O7)C(=O)c8ccccc8)c2c1;;Bioorg Med Chem Lett;2017;1;UO_0000065;False
CHEMBL326684;EC50;=;3.28;nM;8.48;;4;CHEMBL4032004;Agonist activity at recombinant human MOR expressed in CHO cell membranes after 60 mins by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4028881;Scientific Literature;0;0;329.4;25.76;0.48;6.69;14.38;1.79;Homo sapiens;;;;;9606;BAO_0000219;;;;;CO[C@]12CCC(=O)[C@]3(C)Oc4c(O)ccc5C[C@H]1N(C)CC[C@@]23c45;;J Med Chem;2017;1;UO_0000065;False
CHEMBL4083911;EC50;=;72;nM;7.14;;6;CHEMBL4001476;Agonist activity at MOR (unknown origin) by [35S]GTPgamma binding assay;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4000201;Scientific Literature;0;0;389.45;18.34;0.34;4.7;10.2;2.44;Homo sapiens;;;;;9606;BAO_0000357;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@]2(O)C\C(=C/c6ccccc6)\C4=O)c35;;Bioorg Med Chem Lett;2017;1;UO_0000065;False
CHEMBL13786;IC50;=;13;nM;7.89;;Met-Enk;CHEMBL3738454;Agonist activity at mu opioid receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation by bioluminescent assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3734657;Scientific Literature;0;2;573.67;13.75;0.27;8.35;3.94;-0.46;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)O;;J. Med. Chem.;2015;1;UO_0000065;False
CHEMBL2208354;IC50;=;45;nM;7.35;;21;CHEMBL2213834;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203245;Scientific Literature;0;1;482.67;;;;;5.76;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2cc(CCNC(=O)c3ccc4CC5C(C)C(C)(CCN5CC6CC6)c4c3)ccc2c1;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL2208350;IC50;=;29;nM;7.54;;17;CHEMBL2213834;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203245;Scientific Literature;0;2;538.73;;;;;6.28;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc(cc1OC)c2ccc(CCNC(=O)c3ccc4CC5C(C)C(C)(CCN5CC6CC6)c4c3)cc2;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL2208349;IC50;=;64;nM;7.19;;16;CHEMBL2213834;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203245;Scientific Literature;0;1;494.68;;;;;5.97;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC1C2Cc3ccc(cc3C1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cc5)c6ccccc6O;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL3734889;IC50;=;13.18;nM;7.88;;"10; AKG193";CHEMBL3738443;Binding affinity to mu opioid receptor (unknown origin);single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3734657;Scientific Literature;0;;1232.08;6.4;;;;;Homo sapiens;;;;;9606;BAO_0000357;;;;;CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2ccc(I)cc2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc3c(C)cc(O)cc3C)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)NCc6cc(cc(c6)C(F)(F)F)C(F)(F)F;;J. Med. Chem.;2015;1;UO_0000065;False
CHEMBL3736285;IC50;=;89.13;nM;7.05;;"2; AKG117";CHEMBL3738443;Binding affinity to mu opioid receptor (unknown origin);single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3734657;Scientific Literature;0;;1092.15;6.46;;;;;Homo sapiens;;;;;9606;BAO_0000357;;;;;CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2ccccc2)N(C)C(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc3ccc(O)cc3)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)NCc6cc(cc(c6)C(F)(F)F)C(F)(F)F;;J. Med. Chem.;2015;1;UO_0000065;False
CHEMBL511142;EC50;=;0.45;nM;9.35;389730;BDBM50354578;CHEMBL3888318;"?-Opioid Receptor Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared in-house from a cell line expressing recombinant ? opioid receptor in a HEK293 background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25 �C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50 �C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886656;BindingDB Database;4;0;467.65;19.99;0.38;4.94;15.04;4.41;Homo sapiens;;;;;9606;BAO_0000019;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;;2016;37;UO_0000065;False
CHEMBL219319;IC50;=;12;nM;7.92;223802;BDBM50199943;CHEMBL3705131;Binding Assay: The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994).;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3638450;BindingDB Database;0;0;336.48;23.54;0.43;4.22;22.31;3.7;Homo sapiens;;;;;9606;BAO_0000357;;;;;C[C@H]1CN2C[C@@H](NC[C@H]2C[C@@]1(C)c3cccc(O)c3)c4ccccc4;;;2013;37;UO_0000065;False
CHEMBL4114677;IC50;=;34;nM;7.47;326522;BDBM179880;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;384.48;19.42;0.36;5.66;7.19;1.81;Homo sapiens;;;;;9606;BAO_0000249;;;;;CC(=CCN1CC[C@]23CC(=O)CC[C@@]2(O)[C@H]1Cc4ccc(C(=O)N)c(O)c34)C;;;2015;37;UO_0000065;False
CHEMBL4114707;IC50;=;51;nM;7.29;326523;BDBM179881;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;382.5;19.07;0.36;4.49;8.4;2.8;Homo sapiens;;;;;9606;BAO_0000249;;;;;CC(=CCN1CC[C@]23CC(=C)CC[C@@]2(O)[C@H]1Cc4ccc(C(=O)N)c(O)c34)C;;;2015;37;UO_0000065;False
CHEMBL3977887;IC50;=;47;nM;7.33;326535;BDBM179889;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;1;495.67;14.78;0.27;1.97;11.19;5.36;Homo sapiens;;;;;9606;BAO_0000249;;;;;C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cc5)c6ccc(O)nc6;;;2015;37;UO_0000065;False
CHEMBL3735058;IC50;=;10.96;nM;7.96;;"9; AKG192";CHEMBL3738443;Binding affinity to mu opioid receptor (unknown origin);single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3734657;Scientific Literature;0;;1185.08;6.72;;;;;Homo sapiens;;;;;9606;BAO_0000357;;;;;CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2ccc(Br)cc2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc3c(C)cc(O)cc3C)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)NCc6cc(cc(c6)C(F)(F)F)C(F)(F)F;;J. Med. Chem.;2015;1;UO_0000065;False
CHEMBL38874;EC50;=;32.6;nM;7.49;;DAMGO;CHEMBL3270915;Agonist activity at human mu opioid receptor transfected in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259735;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL4106563;EC50;=;38.6;nM;7.41;412558;BDBM236829;CHEMBL3888720;"[35S]GTP?S Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared from a cell line expressing recombinant ? opioid receptor in a HEK-293, CHO or U-2 OS cell background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.; or DiscovRx, Fremont, Calif.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50� C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886801;BindingDB Database;0;0;475.63;15.59;0.29;3.12;12.57;4.29;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]5(CC(=O)[C@@H](CCOCc6ccccc6)C[C@@]35O)c2c1;;;2016;37;UO_0000065;False
CHEMBL3891748;EC50;=;18.6;nM;7.73;412550;BDBM236847;CHEMBL3888720;"[35S]GTP?S Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared from a cell line expressing recombinant ? opioid receptor in a HEK-293, CHO or U-2 OS cell background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.; or DiscovRx, Fremont, Calif.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50� C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886801;BindingDB Database;0;0;426.56;18.12;0.34;5.43;8.6;2.3;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC(C)(C)C(=O)N[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3CC5CC5)CC1=O;;;2016;37;UO_0000065;False
CHEMBL4110263;EC50;=;10.3;nM;7.99;412556;BDBM236853;CHEMBL3888720;"[35S]GTP?S Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared from a cell line expressing recombinant ? opioid receptor in a HEK-293, CHO or U-2 OS cell background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.; or DiscovRx, Fremont, Calif.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50� C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886801;BindingDB Database;0;0;452.6;17.65;0.33;5.16;8.89;2.83;Homo sapiens;;;;;9606;BAO_0000019;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]5(CC(=O)[C@H](C[C@@]35O)NC(=O)C6CCCCC6)c2c1;;;2016;37;UO_0000065;False
CHEMBL49269;EC50;=;0.8;nM;9.1;;6a;CHEMBL749648;Agonistic activity against Opioid receptor mu 1 in Chinese hamster ovary membranes;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149134;Scientific Literature;0;0;297.44;;;;;3.86;Cricetulus griseus;;;;;9606;BAO_0000249;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1;;J. Med. Chem.;2004;1;UO_0000065;True
CHEMBL80;IC50;=;7.3;nM;8.14;;1a;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;4;0;327.38;;;;;1.3;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O;;J. Med. Chem.;2006;1;UO_0000065;True
CHEMBL219319;IC50;=;1.1;nM;8.96;;5;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;336.48;;;;;3.7;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2C[C@@H](NC[C@H]2C[C@@]1(C)c3cccc(O)c3)c4ccccc4;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL169346;EC50;=;62;nM;7.21;;44;CHEMBL749733;Incorporation of [35S]- GTPgammaS into CHO membranes expressing human Opioid receptor mu 1;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145777;Scientific Literature;0;0;298.43;24.15;0.45;3.98;15.56;3.23;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC[C@]12CCN(CC3CC3)C([C@@H]1C)C(=O)c4ccc(N)cc24;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL297428;EC50;=;1;nM;9;;1b;CHEMBL1019886;Activity at human cloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;298.43;;;;;2.72;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC1C2Cc3ccc(cc3C1(C)CCN2CC4CC4)C(=O)N;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL3958318;EC50;=;4.8;nM;8.32;326572;BDBM179887;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;275.39;30.21;0.57;5.76;25.44;2.56;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COCCN1CC[C@]2(C)[C@@H](C)[C@H]1Cc3ccc(O)cc23;;;2015;37;UO_0000065;False
CHEMBL3977887;EC50;=;22;nM;7.66;326573;BDBM179889;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;1;495.67;15.45;0.28;2.3;11.7;5.36;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cc5)c6ccc(O)nc6;;;2015;37;UO_0000065;False
CHEMBL3919938;EC50;=;62;nM;7.21;326576;BDBM179892;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;272.39;26.46;0.49;4.7;10.43;2.51;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@]12CCCCC[C@@H](Cc3ccc(cc13)C(=O)N)[C@@H]2N;;;2015;37;UO_0000065;False
CHEMBL3919938;EC50;=;41;nM;7.39;326577;BDBM179892;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;272.39;27.12;0.5;4.88;10.69;2.51;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@]12CCCCC[C@@H](Cc3ccc(cc13)C(=O)N)[C@@H]2N;;;2015;37;UO_0000065;False
CHEMBL3986245;IC50;=;14;nM;7.85;326518;BDBM179876;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;370.49;21.2;0.4;5.53;9.05;2.32;Homo sapiens;;;;;9606;BAO_0000249;;;;;NC(=O)c1ccc2C[C@@H]3[C@@H]4CC[C@H](O)C[C@]4(CCN3CC5CCC5)c2c1O;;;2015;37;UO_0000065;False
CHEMBL2387191;EC50;=;28;nM;7.55;;7;CHEMBL2389089;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2385080;Scientific Literature;0;0;326.48;;;;;4.01;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(C1CCCCC1)N2CCC(CC2)N3C(=O)Cc4ccccc34;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL2387195;EC50;=;94;nM;7.03;;12;CHEMBL2389089;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2385080;Scientific Literature;0;0;340.51;;;;;4.71;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC1C(=O)N(C2CCN(CC2)C3CCCCCCC3)c4ccccc14;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL38874;EC50;=;15;nM;7.82;;DAMGO;CHEMBL2423628;Agonist activity at human MOR assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins by cell based TR-FRET assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2417445;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL2208361;EC50;=;2.3;nM;8.64;;8;CHEMBL2213832;Partial agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203245;Scientific Literature;0;2;536.76;;;;;7.05;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(C)Oc1ccc(cc1)c2ccc(CCNC(=O)c3ccc4CC5C(C)C(C)(CCN5CC6CC6)c4c3)cc2;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL3764219;EC50;=;20.42;nM;7.69;;2;CHEMBL3766803;Agonist activity at human recombinant MOR expressed in CHO cells by calcium mobilization assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3763121;Scientific Literature;0;1;557.6;13.79;0.26;6.99;4.83;0.7;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3ccccc3)C(=O)N4CC(F)(F)C[C@@H]4C(=O)N;;Bioorg. Med. Chem.;2016;1;UO_0000065;False
CHEMBL3394743;IC50;=;29;nM;7.54;;5;CHEMBL3395052;Displacement of [3H]DAMGO from human Mu opioid receptor expressed in HEK293 cells after 2 hrs by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3393026;Scientific Literature;0;2;610.82;12.34;0.23;2.28;11.04;5.26;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;COc1ccc(CNC[C@H](O)CN2CN(c3ccccc3)C4(CCN(CCc5ccccc5c6cccs6)CC4)C2=O)cc1;;Bioorg. Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL3326228;EC50;=;0.2;nM;9.7;;5a;CHEMBL3366614;Agonist activity at human recombinant MOP receptor expressed in CHO-K1 cells assessed as stimulation of [35S]GTPgammaS binding by scintillation proximity assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3352090;Scientific Literature;0;0;395.98;;;;;4.54;Homo sapiens;;;CHO-K1;;9606;BAO_0000219;;;;;Cl.CN(C)[C@@]1(CC[C@]2(CC1)NCCc3c2[nH]c4ccccc34)c5ccccc5;;ACS Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL3325959;EC50;=;2.6;nM;8.59;;4a;CHEMBL3366614;Agonist activity at human recombinant MOP receptor expressed in CHO-K1 cells assessed as stimulation of [35S]GTPgammaS binding by scintillation proximity assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3352090;Scientific Literature;0;0;556.59;;;;;4.76;Homo sapiens;;;CHO-K1;;9606;BAO_0000219;;;;;CN[C@@]1(CC[C@]2(CC1)OCCc3c2[nH]c4ccc(F)cc34)c5ccccc5.OC(=O)CC(O)(CC(=O)O)C(=O)O;;ACS Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL19019;IC50;=;3.9;nM;8.41;;naltrexone;CHEMBL2444609;Binding affinity to wild type MOR (unknown origin) expressed in CHO cells after 15 mins by Ca2+ mobilization assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440098;Scientific Literature;4;0;341.41;24.63;0.46;6.88;12.01;1.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O;;Bioorg. Med. Chem.;2013;1;UO_0000065;False
CHEMBL80;IC50;=;23;nM;7.64;;Naloxone;CHEMBL919398;Agonist activity at human opioid gamma receptor expressed in CHO cells assessed as inhibition of DAGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147138;Scientific Literature;4;0;327.38;;;;;1.3;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL3264742;EC50;=;2.8;nM;8.55;;4a;CHEMBL3271437;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]-GTP[gammaS] binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259551;Scientific Literature;0;1;500.6;17.09;0.32;5.23;11.97;3.32;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@]56[C@@H]7[C@@H]8O[C@]35CC[C@@]7(OCOc1c26)N(Cc9ccccc9)C8=O;;ACS Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL2443269;EC50;=;12.59;nM;7.9;;(R)-11;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;0;350.51;;;;;4.62;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;C(C[C@]1(CCOC2(CCCC2)C1)c3ccccn3)NCc4ccccc4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL2443268;EC50;=;50.12;nM;7.3;;11;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;0;350.51;;;;;4.62;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;C(CC1(CCOC2(CCCC2)C1)c3ccccn3)NCc4ccccc4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL1834413;EC50;=;6.1;nM;8.21;;1f;CHEMBL1838554;Partial agonist activity at human MOP receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1833948;Scientific Literature;0;2;519.73;;;;;5.19;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)CC4CC5CCC4C5)[C@H]6Cc7ccc(O)c8O[C@@H]2[C@]3(CCN6CC9CC9)c78;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL551074;EC50;=;2.6;nM;8.59;;10;CHEMBL2161464;Inverse agonist activity at human recombinant mu opioid receptor expressed in CHO cells after 3 hrs by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2157973;Scientific Literature;0;0;421.52;;;;;1.3;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CS(=O)(=O)O[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CC6)c45;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL2443262;EC50;=;8;nM;8.1;;(R)-30, TRV130;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;3;0;386.56;;;;;4.69;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;COc1ccsc1CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3086465;EC50;=;20.6;nM;7.69;;6;CHEMBL3089286;Agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085655;Scientific Literature;0;0;364.53;;;;;4.09;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN(CCCc2ccccc2)[C@@H]3C[C@@H](N)C[C@]1(C3)c4cccc(O)c4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3759541;EC50;=;4.8;nM;8.32;;15;CHEMBL3762574;Agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3758122;Scientific Literature;0;1;576.7;14.42;0.26;4.01;7.17;4.31;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)NCC(=O)N(c4ccccc4)c5ccccc5;;Eur. J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL2048762;EC50;=;7.8;nM;8.11;;3c, MCL-662;CHEMBL2050641;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;430.64;18.83;0.35;1.94;33.09;6.17;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc(CNc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4CC6CCC6)c3c2)cc1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2048761;EC50;=;3.8;nM;8.42;;3b, MCL-665;CHEMBL2050641;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;430.64;19.55;0.36;2.25;34.37;6.17;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1cccc(CNc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4CC6CCC6)c3c2)c1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2397019;EC50;=;11.13;nM;7.95;;8;CHEMBL2399071;Agonist activity at mu opioid receptor (unknown origin) expressed CHO cells assessed as stimulation of [35S]-GTP[gammaS] binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2396652;Scientific Literature;0;0;494.59;16.08;0.29;3.83;10.08;4.12;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36NC(=O)c7ccc8ccccc8c7;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL4108566;IC50;=;43;nM;7.37;326545;BDBM179899;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;384.48;19.16;0.36;5.73;7.09;1.64;Homo sapiens;;;;;9606;BAO_0000249;;;;;C[C@H](C1CC1)N2CC[C@]34CC(=O)CC[C@@]3(O)[C@H]2Cc5ccc(C(=O)N)c(O)c45;;;2015;37;UO_0000065;False
CHEMBL2048770;IC50;=;75;nM;7.12;;4c, MCL-706;CHEMBL2050643;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;1;416.61;17.1;0.31;1.26;20.07;5.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc(CNc2ccc3C[C@@H]4[C@@H]5CCCC[C@]5(CCN4CC6CCC6)c3c2)cc1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL333357;EC50;=;13.8;nM;7.86;;EM-2;CHEMBL3584507;Agonist activity at human recombinant mu opioid receptor expressed in CHO cells co-expressing C-terminally modified GGalphaqi5 assessed as stimulation of calcium release by Fluo-4 AM dye-based fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3580572;Scientific Literature;0;1;571.68;13.75;0.26;6.67;4.68;1.19;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N;;ACS Med. Chem. Lett.;2015;1;UO_0000065;False
CHEMBL2158957;IC50;=;12;nM;7.92;;4;CHEMBL2162350;Agonist activity at MOP receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2157899;Scientific Literature;0;;1059.3;;;;;;;;;CHO-K1;;9606;BAO_0000219;;;;;CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@@H]5CCCN5C(=O)[C@@H](N)Cc6ccc(O)cc6)C(=O)N;;Bioorg. Med. Chem.;2012;1;UO_0000065;False
CHEMBL2443279;EC50;=;63.1;nM;7.2;;(R)-20;CHEMBL2445992;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as beta-arrestin recruitment by chemiluminescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;0;356.54;20.19;0.39;2.52;21.08;4.68;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;C(C[C@]1(CCOC2(CCCC2)C1)c3ccccn3)NCc4ccsc4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3983967;EC50;=;2.1;nM;8.68;326559;BDBM179878;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;354.49;24.48;0.46;5.33;13.04;3.35;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1O;;;2015;37;UO_0000065;False
CHEMBL4111224;EC50;=;18.22;nM;7.74;354830;BDBM199337;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;1;505.66;15.31;0.29;3.71;12.82;4.03;Homo sapiens;;;;;9606;BAO_0000019;;;;;CO[C@]12CC[C@@]3(C[C@@H]1COCc4ccccc4C)[C@H]5Cc6ccc(OCCO)c7O[C@@H]2[C@]3(CCN5C)c67;;;2015;37;UO_0000065;False
CHEMBL4114285;IC50;=;1.7;nM;8.77;326543;BDBM179897;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;338.5;25.91;0.48;5.13;18.93;3.64;Homo sapiens;;;;;9606;BAO_0000249;;;;;C[C@H](C1CC1)N2CC[C@]34CCCC[C@H]3[C@H]2Cc5ccc(cc45)C(=O)N;;;2015;37;UO_0000065;False
CHEMBL3758563;EC50;=;22;nM;7.66;;16;CHEMBL3762574;Agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3758122;Scientific Literature;0;1;540.66;14.16;0.26;5.13;6.6;2.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)NCC(=O)N4CCc5ccccc5C4;;Eur. J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL3264747;EC50;=;1.2;nM;8.92;;4h;CHEMBL3271443;Agonist activity at human mu opioid receptor expressed in HEK293 cells by CellKey method;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259551;Scientific Literature;0;0;486.57;18.33;0.34;5.59;12.48;3.33;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@]56[C@@H]7[C@@H]8O[C@]35CC[C@@]7(OCOc1c26)N(C8=O)c9ccccc9;;ACS Med. Chem. Lett.;2014;1;UO_0000065;False
CHEMBL409225;EC50;=;5.17;nM;8.29;;2, SB0304;CHEMBL2156219;Agonist activity at human MOR expressed in HEK293 cell membrane assessed as inhibition of forskolin-induced cAMP accumulation by by liquid scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2150869;Scientific Literature;0;0;479.54;;;;;-0.45;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H](N1Cc2cc(O)ccc2C[C@H](N)C1=O)C(=O)N[C@H]3Cc4ccccc4CN(CC(=O)N)C3=O;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL4106879;EC50;=;2.9;nM;8.54;326575;BDBM179891;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;1;551.69;15.48;0.28;4.35;8.31;4.19;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1c(ccc2C[C@H]3N(CC4CC4)CC[C@@]5(CC(=O)CC[C@@]35O)c12)C(=O)NCCc6ccc(cc6)c7cccnc7;;;2015;37;UO_0000065;False
CHEMBL3911427;EC50;=;2.2;nM;8.66;326581;BDBM179901;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;302.42;28.63;0.54;6.7;15.58;1.96;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COCCN1CC[C@]2(C)[C@@H](C)[C@H]1Cc3ccc(cc23)C(=O)N;;;2015;37;UO_0000065;False
CHEMBL607405;EC50;=;1.45;nM;8.84;;2;CHEMBL4032004;Agonist activity at recombinant human MOR expressed in CHO cell membranes after 60 mins by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4028881;Scientific Literature;0;0;315.37;28.03;0.52;7.44;14.98;1.4;Homo sapiens;;;;;9606;BAO_0000219;;;;;CO[C@]12CCC(=O)[C@@H]3Oc4c(O)ccc5C[C@H]1N(C)CC[C@@]23c45;;J Med Chem;2017;1;UO_0000065;False
CHEMBL115280;IC50;=;83.5;nM;7.08;;36;CHEMBL757059;Binding affinity against mu opiate receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134625;Scientific Literature;0;0;413.52;17.12;0.31;2.67;15.8;4.41;;;;;;9606;BAO_0000357;;;;;O=C1NCN(c2ccccc2)C13CCN(Cc4cccc(Oc5ccccc5)c4)CC3;;J. Med. Chem.;2001;1;UO_0000065;True
CHEMBL592;IC50;=;0.13;nM;9.89;;levorphanol;CHEMBL753178;In vitro binding affinity against cloned human Opioid receptor mu 1 expressed in HEK 293S cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145019;Scientific Literature;4;0;257.38;38.41;0.71;6.81;42.12;3.08;;;;HEK293;;9606;BAO_0000219;;;;;CN1CC[C@]23CCCC[C@H]2[C@H]1Cc4ccc(O)cc34;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL3759981;EC50;=;11.48;nM;7.94;;3;CHEMBL3762660;Agonist activity at human recombinant MOR expressed in CHO cells assessed as calcium mobilization by Fluo-4 AM based fluorescence analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3758180;Scientific Literature;0;2;777.92;10.21;0.19;6.31;3.38;1.63;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N[C@@H]2CCCCNC(=O)C[C@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc4ccc5ccccc5c4)NC2=O)C(=O)N;;Eur. J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL3759167;EC50;=;5.623;nM;8.25;;4;CHEMBL3762660;Agonist activity at human recombinant MOR expressed in CHO cells assessed as calcium mobilization by Fluo-4 AM based fluorescence analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3758180;Scientific Literature;0;2;777.92;10.61;0.2;6.62;3.51;1.63;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N[C@@H]2CCCCNC(=O)C[C@H](NC(=O)[C@@H](Cc3cccc4ccccc34)NC(=O)[C@H](Cc5ccccc5)NC2=O)C(=O)N;;Eur. J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL3759489;EC50;=;45.1;nM;7.35;;59;CHEMBL3762585;Agonist activity at mu opioid receptor (unknown origin) assessed as [35S]GTPgammaS binding by cell based assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3758122;Scientific Literature;0;1;490.65;14.97;0.27;1.11;15.15;6.24;Homo sapiens;;;;;9606;BAO_0000219;;;;;CN1CC[C@@]23c4c5C[C@@H]1[C@]2(CCCc6ccccc6)Cc7c([nH]c8ccccc78)[C@]3(C)Oc4c(O)cc5;;Eur. J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL4071332;IC50;=;80;nM;7.1;;45;CHEMBL3992795;Agonist activity at human MOR expressed in HEK293 cells assessed as inhibition of forskolin-induced adenylyl cyclase-mediated cAMP accumulation after 30 mins by HTRF assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3992491;Scientific Literature;0;0;308.43;23.01;0.42;3.84;21.94;3.26;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;CN1CCc2ccccc2C1CNC(=O)c3ccc(C)c(C)c3;;Eur J Med Chem;2017;1;UO_0000065;False
CHEMBL38874;IC50;=;5.1;nM;8.29;;DAMGO;CHEMBL3992795;Agonist activity at human MOR expressed in HEK293 cells assessed as inhibition of forskolin-induced adenylyl cyclase-mediated cAMP accumulation after 30 mins by HTRF assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3992491;Scientific Literature;0;2;513.6;16.15;0.31;9.23;4.76;-0.94;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Eur J Med Chem;2017;1;UO_0000065;False
CHEMBL2443278;EC50;=;15.85;nM;7.8;;(R)-19;CHEMBL2445994;Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2440083;Scientific Literature;0;0;356.54;;;;;4.68;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;C(C[C@]1(CCOC2(CCCC2)C1)c3ccccn3)NCc4cccs4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL316446;EC50;=;14.4;nM;7.84;;1, EM-1;CHEMBL2166341;Agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by liquid scintillation counter;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2163332;Scientific Literature;0;2;610.72;;;;;1.67;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](Cc5ccccc5)C(=O)N;;J. Med. Chem.;2012;1;UO_0000065;True
CHEMBL3086306;EC50;=;80;nM;7.1;;10, MCL-745;CHEMBL3090458;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085732;Scientific Literature;0;0;423.58;;;;;3.8;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc2C[C@@H]3[C@@H]4Cc5sc(NC(=O)C)nc5C[C@]4(CCN3CC6CC6)c2c1;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL3216611;EC50;=;19.5;nM;7.71;;5a;CHEMBL3089286;Agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085655;Scientific Literature;0;0;437.46;;;;;4.09;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cl.Cl.C[C@@H]1CN(CCCc2ccccc2)[C@H]3C[C@H](N)C[C@@]1(C3)c4cccc(O)c4;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL333357;EC50;=;13.18;nM;7.88;;"EM-2; Tyr-Pro-Phe-Phe-NH2";CHEMBL3762660;Agonist activity at human recombinant MOR expressed in CHO cells assessed as calcium mobilization by Fluo-4 AM based fluorescence analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3758180;Scientific Literature;0;1;571.68;13.78;0.26;6.69;4.69;1.19;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N;;Eur. J. Med. Chem.;2016;1;UO_0000065;False
CHEMBL383320;EC50;=;3;nM;8.52;;8 (MCL-416);CHEMBL863310;Activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148605;Scientific Literature;0;1;495.7;;;;;6.66;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;OC(=O)CCCCCCCCC(=O)Oc1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC5CCC5)c2c1;;J. Med. Chem.;2006;1;UO_0000065;True
CHEMBL301160;EC50;=;1.6;nM;8.8;;1b;CHEMBL863310;Activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148605;Scientific Literature;0;0;311.47;;;;;4.25;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1;;J. Med. Chem.;2006;1;UO_0000065;True
CHEMBL895;IC50;=;24;nM;7.62;;NALBUPHINE;CHEMBL1909182;DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine);cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1909046;DrugMatrix;4;0;357.45;21.32;0.4;5.91;10.42;1.71;;;;CHO-K1;Membrane;9606;BAO_0000249;;;;;O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CCC6)c45;;;;15;UO_0000065;False
CHEMBL316446;IC50;=;14;nM;7.85;;1, endomorphin 1, endo 1;CHEMBL955670;Agonist activity at mu opioid receptor in human SHSY5Y cells assessed as inhibition of forskolin-stimulated cAMP production;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1150362;Scientific Literature;0;2;610.72;;;;;1.67;Homo sapiens;;;SH-SY5Y;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](Cc5ccccc5)C(=O)N;;Bioorg. Med. Chem.;2008;1;UO_0000065;False
CHEMBL49269;EC50;=;0.8;nM;9.1;;1;CHEMBL749732;Inhibitory activity in stimulating [35S]-GTP-gamma S binding mediated by the Opioid receptor mu 1 in chinese Hamster Ovary (CHO) cell membranes was determined;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145905;Scientific Literature;0;0;297.44;30.58;0.56;5.24;38.76;3.86;;;;;;9606;BAO_0000019;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1;;J. Med. Chem.;2003;1;UO_0000065;True
CHEMBL2208352;IC50;=;30;nM;7.52;;19;CHEMBL2213834;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203245;Scientific Literature;0;2;522.73;;;;;6.58;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc(cc1C)c2ccc(CCNC(=O)c3ccc4CC5C(C)C(C)(CCN5CC6CC6)c4c3)cc2;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL2208350;EC50;=;1.6;nM;8.8;;17;CHEMBL2213832;Partial agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203245;Scientific Literature;0;2;538.73;;;;;6.28;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc(cc1OC)c2ccc(CCNC(=O)c3ccc4CC5C(C)C(C)(CCN5CC6CC6)c4c3)cc2;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL2208349;EC50;=;1.5;nM;8.82;;16;CHEMBL2213832;Partial agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203245;Scientific Literature;0;1;494.68;;;;;5.97;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC1C2Cc3ccc(cc3C1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cc5)c6ccccc6O;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL4112548;EC50;=;9.65;nM;8.02;412549;BDBM236846;CHEMBL3888720;"[35S]GTP?S Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared from a cell line expressing recombinant ? opioid receptor in a HEK-293, CHO or U-2 OS cell background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.; or DiscovRx, Fremont, Calif.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50� C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886801;BindingDB Database;0;0;454.61;17.63;0.33;4.94;8.92;3.08;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC(C)CCCC(=O)N[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3CC5CC5)CC1=O;;;2016;37;UO_0000065;False
CHEMBL1834247;EC50;=;0.0832;nM;10.08;;5, BVD05;CHEMBL2156219;Agonist activity at human MOR expressed in HEK293 cell membrane assessed as inhibition of forskolin-induced cAMP accumulation by by liquid scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2150869;Scientific Literature;0;0;495.58;;;;;-0.06;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@H]2Cc3ccccc3CN(CC(=O)N)C2=O;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL260120;EC50;=;3.28;nM;8.48;;1, SB0306;CHEMBL2156219;Agonist activity at human MOR expressed in HEK293 cell membrane assessed as inhibition of forskolin-induced cAMP accumulation by by liquid scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2150869;Scientific Literature;0;0;483.57;;;;;-0.22;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;C[C@@H](N(C)C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)N(C)CC(=O)N;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL3927136;EC50;=;5.04;nM;8.3;354881;BDBM199419;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;1;510.68;16.25;0.31;4.77;8.8;3.53;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC[C@H](C)[C@H](N)C(=O)OC[C@H]1C[C@]23CC[C@]1(OC)[C@@H]4Oc5c(O)ccc6C[C@H]2N(CC7CC7)CC[C@@]34c56;;;2015;37;UO_0000065;False
CHEMBL3219777;IC50;=;40;nM;7.4;;1;CHEMBL3227490;Antagonist activity at human mu opioid receptor expressed in Gqi5 transfected CHO cells assessed as inhibition of DAMGO-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3217593;Scientific Literature;0;;1197.48;6.18;;;;;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(C)c1nnc(C)n1C2CC3CCC(C2)N3CC[C@H](NC(=O)C4CCC(F)(F)CC4)c5ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]6CC[C@@]7(O)[C@H]8Cc9ccc(O)c%10O[C@@H]6[C@]7(CCN8CC%11CC%11)c9%10)cc5;;MedChemComm;2013;1;UO_0000065;True
CHEMBL4092125;EC50;=;10;nM;8;;46;CHEMBL3992793;Agonist activity at human MOR expressed in CHO-K1 cells co-expressing Galpha 15 assessed as increase in intracellular calcium release incubated for 1 measured every 1.52 secs for 90 secs by FLIPR assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3992491;Scientific Literature;0;0;349.26;22.91;0.48;4.05;24.74;3.95;Homo sapiens;;;;;9606;BAO_0000219;;;;;CN1CCc2ccccc2C1CNC(=O)c3ccc(Cl)c(Cl)c3;;Eur J Med Chem;2017;1;UO_0000065;False
CHEMBL4103328;EC50;=;0.13;nM;9.89;;3a;CHEMBL4032004;Agonist activity at recombinant human MOR expressed in CHO cell membranes after 60 mins by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4028881;Scientific Literature;0;0;377.48;26.19;0.48;6.1;23.58;3.79;Homo sapiens;;;;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@@H]4CCC[C@@]2(OCc5ccccc5)[C@H]1Cc6ccc(O)c(O4)c36;;J Med Chem;2017;1;UO_0000065;False
CHEMBL333357;EC50;=;11.8;nM;7.93;;2, EM-2;CHEMBL2166341;Agonist activity at mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by liquid scintillation counter;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2163332;Scientific Literature;0;1;571.68;;;;;1.19;Homo sapiens;;;HEK293;;9606;BAO_0000219;;;;;N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL3215668;EC50;=;52;nM;7.28;;32;CHEMBL2051429;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 1 hr by HTRF assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046316;Scientific Literature;0;0;526.47;;;;;3.5;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Cl.Cl.CCOc1ccc(Cc2nc3cc(NC(=N)N[N+](=O)[O-])ccc3n2CCN(CC)CC)cc1;;ACS Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL38874;EC50;=;55;nM;7.26;;DAGO;CHEMBL941715;Agonist activity at human mu opioid receptor expressed in CHO cell membrane by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140563;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;True
CHEMBL2204031;EC50;=;6;nM;8.22;;19b;CHEMBL2215257;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 2 hrs by liquid scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203184;Scientific Literature;0;0;470.57;;;;;1.84;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@]2(O)CC[C@]46O[C@H]7N8[C@H](OC7(C)C)C(C)(C)O[C@H]68)c35;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL10872;IC50;=;41;nM;7.39;;2, JDTic;CHEMBL1259357;Antagonist activity at human mu opioid receptor assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1255514;Scientific Literature;0;0;449.64;;;;;3.85;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC(C)[C@@H](CN1CC[C@](C)([C@@H](C)C1)c2cccc(O)c2)NC(=O)[C@H]3Cc4ccccc4CN3;;Bioorg. Med. Chem. Lett.;2010;1;UO_0000065;False
CHEMBL4080324;EC50;=;48.8;nM;7.31;;21;CHEMBL4057029;Agonist activity at human mu opioid receptor expressed in CHO-dhfr(-) cells assessed as inhibition of forskolin-induced cAMP accumulation by TR-FRET assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4052747;Scientific Literature;0;1;537.06;13.61;0.26;3.67;7.82;3.64;Homo sapiens;;;;;9606;BAO_0000219;;;;;CN([C@@H]1CC[C@@]2(O)[C@H]3[C@@H](O)c4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CC6)c45)C(=O)\C=C\c7ccc(Cl)cc7;;Bioorg Med Chem Lett;2017;1;UO_0000065;False
CHEMBL4063074;IC50;=;22.61;nM;7.65;;(+/-)-LY2456302;CHEMBL4049840;Antagonist activity at recombinant human mu-opioid receptor expressed in CHO cell membranes assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 4 hrs by microbeta scintillation counting method;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4049389;Scientific Literature;0;1;418.51;18.27;0.34;1.98;13.76;5.67;Homo sapiens;;;;;9606;BAO_0000219;;;;;Cc1cc(C)cc(c1)C2CCCN2Cc3ccc(Oc4ccc(cc4F)C(=O)N)cc3;;Eur J Med Chem;2017;1;UO_0000065;False
CHEMBL319536;IC50;=;2;nM;8.7;;1;CHEMBL866455;Inhibition of loperamide-stimulated [35S]GTP-gamma-S binding to membranes containing mu opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149448;Scientific Literature;0;0;309.45;;;;;4.23;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(CCc2ccccc2)CC[C@@]1(C)c3cccc(O)c3;;Bioorg. Med. Chem. Lett.;2006;1;UO_0000065;False
CHEMBL3971169;EC50;=;1.81;nM;8.74;412560;BDBM236832;CHEMBL3888720;"[35S]GTP?S Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared from a cell line expressing recombinant ? opioid receptor in a HEK-293, CHO or U-2 OS cell background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.; or DiscovRx, Fremont, Calif.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50� C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886801;BindingDB Database;0;0;371.48;23.53;0.44;6.98;10.79;1.76;Homo sapiens;;;;;9606;BAO_0000019;;;;;OCC[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3CC5CC5)CC1=O;;;2016;37;UO_0000065;False
CHEMBL4111936;EC50;=;3.66;nM;8.44;412575;BDBM236867;CHEMBL3888720;"[35S]GTP?S Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared from a cell line expressing recombinant ? opioid receptor in a HEK-293, CHO or U-2 OS cell background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.; or DiscovRx, Fremont, Calif.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50� C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886801;BindingDB Database;0;0;353.51;23.87;0.44;4.52;20.81;3.92;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC(C)[C@H]1C[C@H]2[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3CC5CC5)CC1=O;;;2016;37;UO_0000065;False
CHEMBL4113162;EC50;=;1.4;nM;8.85;389732;BDBM222960;CHEMBL3888318;"?-Opioid Receptor Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared in-house from a cell line expressing recombinant ? opioid receptor in a HEK293 background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25 �C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50 �C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886656;BindingDB Database;0;1;493.69;17.93;0.34;3.29;17.31;5.56;Homo sapiens;;;;;9606;BAO_0000019;;;;;CCC1O[C@]23CC[C@@]4(C[C@@H]2[C@](C)(O1)C(C)(C)C)[C@H]5Cc6ccc(O)c7O[C@@H]3[C@]4(CCN5CC8CC8)c67;;;2016;37;UO_0000065;False
CHEMBL4111049;EC50;=;3.54;nM;8.45;389733;BDBM222961;CHEMBL3888318;"?-Opioid Receptor Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared in-house from a cell line expressing recombinant ? opioid receptor in a HEK293 background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25 �C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50 �C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886656;BindingDB Database;0;2;507.72;16.64;0.31;2.5;16.52;5.95;Homo sapiens;;;;;9606;BAO_0000019;;;;;CCCC1O[C@@](C)([C@H]2C[C@]34CC[C@]2(O1)[C@@H]5Oc6c(O)ccc7C[C@H]3N(CC8CC8)CC[C@@]45c67)C(C)(C)C;;;2016;37;UO_0000065;False
CHEMBL4113900;EC50;=;5.35;nM;8.27;389734;BDBM222962;CHEMBL3888318;"?-Opioid Receptor Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared in-house from a cell line expressing recombinant ? opioid receptor in a HEK293 background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25 �C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50 �C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886656;BindingDB Database;0;2;541.73;15.27;0.28;1.75;16.17;6.52;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC(C)(C)[C@@]1(C)OC(O[C@]23CC[C@@]4(C[C@H]12)[C@H]5Cc6ccc(O)c7O[C@@H]3[C@]4(CCN5CC8CC8)c67)c9ccccc9;;;2016;37;UO_0000065;False
CHEMBL3954177;EC50;=;0.39;nM;9.41;326558;BDBM179877;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;368.48;25.53;0.48;6.88;11.25;2.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;NC(=O)c1ccc2C[C@@H]3[C@@H]4CCC(=O)C[C@]4(CCN3CC5CCC5)c2c1O;;;2015;37;UO_0000065;False
CHEMBL3697625;IC50;=;37.8;nM;7.42;304256;BDBM160933;CHEMBL3706101;Flux Assay: As Ca2+ flux is associated with the activation of the MOR, the functional activity of bivalent ligand 1, monovalent ligand 2, and naltrexone was then evaluated in a Ca2+ mobilization assay in hMORCHO cells transfected with chimeric Ca2+ following a published protocol.23 No agonism was observed for any of the tested compounds (data not shown). Thus, they were further assessed for their antagonist properties as the ability to inhibit DAMGO (a MOR agonist) induced Ca2+ flux.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3638635;BindingDB Database;0;;1197.48;6.2;;;;;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(C)c1nnc(C)n1C2CC3CCC(C2)N3CC[C@H](NC(=O)C4CCC(F)(F)CC4)c5cccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]6CC[C@@]7(O)[C@H]8Cc9ccc(O)c%10O[C@@H]6[C@]7(CCN8CC%11CC%11)c9%10)c5;;;2015;37;UO_0000065;False
CHEMBL596;IC50;=;1.3;nM;8.89;;fantanyl;CHEMBL757060;Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1134447;Scientific Literature;4;0;336.48;26.41;0.49;4.75;37.73;4.14;;;;;;9606;BAO_0000357;;;;;CCC(=O)N(C1CCN(CCc2ccccc2)CC1)c3ccccc3;;J. Med. Chem.;2001;1;UO_0000065;False
CHEMBL2208352;EC50;=;0.6;nM;9.22;;19;CHEMBL2213832;Partial agonist activity at human mu opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2203245;Scientific Literature;0;2;522.73;;;;;6.58;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;COc1ccc(cc1C)c2ccc(CCNC(=O)c3ccc4CC5C(C)C(C)(CCN5CC6CC6)c4c3)cc2;;Bioorg. Med. Chem. Lett.;2012;1;UO_0000065;False
CHEMBL278789;IC50;=;2.4;nM;8.62;;Dermorphin;CHEMBL1837092;Agonist activity at Mu-type opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1833812;Scientific Literature;0;3;802.89;;;;;-2;;;;;;9606;BAO_0000019;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)N;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL147511;IC50;=;16;nM;7.8;;17 MCL-144;CHEMBL754564;Inhibitory activity was determined in stimulating [35S]-GTP-gamma S binding mediated by the Opioid receptor mu 1 in chinese Hamster Ovary (CHO)membranes;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145905;Scientific Literature;0;2;789.16;9.88;0.18;-3.24;13.2;11.04;;;;;;9606;BAO_0000019;;;;;O=C(CCCCCCCCC(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6;;J. Med. Chem.;2003;1;UO_0000065;True
CHEMBL49269;IC50;=;1.7;nM;8.77;;(-)2a;CHEMBL887397;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as DAMGO-stimulated [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;0;297.44;;;;;3.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;True
CHEMBL426523;IC50;=;0.54;nM;9.27;;4;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;0;0;335.49;;;;;4.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1CN2C[C@@H](CC[C@H]2C[C@@]1(C)c3cccc(O)c3)c4ccccc4;;J. Med. Chem.;2006;1;UO_0000065;True
CHEMBL895;EC50;=;14;nM;7.85;;2;CHEMBL919396;Agonist activity at human opioid gamma receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147138;Scientific Literature;4;0;357.45;;;;;1.71;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CCC6)c45;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL511142;IC50;=;0.59;nM;9.23;;17a;CHEMBL1019888;Activity at human cloned mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;4;0;467.65;;;;;4.41;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL4112771;EC50;=;22.15;nM;7.66;354851;BDBM199365;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;1;542.72;14.1;0.26;2.68;14.94;4.97;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@]7(CC[C@@]36C[C@@H]7CN(Cc8ccccc8)C(=O)C)OC;;;2015;37;UO_0000065;False
CHEMBL4108066;EC50;=;50.36;nM;7.3;354853;BDBM199367;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;1;533.73;13.67;0.26;2.43;15.2;4.87;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@]7(CC[C@@]36C[C@@H]7C[S+]([O-])Cc8ccccc8)OC;;;2015;37;UO_0000065;False
CHEMBL19019;EC50;=;0.38;nM;9.42;;NTX;CHEMBL2399071;Agonist activity at mu opioid receptor (unknown origin) expressed CHO cells assessed as stimulation of [35S]-GTP[gammaS] binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2396652;Scientific Literature;4;0;341.41;27.59;0.51;7.89;13.46;1.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL147511;EC50;=;1.3;nM;8.89;;17 MCL-144;CHEMBL749732;Inhibitory activity in stimulating [35S]-GTP-gamma S binding mediated by the Opioid receptor mu 1 in chinese Hamster Ovary (CHO) cell membranes was determined;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145905;Scientific Literature;0;2;789.16;11.26;0.21;-2.15;15.04;11.04;;;;;;9606;BAO_0000019;;;;;O=C(CCCCCCCCC(=O)Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1)Oc6ccc7C[C@@H]8[C@@H]9CCCC[C@]9(CCN8CC%10CCC%10)c7c6;;J. Med. Chem.;2003;1;UO_0000065;True
CHEMBL270190;IC50;=;3.162;nM;8.5;;1;CHEMBL4040566;Antagonist activity at recombinant human MOR expressed in HEK293T cells assessed as reduction in DAMGO-induced inhibition of forskolin-stimulated cAMP level preincubated for 15 to 20 mins followed by DAMGO and forskolin addition by GloSensor assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4038325;Scientific Literature;4;0;424.54;20.02;0.37;5.45;9.46;3.05;Homo sapiens;;;HEK-293T;;9606;BAO_0000219;;;;;C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c3cccc(O)c3;;J Med Chem;2017;1;UO_0000065;False
CHEMBL49269;IC50;=;1.7;nM;8.77;;Cyclorphan;CHEMBL2050643;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;0;297.44;29.48;0.54;4.91;37.36;3.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL398707;EC50;=;2.6;nM;8.59;;16;CHEMBL958391;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;4;0;285.34;;;;;1.63;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@@]23[C@H]4CCC(=O)[C@@H]2Oc5c(O)ccc(C[C@@H]14)c35;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL70;EC50;=;10;nM;8;;Morphine;CHEMBL3370190;Agonist activity at human mu opioid receptor expressed CHO-K1 cells coexpressing Galpha15 assessed as induction of intracellular calcium release by FLIPR calcium assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3351626;Scientific Literature;4;0;285.34;28.04;0.52;6.8;15.11;1.2;Homo sapiens;;;CHO-K1;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35;;Bioorg. Med. Chem.;2014;1;UO_0000065;False
CHEMBL4098662;EC50;=;21;nM;7.68;;3e;CHEMBL4036559;Agonist activity at human recombinant MOR expressed in CHO cells assessed as cAMP accumulation;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4033739;Scientific Literature;0;1;446.68;17.19;0.32;2.33;28.74;5.35;Homo sapiens;;;;;9606;BAO_0000219;;;;;Oc1ccc2CC3N(CC4CC4)CCC5(C6[C@H]7CN(CC8CCCCC8)C6CCC35C7)c2c1;;Bioorg Med Chem Lett;2017;1;UO_0000065;False
CHEMBL4114677;EC50;=;4.2;nM;8.38;326561;BDBM179880;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;384.48;21.79;0.41;6.57;8.07;1.81;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC(=CCN1CC[C@]23CC(=O)CC[C@@]2(O)[C@H]1Cc4ccc(C(=O)N)c(O)c34)C;;;2015;37;UO_0000065;False
CHEMBL4109400;EC50;=;13;nM;7.89;326570;BDBM179885;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;285.43;27.63;0.51;4.17;33.6;3.72;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CC1C2Cc3ccc(O)cc3[C@]1(C)CCN2CC4(C)CC4;;;2015;37;UO_0000065;False
CHEMBL4115091;EC50;=;9.32;nM;8.03;354835;BDBM199344;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;0;499.61;16.07;0.3;3.93;11.64;4.1;Homo sapiens;;;;;9606;BAO_0000019;;;;;CO[C@]12CC[C@@]3(C[C@@H]1COc4ccc(cc4)n5ccnc5)[C@H]6Cc7ccc(O)c8O[C@@H]2[C@]3(CCN6C)c78;;;2015;37;UO_0000065;False
CHEMBL4106722;EC50;=;50.27;nM;7.3;354885;BDBM199427;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;0;487.64;14.97;0.28;2.82;14.27;4.48;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@]7(O)CC[C@@]36C[C@@H]7COCc8ccccc8;;;2015;37;UO_0000065;False
CHEMBL3903900;EC50;=;2.3;nM;8.64;326563;BDBM179882;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;312.46;27.65;0.51;5.53;18.65;3.11;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1[C@H]2Cc3ccc(cc3[C@]1(C)CCN2CC4CCC4)C(=O)N;;;2015;37;UO_0000065;False
CHEMBL3928839;EC50;=;5.2;nM;8.28;326574;BDBM179890;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;468.65;17.68;0.32;3.3;13.58;4.98;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2CC4CC4)C(=O)NCCc5ccc(cc5)c6cn[nH]c6;;;2015;37;UO_0000065;False
CHEMBL4115338;EC50;=;18.69;nM;7.73;354832;BDBM199339;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;0;457.61;16.89;0.31;2.74;24.99;4.99;Homo sapiens;;;;;9606;BAO_0000019;;;;;CO[C@]12CC[C@@]3(C[C@@H]1COCc4ccccc4)[C@H]5Cc6ccc(C=C)c7O[C@@H]2[C@]3(CCN5C)c67;;;2015;37;UO_0000065;False
CHEMBL4108017;EC50;=;11.37;nM;7.94;354837;BDBM199350;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;1;489.63;16.22;0.3;2.67;25.68;5.27;Homo sapiens;;;;;9606;BAO_0000019;;;;;CO[C@]12CC[C@@]3(C[C@@H]1COCc4ccccc4)[C@H]5Cc6ccc(F)c7O[C@@H]2[C@]3(CCN5CC8CC8)c67;;;2015;37;UO_0000065;False
CHEMBL3948713;EC50;=;0.84;nM;9.08;412574;BDBM236866;CHEMBL3888720;"[35S]GTP?S Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared from a cell line expressing recombinant ? opioid receptor in a HEK-293, CHO or U-2 OS cell background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.; or DiscovRx, Fremont, Calif.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50� C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886801;BindingDB Database;0;0;353.51;25.67;0.48;5.16;22.39;3.92;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC(C)[C@@H]1C[C@H]2[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3CC5CC5)CC1=O;;;2016;37;UO_0000065;False
CHEMBL3983967;IC50;=;5;nM;8.3;326520;BDBM179878;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;354.49;23.42;0.44;4.95;12.47;3.35;Homo sapiens;;;;;9606;BAO_0000249;;;;;NC(=O)c1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1O;;;2015;37;UO_0000065;False
CHEMBL80;IC50;=;7.3;nM;8.14;;Naloxone;CHEMBL754686;Concentration required to inhibit agonist (loperamide) stimulated [35S]GTP-gamma-S, binding to membranes containing the cloned human mu opioid receptor;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136497;Scientific Literature;4;0;327.38;;;;;1.3;Homo sapiens;;;;;9606;BAO_0000019;;;;;Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O;;Bioorg. Med. Chem. Lett.;2003;1;UO_0000065;True
CHEMBL19019;IC50;=;4.1;nM;8.39;;1b;CHEMBL909298;Antagonist activity assessed as inhibition of loperamide-stimulated [35S]GTPgammaS binding to human mu opioid receptor expressed in CHO cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137297;Scientific Literature;4;0;341.41;;;;;1.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL511142;EC50;=;14.8;nM;7.83;;buprenorphine;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;4;0;467.65;;;;;4.41;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL506616;IC50;=;25;nM;7.6;;1, CJ-15208;CHEMBL1000649;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of 100 nM loperamide-stimulated GTPgammaS binding by cell based assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1136971;Scientific Literature;0;1;577.69;13.16;0.24;4.95;6.16;2.65;Homo sapiens;;;;;9606;BAO_0000219;;;;;O=C1N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](Cc4ccccc4)C(=O)N5CCC[C@@H]5C(=O)N[C@H]1Cc6ccccc6;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL301160;IC50;=;20;nM;7.7;;(-)3a;CHEMBL887397;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as DAMGO-stimulated [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;0;311.47;;;;;4.25;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;True
CHEMBL38874;EC50;=;35.3;nM;7.45;;DAMGO, MOP;CHEMBL1838554;Partial agonist activity at human MOP receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1833948;Scientific Literature;0;2;513.6;;;;;-0.94;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Med. Chem.;2011;1;UO_0000065;False
CHEMBL1685;EC50;=;38;nM;7.42;;dezocine;CHEMBL1028119;Agonist activity at human cloned mu opioid receptor by [35S]GTPgammaS binding assay;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1152717;Scientific Literature;4;0;245.37;;;;;3.11;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@@]12CCCCC[C@@H](Cc3ccc(O)cc13)[C@@H]2N;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL270190;IC50;=;1.7;nM;8.77;;1, alvimopan;CHEMBL933966;Antagonist activity at human cloned mu opioid receptor assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144033;Scientific Literature;4;0;424.54;;;;;3.05;Homo sapiens;;;;;9606;BAO_0000019;;;;;C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c3cccc(O)c3;;Bioorg. Med. Chem. Lett.;2008;1;UO_0000065;False
CHEMBL511142;EC50;=;2.3;nM;8.64;;1a;CHEMBL843115;Activity was evaluated in human mu opioid receptors transfected with CHO cells by [35S]GTP-gamma-S, assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1132136;Scientific Literature;4;0;467.65;;;;;4.41;;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;Bioorg. Med. Chem. Lett.;1999;1;UO_0000065;True
CHEMBL522143;EC50;=;1.14;nM;8.94;;6, NAP;CHEMBL1007140;Activity at monocloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140920;Scientific Literature;0;0;447.54;;;;;2.15;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@@H](CC[C@@]36O)NC(=O)c7ccncc7;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL19019;IC50;=;0.59;nM;9.23;;Naltrexone;CHEMBL907187;Activity at human recombinant mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137387;Scientific Literature;4;0;341.41;;;;;1.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O;;J. Med. Chem.;2006;1;UO_0000065;False
CHEMBL200199;IC50;=;1.4;nM;8.85;;Biphalin;CHEMBL870570;Displacement of [3H]DAMGO from mu opioid receptor;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147769;Scientific Literature;0;3;909.01;9.74;0.18;10.47;2.72;-1.62;Homo sapiens;;;;;9606;BAO_0000357;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)NNC(=O)[C@H](Cc3ccccc3)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc4ccc(O)cc4;;Bioorg. Med. Chem. Lett.;2006;1;UO_0000065;False
CHEMBL301160;IC50;=;20;nM;7.7;;3b (MC 101);CHEMBL893251;Antagonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding after 60 mins;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147995;Scientific Literature;0;0;311.47;;;;;4.25;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1;;Bioorg. Med. Chem.;2007;1;UO_0000065;True
CHEMBL19019;IC50;=;17;nM;7.77;;2b;CHEMBL919398;Agonist activity at human opioid gamma receptor expressed in CHO cells assessed as inhibition of DAGO-stimulated [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147138;Scientific Literature;4;0;341.41;;;;;1.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O;;J. Med. Chem.;2007;1;UO_0000065;False
CHEMBL19019;IC50;=;4.1;nM;8.39;;2b;CHEMBL909317;Antagonist activity against human cloned mu opioid receptor expressed in CHO cells assessed as inhibition of loperamide-stimulated [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1137299;Scientific Literature;4;0;341.41;;;;;1.53;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O;;J. Med. Chem.;2006;1;UO_0000065;True
CHEMBL301160;EC50;=;1.6;nM;8.8;;MCL-101;CHEMBL749648;Agonistic activity against Opioid receptor mu 1 in Chinese hamster ovary membranes;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149134;Scientific Literature;0;0;311.47;;;;;4.25;Cricetulus griseus;;;;;9606;BAO_0000249;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1;;J. Med. Chem.;2004;1;UO_0000065;True
CHEMBL522201;EC50;=;4.36;nM;8.36;;9, NAQ;CHEMBL1007140;Activity at monocloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1140920;Scientific Literature;0;0;497.6;;;;;3.3;;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@H](CC[C@@]36O)NC(=O)c7cc8ccccc8cn7;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL471806;IC50;=;26.3;nM;7.58;;2, Rac C8Laa-Endo-1;CHEMBL955670;Agonist activity at mu opioid receptor in human SHSY5Y cells assessed as inhibition of forskolin-stimulated cAMP production;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1150362;Scientific Literature;0;2;751.93;;;;;3.13;Homo sapiens;;;SH-SY5Y;;9606;BAO_0000219;;;;;CCCCCCC(N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](Cc5ccccc5)C(=O)N;;Bioorg. Med. Chem.;2008;1;UO_0000065;False
CHEMBL80;IC50;=;1.87;nM;8.73;;Naloxone;CHEMBL3088793;Displacement of radiolabeled DAMGO from human recombinant mu opioid receptor expressed in OPRM1 cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085664;Scientific Literature;4;0;327.38;26.66;0.5;7.43;12.47;1.3;Homo sapiens;;;OPRM1;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O;;J. Med. Chem.;2013;1;UO_0000065;False
CHEMBL35838;IC50;=;57.8;nM;7.24;;6;CHEMBL970213;Agonist activity at mu opioid receptor assessed as inhibition of forskolin-induced cAMP production in human SH-SY5Y cells pretreated for 24 hrs with excess ligand after 15 mins;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1149874;Scientific Literature;0;2;554.65;;;;;-0.76;Homo sapiens;;;SH-SY5Y;;9606;BAO_0000219;;;;;CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)N;;Bioorg. Med. Chem.;2008;1;UO_0000065;False
CHEMBL511142;EC50;=;10.2;nM;7.99;;1a;CHEMBL1838554;Partial agonist activity at human MOP receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1833948;Scientific Literature;4;0;467.65;;;;;4.41;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;J. Med. Chem.;2011;1;UO_0000065;True
CHEMBL19019;EC50;=;0.59;nM;9.23;;18;CHEMBL749730;Effective concentration agonistic activity towards Opioid receptor mu 1;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145844;Scientific Literature;4;0;341.41;;;;;1.53;Homo sapiens;;;;;9606;BAO_0000019;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL567175;EC50;=;4.26;nM;8.37;;1;CHEMBL749730;Effective concentration agonistic activity towards Opioid receptor mu 1;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145844;Scientific Literature;0;0;414.51;;;;;3.57;Homo sapiens;;;;;9606;BAO_0000019;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)c7[nH]c8ccccc8c7C[C@@]36O;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL4107585;EC50;=;0.86;nM;9.07;389731;BDBM222959;CHEMBL3888318;"?-Opioid Receptor Functional Assay: [35S]GTP?S functional assays were conducted using freshly thawed ?-receptor membranes prepared in-house from a cell line expressing recombinant ? opioid receptor in a HEK293 background or purchased from a commercial source (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTP?S (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ?l/well) was transferred to 96-shallow well polypropylene plates containing 10 ?l of 20� concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25 �C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 200 ?l of ice-cold wash buffer (10 mM NaH2PO4, 10 mM Na2HPO4, pH 7.4). Filter plates were subsequently dried at 50 �C. for 2-3 hours. BetaScint scintillation cocktail (Perkin Elmer, Shelton, Conn.) was added (50 ?l/well) and plates were counted using a Packard Top-Count for 1 min/well.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886656;BindingDB Database;0;0;465.63;19.47;0.36;4.29;17.72;4.78;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC(C)(C)[C@@]1(C)OCO[C@]23CC[C@@]4(C[C@H]12)[C@H]5Cc6ccc(O)c7O[C@@H]3[C@]4(CCN5CC8CC8)c67;;;2016;37;UO_0000065;False
CHEMBL4108042;IC50;=;44;nM;7.36;326534;BDBM179888;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;312.46;23.54;0.44;4.25;15.88;3.11;Homo sapiens;;;;;9606;BAO_0000249;;;;;CC1C2Cc3ccc(cc3[C@]1(C)CCN2CC4(C)CC4)C(=O)N;;;2015;37;UO_0000065;False
CHEMBL4113058;EC50;=;50.43;nM;7.3;354849;BDBM199363;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;1;500.68;14.57;0.27;2.59;16.99;4.71;Homo sapiens;;;;;9606;BAO_0000019;;;;;COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@]7(CC[C@@]36C[C@@H]7CNCc8ccccc8)OC;;;2015;37;UO_0000065;False
CHEMBL4111124;EC50;=;53.07;nM;7.28;354854;BDBM199370;CHEMBL3887793;"Functional Assay: [35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepared by sequentially adding the following reagents to binding buffer (100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4) on ice (final concentrations indicated): membrane protein (0.026 mg/mL), saponin (10 mg/mL), GDP (3 mM) and [35S]GTPgammaS (0.20 nM; Perkin Elmer, Shelton, Conn.). The prepared membrane solution (190 ul/well) was transferred to 96-shallow well polypropylene plates containing 10 ul of 20x concentrated stock solutions of the agonist [D-Ala2, N-methyl-Phe4 Gly-ol5]-enkephalin (DAMGO) prepared in dimethyl sulfoxide (DMSO). Plates were incubated for 30 min at about 25� C. with shaking. Reactions were terminated by rapid filtration onto 96-well Unifilter GF/B filter plates (Perkin Elmer, Shelton, Conn.) using a 96-well tissue harvester (Perkin Elmer, Shelton, Conn.) followed by three filtration washes with 2001 of ice-cold binding buffer.";assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886452;BindingDB Database;0;2;633.83;11.48;0.22;2.09;10.72;5.19;Homo sapiens;;;;;9606;BAO_0000019;;;;;COCCOCCOCCOc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)[C@]7(CC[C@@]36C[C@@H]7COCc8ccccc8)OC;;;2015;37;UO_0000065;False
CHEMBL511645;IC50;=;3.8;nM;8.42;326528;BDBM50278263;CHEMBL3887250;null: The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of Med. Chem. 2012, p 3878), which is incorporated herein in its entirety. Briefly, membrane protein from CHO (Chinese Hamster Ovarian) cells that stably expressed the cloned human u opioid receptor were incubated with 12 different concentrations of the compound set forth herein in the presence of 0.25 nM [3H]DAMGO (see Tiberi et al., Can. J. Physiol. Pharmacol. 1988, Vol. 66, p 1368, which is incorporated by reference herein in its entirety) in a final volume of 1 mL of 50 mM Tris-HCl, pH 7.5 at 25� C. Incubation times of 60 min were used for [3H]DAMGO (see Gulati et al., Life Sci. 1990, Vol. 47, p 159, which is incorporated by reference herein in its entirety). Nonspecific binding was measured by inclusion of 10 uM naloxone. The binding was terminated by filtering the samples through Schleicher & Schuell No. 32 glass fiber.;cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;0;0;386.49;21.79;0.41;6.98;7.87;1.44;Homo sapiens;;;;;9606;BAO_0000249;;;;;NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(C[C@H](O)CC[C@@]35O)c2c1O;;;2015;37;UO_0000065;False
CHEMBL70;EC50;=;15.6;nM;7.81;;Morphine;CHEMBL1023001;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1152801;Scientific Literature;4;0;285.34;;;;;1.2;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35;;J. Med. Chem.;2009;1;UO_0000065;False
CHEMBL38874;IC50;=;1.6;nM;8.8;;DAMGO;CHEMBL872833;Binding activity against human Opioid receptor mu 1 using [3H]DAMGO as a radioligand;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1135899;Scientific Literature;0;2;513.6;17.13;0.32;9.74;5.05;-0.94;;;;;;9606;BAO_0000357;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;J. Med. Chem.;2002;1;UO_0000065;False
CHEMBL70;IC50;=;0.57;nM;9.24;;(-)-morphine;CHEMBL753178;In vitro binding affinity against cloned human Opioid receptor mu 1 expressed in HEK 293S cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145019;Scientific Literature;4;0;285.34;32.4;0.6;8.04;17.46;1.2;;;;HEK293;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL279968;EC50;=;5.5;nM;8.26;;(-)42;CHEMBL749733;Incorporation of [35S]- GTPgammaS into CHO membranes expressing human Opioid receptor mu 1;assay format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1145777;Scientific Literature;0;0;299.41;27.59;0.51;4.9;20.37;3.36;Homo sapiens;;;;;9606;BAO_0000019;;;;;CC[C@]12CCN(CC3CC3)C([C@@H]1C)C(=O)c4ccc(O)cc24;;J. Med. Chem.;2003;1;UO_0000065;False
CHEMBL841;IC50;=;1.445;nM;8.84;;Loperamide;CHEMBL1909182;DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine);cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1909046;DrugMatrix;4;1;477.05;18.53;0.36;3.75;20.19;5.09;;;;CHO-K1;Membrane;9606;BAO_0000249;;;;;CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4;;;;15;UO_0000065;False
CHEMBL49269;EC50;=;0.8;nM;9.1;;1;CHEMBL887396;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as maximal stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1144610;Scientific Literature;0;0;297.44;;;;;3.86;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CC5)c2c1;;Bioorg. Med. Chem. Lett.;2007;1;UO_0000065;True
CHEMBL895;EC50;=;46;nM;7.34;;6;CHEMBL958391;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1153960;Scientific Literature;4;0;357.45;;;;;1.71;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CCC6)c45;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;False
CHEMBL56585;EC50;=;4;nM;8.4;;(-)2;CHEMBL1019886;Activity at human cloned mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1139291;Scientific Literature;0;0;271.4;;;;;3.33;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;C[C@H]1[C@H]2Cc3ccc(O)cc3[C@]1(C)CCN2CC4CC4;;Bioorg. Med. Chem. Lett.;2009;1;UO_0000065;True
CHEMBL19019;IC50;=;4.083;nM;8.39;;Naltrexone;CHEMBL1909182;DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine);cell membrane format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1909046;DrugMatrix;4;0;341.41;24.57;0.46;6.86;11.98;1.53;;;;CHO-K1;Membrane;9606;BAO_0000249;;;;;Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O;;;;15;UO_0000065;False
CHEMBL70;EC50;=;50;nM;7.3;;Morphine;CHEMBL2423628;Agonist activity at human MOR assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins by cell based TR-FRET assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2417445;Scientific Literature;4;0;285.34;;;;;1.2;Homo sapiens;;;;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL511142;EC50;=;10.2;nM;7.99;;1a;CHEMBL3267139;Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by beta-plate liquid scintillation counting analysis;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3259633;Scientific Literature;4;0;467.65;;;;;4.41;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56;;J. Med. Chem.;2014;1;UO_0000065;False
CHEMBL301160;EC50;=;1.6;nM;8.8;;Butorphan;CHEMBL2050641;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [33S]GTPgammaS binding after 60 mins by scintillation counting;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2046406;Scientific Literature;0;0;311.47;28.24;0.52;4.55;37.48;4.25;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC5CCC5)c2c1;;J. Med. Chem.;2012;1;UO_0000065;False
CHEMBL70;EC50;=;15.6;nM;7.81;;MF, morphine;CHEMBL896955;Agonist activity at human mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1148829;Scientific Literature;4;0;285.34;;;;;1.2;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35;;J. Med. Chem.;2007;1;UO_0000065;True
CHEMBL70;EC50;=;6;nM;8.22;;Morphine;CHEMBL925795;Activation of human mu opioid receptor expressed in HEK293a cells co-expressing YFP-labelled alphai1 and CFP-labelled beta1gamma2 Gi subunits assessed as Gi protein activation by fluorescence resonance energy transfer;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1147037;Scientific Literature;4;0;285.34;28.81;0.53;7.02;15.53;1.2;Homo sapiens;;;HEK293-A;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35;;J. Biol. Chem.;2007;1;UO_0000065;False
CHEMBL200199;IC50;=;1.4;nM;8.85;;Bph;CHEMBL744603;In vitro binding affinity towards mu opioid receptors was determined using [3H][p-Cl-Phe]- 4] DPDPE or [3H]deltorphin II;single protein format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL1131989;Scientific Literature;0;3;909.01;9.74;0.18;10.47;2.72;-1.62;;;;;;9606;BAO_0000357;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)NNC(=O)[C@H](Cc3ccccc3)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc4ccc(O)cc4;;Bioorg. Med. Chem. Lett.;1999;1;UO_0000065;True
CHEMBL38874;IC50;=;20;nM;7.7;;DAGO;CHEMBL2395088;Displacement of [3H]Diprenorphine from human recombinant mu opioid receptor expressed in CHOK1 cells after 60 mins;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL2390918;Scientific Literature;0;2;513.6;14.99;0.28;8.64;4.42;-0.94;Homo sapiens;;;CHO-K1;;9606;BAO_0000219;;;;;C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCCO;;Bioorg. Med. Chem. Lett.;2013;1;UO_0000065;False
CHEMBL70;EC50;=;34;nM;7.47;326584;MF, morphine;CHEMBL3887251;Functional Assay (GTPgammaS Binding): The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a compound by quantifying the level of G-protein activation following agonist binding in studies using stably transfected cells, and is considered to be a measure of the efficacy of a compound. Membranes from CHO (Chinese Hamster Ovary) cells that stably expressed the cloned human Mu opioid receptor were used in the experiments. Specifically, in a final volume of 0.5 mL, 12 different concentrations of each test compound were incubated with 7.5 ug of CHO cell membranes that stably expressed the human mu opioid receptor. The assay buffer consisted of 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 0.2 mM EGTA, 3 uM GDP, and 100 mM NaCl. The final concentration of [35S]GTPgammaS was 0.080 nM. Nonspecific binding was measured by inclusion of 10 uM GTPgammaS. Binding was initiated by the addition of the membranes.;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3886239;BindingDB Database;4;0;285.34;26.17;0.49;6.27;14.11;1.2;Homo sapiens;;;CHO;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35;;;2015;37;UO_0000065;False
CHEMBL80;IC50;=;94.84;nM;7.02;;Naloxone;CHEMBL4040566;Antagonist activity at recombinant human MOR expressed in HEK293T cells assessed as reduction in DAMGO-induced inhibition of forskolin-stimulated cAMP level preincubated for 15 to 20 mins followed by DAMGO and forskolin addition by GloSensor assay;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL4038325;Scientific Literature;4;0;327.38;21.45;0.4;5.72;10.03;1.3;Homo sapiens;;;HEK-293T;;9606;BAO_0000219;;;;;Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O;;J Med Chem;2017;1;UO_0000065;False
CHEMBL70;IC50;=;2.5;nM;8.6;;Morphine-1;CHEMBL3088793;Displacement of radiolabeled DAMGO from human recombinant mu opioid receptor expressed in OPRM1 cells;cell-based format;CHEMBL233;Mu opioid receptor;Homo sapiens;SINGLE PROTEIN;CHEMBL3085664;Scientific Literature;4;0;285.34;30.15;0.56;7.4;16.25;1.2;Homo sapiens;;;OPRM1;;9606;BAO_0000219;;;;;CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35;;J. Med. Chem.;2013;1;UO_0000065;False
